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 1 
CHAPTER I 
 
INTRODUCTION  
 
Chirality  
Chirality, the existence of mirror-imaged “right-“ and “left-handed” forms of an 
object, exists in many types of matter, from elementary particles and atoms to natural 
objects and galaxies. Molecular chirality is of particular importance because of its 
relevance to life.  More than 90% of natural biomolecules are chiral and more than 70% 
of drugs in the market are chiral. Right-handed and left-handed molecules, known as 
enantiomers, often possess drastically different biological functions. In an extreme 
example, as in the notorious case of thalidomide, one could be beneficial and the other 
harmful.1a Since 1992, the US Food and Drug Administration (FDA) has been enforcing 
the policy of "racemic switch." If only one enantiomer has medical efficacy, either this 
enantiomer must be used singly, or the other enantiomer must be proved harmless before 
marketing. 
  So it is very important to develop methods to obtain single enantiomers, and to develop 
analytical techniques for determination of enantiomeric purity. It is also very necessary to 
develop analytical methods to determine the configuration and conformation of chiral 
molecules. 
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Chiral separation by HPLC 
Chromatography is the fastest, most expedient method to obtain the pure enantiomers 
of a racemate. Chiral chromatography is also the most widely-used analytical method to 
determine enantiomeric purity in the pharmaceutical industry.1b 
Among all the chiral separation chromatographic techniques, HPLC has proven to be 
the most convenient, reproducible and widely applicable methos. Most of the HPLC 
methods employ a chiral selector as the chiral stationary phase (CSP). There are basically 
five types of chiral stationary phase in common use in HPLC2: protein CSP, brush type 
CSP, cellulose and amylase CSP, macrocyclic glycopeptides CSP and cyclodextrin CSP. 
Brush type chiral stationary phase has a lot advantages over other types of CSPs: a 
large number of choices of chiral selectors, excellent column durability, stability in both 
the reversed phase mode and the normal mode and universal solvent compatibility. 
Another advantage is that for a targeted analyte, specific structure of CSP can be 
designed and optimized to achieve very high enantio-selectivity. 
In our study, we are focused on the development of new brush type CSPs with high 
efficiency and versatility. 
 
Chiroptical techniques 
Chiroptical techniques3 refer to optical techniques which use refraction, absorption 
or emission of anisotropic radiation for investigating chiral substances. Chiroptical 
techniques mainly include optical rotation at a fixed wavelength, optical rotatory 
dispersion (ORD), electronic circular dichroism (ECD), vibrational circular dichroism 
(VCD), Raman optical activity (ROA), and circular polarization of luminescence (CPL). 
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In our research, we have combined the use of optical rotation, ECD and VCD techniques 
and DFT calculations for conformational analysis of chiral molecules. 
ECD and VCD 
Circular dichroism (CD) spectroscopy measures differences in the absorption of left-
handed polarized light versus right-handed polarized light which arise due to structural 
asymmetry. The electronic transitions of a chiral molecule give rise to circular dichroism 
(CD) in the visible ultraviolet (VIS-UV) spectral region, which is called ECD, while 
vibrational transitions give rise to CD in the infrared region, which is VCD.   
One of the earliest and most elegant papers dealing with various instrumental 
approaches for the measurement of ECD was published by Cotton in 1896.4  In 1960 
Grosjean and Legrand5 introduced modulation technique to the measurement of CD. ECD 
spectrometers have been widely available for routine measurements since then. A 
diagram of a conventional ECD instrument is shown in Figure 1-1.6 
 
Figure 1-1 A block diagram of a conventional ECD instrument6 
(LCP and RCP are left and right circularly polarized light beams, respectively.) 
 
The first VCD spectrum was measured on a dispersive instrument around 1975.7 The 
first Fourier Transform (FT) VCD instrument was built around 1979.8 The FT-VCD 
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instrument has throughout and multiplex advantages compared to a dispersive instrument. 
The application of dual polarization modulation technique further improves the baseline 
in VCD measurement.9 
Figure 1-2 shows a general diagram of FT-VCD instrument. The infrared radiation 
passes through an interferometer and the light is then polarized by a linear polarizer and a 
photoelastic modulator (PEM), which is used to generate the circularly polarized 
radiation.. The circularly polarized light then passes through the sample and a second 
PEM, which cancels out the linear birefringence intensity. The light is finally focused on 
the detector. The signal is amplified by the pre-amplifier and separated by the electronic 
filter to a low frequency DC signal, which is a normal absorption spectrum, and a high 
frequency AC signal, which is related to the VCD spectra. Two lock-in-amplifier (LA) 
are used in measurement of the differential signal. The Fourier transform is done by the 
computer and the raw signal is demodulated to get the absorption and VCD spectrum. 
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Figure 1-2. A block diagram of a FT-VCD spectrometer9 
 
 
The interpretation of ECD and VCD spectra has greatly benefited from the 
development of theoretical chemistry, especially the development of density functional 
theory (DFT).10  The theoretical quantity which corresponds to the normal absorption is 
dipole strength (D01) and the theoretical quantity which corresponds to the CD is 
rotational strength (R01). Their expressions are listed in Equations 1-1 and 1-2. Ψ0 and 
Ψ1 are the wave functions of ground and excited states respectively. µ and m are electric 
dipole moment and magnetic dipole moment operators. 
 
 
 
 
  By combining the experimental spectra with theoretical prediction, ECD and VCD can 
be used as a powerful tool in studying the absolute configuration and conformation of 
(1-1) 
(1-2) 
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chiral molecules. Furthermore, ECD and VCD can be used in conformational analysis of 
biological molecules, such as peptides, proteins and nucleic acids.  In my study, VCD, 
combined with DFT calculation, is used to study the conformation of small chiral 
molecules. ECD and VCD are also used for conformational analysis of biomolecules. 
Optical Rotation 
Optical rotation is a century old technique which measures the rotation of linearly 
polarized light after it passes through a chiral sample.11  The sign of optical rotation is 
related to the absolute configuration of chiral molecules. Optical rotation plays an 
important role in the development of modern stereochemistry and is widely used in the 
organic labs. Although the measurement of optical rotation is very simple, the theoretical 
prediction of optical rotation is rather complex. The first ab initio prediction of optical 
rotation was published at 1997.12  The density functional theory also was applied in 
prediction of optical rotaiton.13 The quantum chemistry quantity related to optical rotation 
is the electric dipole-magnetic dipole polarizability tensor as shown in Equation 1-3.14 µ 
and m are electric dipole moment and magnetic dipole moment operators. 0sψ and 0nψ are 
the wave functions of ground and excited electronic state. nsω relates to the excitations 
energy between n and s. ω  is the angular frequency of exciting radiation, which is 
usually the sodium D line. 
(1-3) 
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  The specific rotation in units of deg·cm3·g-1·dm-1 can be related to G’ by Equations 1-4 
and 1-5, where 
_
ν  is wavenumber where the optical rotation is measured. n is refractive 
index and M is concentration in g·mol-1. 
In my study, optical rotation is used as a tool to research the conformation of small 
chiral molecules and biomolecules. The combination use of multiple chiroptical 
techniques will provide a powerful and convenient tool for stereochemistry research. 
 
Instruments 
A Beckman HPLC system consisting of two 126 pumps, a 507 auto-sampler and a 166 
UV detector, and controlled by Gold system, was used for all of the chromatography. 
The ECD was measured on a JASCO J720 spectropolarimeter (Jasco, Easton, MD). 
The sample solutions (100 µL) were held in a circular quartz cell with a path length of 
100-µm.   
The VCD was measured on a modified commercial Chiralir (BioTools, Wauconda IL) 
VCD instrument which has dual PEMs. The instrument has a ZnSe beam splitter (BS) 
and BaF2 polarizer. The detector is a 2X2mm mercury cadmium telluride (HgCdTe) 
detector which needs to be kept at liquid nitrogen temperature. The PEMs are PEM-80 
and PEM-90 (Hinds Instrument, Hillsboro, OR) without antireflection coating on the 
ZnSe optical element. Samples were held in variable pathlength cell with BaF2 windows 
or fixed pathlength cell with BaF2 windows. 
(1-4) 
(1-5) 
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The optical rotation was recorded on either Autopol III or Autopol IV polarimeter 
(Rudolph, Hackettstown, NJ). Samples were held in a 0.5dm cell with quartz windows. 
More detailed experimental condition will be given out in the following chapters. 
 
Calculation 
The theoretical prediction was carried out using Gaussian 98 or 0315 software package. 
More detailed calculation details will be given out in the following chapters. 
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CHAPTER II 
 
EVALUATION OF NEW L-PROLINE BASED CHIRAL STATIONARY PHASES 
FOR THE RESOLUTION OF ENANTIOMERS 
 
 
Introduction 
  One of the most challenging goals relating to the use of enantio-selective HPLC for 
the resolution of racemic mixtures is the development of chiral stationary phases (CSPs) 
capable of separating the enantiomers of a wide variety of structurally different racemates. 
Through significant efforts by many research groups, a number of CSPs of efficiency and 
versatility have been developed, many of which are commercially available now.1 
There are basically five types of chiral stationary phase in common use in LC 2. The 
first type is the protein stationary phases.3 These stationary phases were the first to be 
developed and usually take the form of natural proteins bonded to a silica matrix. These 
stationary phases are used with mobile phases with a high water content (mostly > 90%) 
and thus separations are largely by dispersive interactions. There are three commonly 
used commercial protein type stationary phases, α1-acid glycoprotein phase (CHIRAL-
AGP), cellobiohydralase (CHIRAL-CBH) and human serum albumin (CHIRAL-HSA). 
The second type of chiral stationary phase consisted of relatively small molecular weight 
chiral substances bonded to silica 4. It is called brush type CSP. There are quite a large 
number of small chiral molecules that are used as chiral selectors for brush type 
stationary phase. These types of stationary phases can be operated either in the reversed 
phase mode or the normal mode. The most popular brush type stationary phase today is 
the Whelk-O1 CSP developed by Pirkle. The third type is cellulose and amylose 
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stationary phase 5. Polymers of cellulose and amylose are derived to link appropriate 
interactive groups and then they are coated onto a silica support. Hexane-alcohol 
mixtures are usually employed as the mobile phase, so separations largely depend on 
polar interactions. There are more than 20 commercial columns available for cellulose 
and amylose phases. Among them, CHIRALPAK AD and CHIRALPAK OD are most 
widely used. The fourth type is the macrocyclic glycopeptides stationary phase 
introduced by Armstrong 6. These are materials that contain a large number of chiral 
centers, together with molecular cavities in which solute molecules can enter and interact 
with neighboring groups. The macrocyclic glycopeptides are chemically bonded to silica 
gel. Three popular materials are Vancomycin and Teicoplanin and Avoparcin. The two 
best macrocyclic glycopeptides stationary phase are Chirobiotic V (Vancomycin) and 
Chirobiotic T (Teicoplanin). The fifth type is the cyclodextrin stationary phase.7 The 
stationary phase is chemically bonded to a silica substrate. The cyclodextrin phases can 
be made from α, β or γ- cyclodextrins and offer a large number of chiral centers and 
contain a number of substantially deep inclusion centers that augment spatial selectivity. 
α, β and γ- cyclodextrins are the basis for the production of the CYCLOBOND І, 
CYCLOBOND П and CYCLOBOND Ш stationary phases, respectively. 
Despite these advances in the development of CSPs, new CSPs with excellent 
versatility and enantio-discriminating abilities are still in great demands because more 
and more single-enantiomer chiral compounds are needed by chemical industry, 
especially drug industry. Chiral stationary phase method is still the best way to determine 
enantiomeric purity of chiral compounds.  And it is also the fastest, most expedient 
method to obtain the pure enantiomers. 
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Brush type chiral stationary phase has some advantages over other types of CSPs. 
Firstly, there are quite a large number of small chiral molecules that are used as chiral 
selectors for this kind of stationary phase so it is very promising to design and develop 
new brush type stationary phases. And bush type stationary phases are covalently bonded 
to the silica, providing excellent column durability.  Furthermore, brush type stationary 
phases are stable to use either in the reversed phase mode or the normal mode. They can 
stand most of the widely used solvents for HPLC. Another advantage is that for a targeted 
analyte, specific structure of CSP can be designed and optimized to achieve very high 
enantio-selectivity. 
Our research is focused on the development of new brush type CSPs with high 
efficiency and versatility. L-proline structure is chosen as the key element in our design 
of new CSPs. Proline is a unique amino acid in many ways. Instead of having a primary 
amino group, as in other α-amino acids, it contains a secondary amine. Because of the 
cyclic structure, rotation around the nitrogen-α-carbon bond is restricted. Also because of 
the cyclic structure,  proline is not ideally suited for α-helix or β-sheet conformation; 
instead, oligoproline and polyproline form unique helical conformations (polyproline I，
or polyproline II, or both depending on preparation methods, states and solvents). 8 
Haurou et al prepared 4 CSPs containing benzyloxycarbonyl L-proline or tert-
butoxycarbonyl L-proline as chiral selector 9. The enantiomeric separation of a series of 
N-3,5-dinitrobenzyl amino acid esters was investigated using this CSPs. The influence of 
the amino acid, spacer and protective group of CSPs on the retention and selectivity was 
studied.  
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Pirkle et al also did some research on L-proline derived chiral stationary phases 
before10-14. They first designed two CSPs containing 3,5-dimethyl anilides of L-proline, 
which were used to separate the enantiomers of N-(3,5-dinitrobenzoyl)amino acid esters 
and amides and related analytes. They also investigated the effects of intercalative 
processes on chiral recognition with these two CSPs. Then they designed a CSP 
containing 3,5-dimethoxyl anilides of proline for use in the preparative chromatographic 
separation of enantiomers of two chiral selectors for commercial CSPs. 
For the L-proline based CSPs in the previous study, there is only one residue of L-
proline in the structure of chiral selector. In our study, more residues of L-prolines are 
adopted in the design of CSPs. Peptide structures are formed for the chiral selectors of 
CSPs with more residues of L-prolines. It turns out from our results that these peptide 
structures are one of the key factors to achieve good versatility and enantio-selectivity for 
these CSPs.  In previous study, the chiral selectors were prepared in solution and then 
were coupled to the silica gel support. In our study, solid phase synthesis technique is 
adopted to prepare the CSPs. It is a simpler and more efficient method without the 
purification of compounds between steps in the synthesis. In previous study, separation of 
quite a narrow range of racemic compounds were investigated for the L-proline based 
CSPs.  A wide range of analytes with diverse structures are chosen to test the versatility 
of L-proline based CSPs in our study. 
 In our research, 17 L-proline based CSPs, which have different support, linker, 
number of L-proline units and end group were designed, prepared and evaluated. 22 
kinds of analytes were used to investigate the versatility and enantio-selectivity of these 
CSPs. The influence of these structural components on separation abilities of CSPs was 
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investigated. And effects of modification of L-proline residue and mobile phase system 
on the versatility and enantio-selectivity of CSPs were also investigated. The versatility 
and separation ability of the best CSP among them was compared with 3 commercial 
CSPs to study the possibility of developing this type of CSP into commercial CSPs. 
 
Experimental  
 
General supplies and equipment 
Fmoc-L-proline-OH, N-α-Fmoc-O-t-butyl-trans-4-L-Hydroxyproline, and coupling 
reagents were purchased from NovaBiochem (San Diego, CA). All other chemicals and 
solvents were purchased from either Aldrich&Sigma (Milwaukee, WI), Fluka 
(Ronkonkoma, NY), or Fisher Scientific (Pittsburgh, PA). For three commercial chiral 
columns: CHIRALPAK OD-H(150×4.6 mm), CHIRALPAK AD-H(250×4.6 mm) were 
purchased from Daicel Chemical IND., LTD and Whelk-O2(250×4.6 mm) was purchased 
from Regis Technologies, Inc.(Morton Grove, IL). 
For analytes, 1,2,3,4-Tetrahydro-4-(4-methoxyphenyl)-6-methyl-2-thioxo-5-
pyrimidinecarboxylic acid ethyl ester, 1,2,3,4-Tetrahydro-4-(4-hydroxyphenyl)-6-methyl-
2-thioxo-, 5-Pyrimidinecarboxylic acid ethyl ester, 5-Methyl-5-(2,5-
dichloro)phenylhydantoin and 5-Methyl-5-phenyl hydantoin were synthesized by Dr. 
Yan Wang in our group. Temazepam was offered by Dr. David M. Hercules. Mephentoin 
was purchased from MicroSource Discovery Systems, Inc (Gaylordsville, CT). Other 
analytes were purchased from Aldrich&Sigma(Milwaukee, WI).  
HPLC grade Kromasil silica gel (particle size 5 µm, pore size 100 Å, and surface area 
298 m2/g) was purchased from Akzo Nobel(EKA Chemicals, Bohus, Sweden). PRP-1 
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resin(particle size 7µm, pore size 100 Å, and surface area 396 m2/g) was purchased from 
Hamilton(Reno, NV, USA). A Beckman HPLC system consisting of two 126 pumps, a 
507 auto-sampler and a 166 UV detector, and controlled by Gold system, was used for all 
of the chromatography. Elemental analysis was conducted by Atlantic Microlab, Inc. 
(Norcross, GA). UV spectra were obtained with a Shimadzu UV 201 spectrometer (cell 
volume 3 mL; cell pass-length 10 mm).  
 
Preparation of CSPs 
Preparation of Piv-Pro-Pro-N(Me)-Ahx-PRP1(CSP-1) 
(1). Preparation of amino-PRP-1 resin 
To 8.0g of PRP-1 resin(7µm, 100Å) in 160mL anhydrous DCM were added N-
(chloromethyl)phthalimide(4.0g, 20mmol) and anhydrous iron(Ш) chloride(0.4g, 
2.4mmol). After stirring at r.t. under argon for 10h, the resin was collected by filtration 
and washed with dioxane, 10%(V/V) concentrated hydrochloric acid in dioxane, water 
and methanol. The resulting resin was then refluxed with 20ml hydrazine in 80mL 
methanol and 80mL THF for 24h. The desired amino-PRP-1 resin was collected by 
filtration and washed with hot ethanol, hot methanol, DMF and DCM. The resin was 
dried under vacuum overnight, and the surface loading of amino group was determined to 
be 1.26mmol/g by Elem. Anal.(N:1.76). 
(2). Synthesis of Fmoc-N(Me)-Ahx-OH 
A solution of 100mmol(12.72g) of N-methylcaprolactam in 200ml of concentrated 
hydrochloric acid was stirred at r.t. for 1 h, and then heated to reflex for 24 h. The 
solution was washed with ethyl acetate, and after evaporation under vacuum, the residue 
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was crystallized in the mixture of ethanol and ether. 6-Methylamino hexanoic acid 
hydrochloride was isolated with 88% yield, as a white solid, m.p. 66~67ºC. 1H 
NMR(D2O): δ 1.31(m, 2H), 1.57(m, 4H), 2.31(t, J=7.3Hz, 2H), 2.60(s, 3H), 2.93(t, 
J=7.6Hz, 2H). 
  To a stirred solution of 6-Methylamino hexanoic acid hydrochloride(35mmol, 6.36g) 
and sodium hydroxide(70mmol) in 100ml of water was added gradually Fmoc-OSu(30 
mmol, 10.12g) in 100ml of THF. After being stirred at r.t. for 8h, the reaction mixture 
was acidified to pH 2 with concentrated hydrochloric acid. The solution was exacted with 
ethyl acetate(3×100 mL), and the organic extract phase was washed with water and then 
dried over anhydrous sodium sulfate. After evaporation of the solvent the crude product 
was obtained. It was purified by flash column chromatography on silica gel (mobile 
phase 10% methanol in DCM) to give the desired compound as a colorless oil(9.04g, 
82% yield),  1H NMR(CD2Cl2): δ 1.1~1.7(m, 6H), 2.37(m, 2H), 2.8~3.3(m, 5H), 
4.2~4.6(m, 3H), 7.2~7.9(m, 8H). 
(3). Preparation of the CSP of Piv-Pro-Pro-N(Me)-Ahx-PRP1 
To a 50mL peptide synthesis vessel were added amino-PRP1 resin(2.00g, 2.52mmol of 
amino group), Fmoc-N(Me)-Ahx-OH(5equiv,4.63g), HOBt(3eqiv., 1.16g), 20mL of 
DMF and 20mL of DCM. After shaking for 5min, DIC(5eqiv., 1.59g) was added and 
then the mixture was agitated at r.t. for 8h. The resin was collected by filtration and 
washed with DMF, Methanol, and DCM(30mL×3). The unreacted free amine group on 
the silica gel was end-capped by reacting with acetic anhydride and pyridine in 
DCM(3:2.5:30, V/V/V). The surface Fmoc-N(Me)-Ahx concentration was determined to 
be 0.58mmol/g based on the Fmoc cleavage method. Then the Fmoc protecting group 
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was removed by treatment of the silica with 10mL of 20%(V/V) piperidine in DMF for 
1h to get NH(Me)-Ahx-PRP1.  
To 1.0g of NH(Me)-Ahx-PRP1 prepared above(loading: 0.58mmol/g)were added 
mixtures of Fmoc-Pro-OH(3equiv, 0.78g), HATU(3equiv,.0.88g), and DIPEA(3equiv., 
0.40g) in 8mL of DMF. After agitating for 6h, the silica was filtered and washed with 
DMF, Methanol and DCM. The surface Pro concentration was determined to be 
0.49mmol/g based on the Fmoc cleavage method. Then the Fmoc protecting group was 
removed by 20%(V/V) piperidine in DMF. The second module of Fmoc-Pro-OH was 
coupled following an identical reaction. The surface Pro concentration was determined to 
be 0.52 mmol/g. Then the Fmoc group was removed by 20%(V/V) piperidine in DMF. 
And the resin was end-capped by reacting with trimethylacetic anhydride(0.93g, 5mmol) 
and DIPEA(0.65g, 5mmol) in 10mLof DMF for 3h. The resulting chiral stationary phase 
was packed into a 50×4.6 mm HPLC column using a standard slurry packing method. 
Other CSPs were prepared by following the similar solid phase synthesis procedures 
by Dr. Junmin Huang in our group. 
 
Chromatographic Measurement 
  22 kinds of racemic analytes (see table 2-1) were chosen to test the CSPs. Isocratic 
system of IPA/Hexane  and DCM/Hexane/MeOH were used as the mobile phase. 
  Retention factor (k) equals (tr - t0)/t0, in which tr is the retention time and t0 is the dead 
time. Dead time t0 was measured with 1,3,5-tri-tert-butylbenzene as the void volume 
marker. Separation factor(α) equals k2/k1, in which k1 and k2 are the retention factors of 
two enantiomers. 
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Results and discussion 
  Generally the structures of the proline-based CSPs in our study are composed of four 
parts: support, linker, proline residue and end group. Each CSP differs in some parts from 
others. Two kinds of support: APS (aminopropyl silica gel)and  a high performance 
cross-linked polystyrene support  PRP-1 resin, two linker molecules with a chain of 6 
carbon atoms: -N(Me)-Ahx-(methylamino hexanoyl) and –NH-Ahx-(amino hexanoyl), 
1,2, 4 and 6 residues of prolines, and 8 kinds of ending group: Fmoc(9-
fluorenylmethoxycarbonyl), Boc(tert-butyloxycarbonyl), Cbz(benzyloxycarbonyl), 
Piv(pivaloyl), Aca(9-anthracenecarboxylyl), Tapa( (-)-2-(2,4,5,7-Tetranitro-9-
fluorenylideneaminooxy)propionyl),  Dmb(dimethylbenzyl) and Tpa(triphenyl acetyl) 
were studied in our research. CSPs containing t-butyl-trans-4-L-Hydroxyproline structure 
were also prepared and evaluated in the study. 
According to the chiral interaction model, a minimum of three interaction sites 
between chiral selector and analyte is needed to achieve enantio-selective recognition. 
Most L-proline based CSPs in our study can have hydrogen bonding interaction, pi-pi 
interaction and steric hindrance with analytes. 
  Resolution of 22 kinds of racemic analytes (their structures are shown in table 2-1.) 
was tested by these CSPs. These analytes include alcohol and their derivatives, axially 
and planar dissymmetric compounds, 4-aryldihydropyrimidine derivatives, 5-
arylhydantoin derivatives and miscellaneous compounds. These analytes were chosen 
based on not only the pharmaceutical importance but also their structural diversity.  
The influence of structural components(support, linker, number of L-proline units and 
end group), modification of L-proline structure, and mobile phase system on the 
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versatility and enantio-selectivity of CSPs was investigated.  The versatility and enantio-
selectivity of the most powerful CSP among the 17 was also compared with those of  3 
commercial CSPs to investigate the possibility of developing proline-based CSP into a 
commercial one .  
 
1. Influence of structural components on separation abilities of CSPs 
(1). Support  
    Two CSPs were used to study the effects of support on chiral discrimination. Their 
structures are shown in Figure 2-1. For CSP-1and CSP-2, they both have the linker of -
N(Me)-Ahx-, 2 residues of L-proline and Piv end group. The only difference is the 
support.  
 
 
Figure 2-1 Structures of CSP-1 and CSP-2  
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The separation results for the 22 racemic analytes using these 2 CSPs are summarized 
on Table 2-1. The names and structures of analytes, separation factors, retention factors 
and mobile phase conditions are listed on this table. 
  By comparison of results of CSP-1 and CSP-2, aminopropyl silica gel seems to be a 
better support for these CSPs. 15 analytes were successfully separated by Piv-Pro-Pro-
N(Me)-Ahx-APS(CSP-1) while only 6 analytes were resolved by Piv-Pro-Pro-N(Me)-
Ahx-PRP1(CSP-2). This may be resulted from the fact that aminopropyl silica gel is 
hydrophilic and have a relatively rigid structure while PRP-1 resin is hydrophobic and its 
structure is more flexible. The hydrophilic and rigid support enhances chiral interaction 
between analytes and chiral selectors.  
 
 21 
Table2-1 Comparison results for CSP-1 and CSP-2 
 
 
Analyte name Analyte Structure CSP-1 CSP-2 
Benzoin OH
O  
αa: 1.12 
k1
b:6.34  
3%IPA 
in 
hexanec 
α: 1.41 
k1:6.40  
3%IPA 
in 
hexane 
Hydrobenzoin OH
OH
 
α: 1.22 
k1:17.00  
4%IPA 
in 
hexane 
α: 1 
k1:21.40  
4%IPA 
in 
hexane 
Benzoin oxime OH
N
OH  
α: 1.12 
k1:14.65 
20%IPA 
in 
hexane 
α:1 
k1:13.04 
20%IPA 
in 
hexane 
2,2,2-Trifluoro-1- 
(9-anthryl) 
ethanol 
F3C
OH  
α: 1.58 
k1:22.40  
10%IPA 
in 
hexane 
α: 1.61 
k1:17.40  
10%IPA 
in 
hexane 
 a-(pentafluoroethyl)- 
a-(trifluoromethyl)- 
Benzenemethanol 
F3C C2F5
OH  
α: 1.14 
k1:8.89  
3%IPA 
in 
hexane 
α: 1.18 
k1:6.80  
3%IPA 
in 
hexane 
Warfarin O O
OH O
 
α: 1.20 
k1:12.41  
10%IPA 
& 
1% 
AcOH in 
hexane 
α: 1 
k1:11  
10%IPA 
& 
1% 
AcOH in 
hexane 
Sec-Phenethyl  
alcohol 
OH
 
α: 1.08 
k1:8.42  
1%IPA 
in 
hexane 
α: 1 
k1:9.44  
1%IPA 
in 
hexane 
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Table 2-1 continued. 
 
α-Methyl-2-  
Naphalenemethanol OH
 
α: 1 
k1:17.31  
1%IPA in 
hexane 
α: 1 
k1:21.54  
1%IPA in 
hexane 
1-Acenaphthenol OH
 
α: 1 
k1:10.78  
3%IPA in 
hexane 
α: 1 
k1:14  
3%IPA in 
hexane 
3-Phenyl-Glycidol O
OH
 
α: 1 
k1:11.13  
3%IPA in 
hexane 
α: 1 
k1:15.4  
3%IPA in 
hexane 
1,1'-Bi-2-naphthol 
OH
OH
 
α: 1.34 
k1:20.90  
75%IPA 
in hexane 
α: 1.19 
k1:21  
75%IPA 
in hexane 
2,2'-Dihydroxy- 
5,5',6,6',7,7',8,8'- 
Octahydro-1,1'-binaphthyl OH
OH
 
α: 1.08 
k1:17.92  
10%IPA 
in hexane 
α: 1 
k1:10.9  
10%IPA 
in hexane 
1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinecarboxylic 
acid ethyl ester 
 
 
 
N
H
NH
OMe
S
O
EtO
 
α: 1.30 
k1:11.34  
15%IPA 
in hexane 
α: 1.21 
k1:24  
15%IPA 
in hexane 
1,2,3,4-Tetrahydro-4- 
(4-hydroxyphenyl)- 
6-methyl-2-thioxo-, 5-
Pyrimidinecarboxylic 
acid ethyl ester 
 
 
 N
H
NH
OH
S
O
EtO
 
α: 1.49 
k1:39.00  
30%IPA 
in hexane 
α: 1.46 
k1:35.00  
30%IPA 
in hexane 
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Table 2-1 continued. 
1-[1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinyl]ethanone 
N
H
NH
OMe
S
Ac
 
α: 1.29 
k1:26.27  
15%IPA 
in hexane 
α: 1 
k1:27.00  
15%IPA 
in hexane 
Hexobarbital 
NH
O
N
O
O  
α: 1 
k1:11.51  
1%IPA 
in hexane 
α: 1 
k1:13.80  
1%IPA 
in hexane 
Temazepam  
Ph
N
N
O
OH
Cl
 
α: 1 
k1:17.73  
2%IPA 
in hexane 
α: 1 
k1:16.20  
2%IPA 
in hexane 
5-Methyl- 
5-(2,5-dichloro) 
phenylhydantoin 
NH
HN
O
O
Cl
Cl
 
α: 1.30 
k1:10.00  
15%IPA 
in hexane 
α: 1 
k1:9.4  
15%IPA 
in hexane 
5-Methyl-5-phenyl 
hydantoin NH
HN
O
O
 
α: 1.18 
k1:17.91  
8%IPA 
in hexane 
α: 1 
k1:17.40  
8%IPA 
in hexane 
Mephentoin 
N
HN
O
O
Et
 
α: 1 
k1:5.73  
2%IPA 
in hexane 
α: 1 
k1:6.80  
2%IPA 
in hexane 
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Table 2-1 continued. 
 
 
 
 
 
 
 
 
 
a. separation  factor; b. retention factor of the first eluted enantiomer; c. IPA percentage in hexane 
of the mobile phase 
 
 (2). linker 
    4 CSPs are used to investigate the influence of linker structure on versatility and 
enantio-discrimination. Their structures are shown in Figure 2-2.  For CSP-3 and CSP-4, 
they both have APS as the support, 1 residue of L-proline and Fmoc as end group. The 
only structural difference between CSP-3 and CSP-4 lies in the linker part: for CSP-3, 
NH-Ahx is used as the linker while N(Me)-Ahx is used as the linker for CSP-4. CSP-5 
and CSP-6 with 2 residues of L-proline also only differ in the linker in their structures.  
  The separation results using these 4 CSPs are summarized on Table 2-2. By 
comparison of results of CSP-3 and CSP-4, and results of CSP-5 and CSP-6 respectively, 
it can be concluded that the N-methyl group in the linker(N(Me)-Ahx) plays a key role in 
the resolution of racemic analytes. Fmoc-Pro-N(Me)-Ahx-APS(CSP-4) resolved 6 
analytes while Fmoc-Pro-NH-Ahx-APS(CSP-3) could only separate 1, and Fmoc-Pro-
Pro-N(Me)-Ahx-APS(CSP-6) separated 16 analytes while Fmoc-Pro-Pro-NH-Ahx-
APS(CSP-5) could only resolve 4 ones. The N-methylamino acid linker does not 
introduce a hydrogen-bonding donor NH group next to the Pro residue and a potential 
sec-Butyl carbanilate 
O
O
N
H
 
α: 1 
k1:9.04  
1%IPA 
in 
hexane 
α: 1 
k1:7.00  
1%IPA 
in 
hexane 
Methyl Mandelate OH
COOMe
 
α: 1.23 
k1:9.00  
1%IPA 
in 
hexane 
α: 1 
k1:13.40  
1%IPA 
in 
hexane 
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source of nonspecific interaction due to hydrogen bonding is removed. The methyl group 
increases the steric hindrance near a chiral center which could amplify chiral recognition. 
The methyl group could also influence the rotation barrier of the amide bond that has 
partial double bond character.   
For Fmoc-Pro-N(Me)-Ahx-APS(CSP-4) and Fmoc-Pro-Pro-N(Me)-Ahx-APS(CSP-6), 
there is a big difference on their versatility and enantio-selectivity so the number of L-
proline units also has great effects on the separation abilities of the CSPs.  
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Figure 2-2 Structures of CSP-3 ~ CSP-6
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Table 2-2 Comparison results for CSP-3 ~ CSP-6 
Analyte name CSP-3 CSP-4 CSP-5 CSP-6 
Benzoin α: 1a 
k1:3.26 
b 
3%IPA c 
α: 1 
k1:5.78  
3%IPA 
α: 1 
k1:3.93  
3%IPA  
α: 1.07 
k1:8.22  
3%IPA  
Hydrobenzoin α: 1 
k1:9.33  
4%IPA  
α: 1 
k1:17.71  
4%IPA  
α: 1 
k1:27.45  
4%IPA  
α: 1.12 
k1:21.15  
4%IPA 
Benzoin oxime α: 1 
k1:5.00 
20%IPA  
α: 1 
k1:12.28  
20%IPA  
α: 1 
k1:7.69 
20%IPA  
α: 1.09 
k1:16.08  
20%IPA  
2,2,2-Trifluoro-1- 
(9-anthryl) 
ethanol 
α: 1 
k1:5.86  
10%IPA  
α: 1 
k1:16.40  
10%IPA  
α: 1 
k1:9.66  
10%IPA  
α: 1.28 
k1:23.44  
10%IPA  
 a-(pentafluoroethyl)- 
a-(trifluoromethyl)- 
Benzenemethanol 
α: 1 
k1:13.21  
3%IPA  
α: 1 
k1:19.31  
3%IPA  
α: 1 
k1:6.83  
3%IPA  
α: 1.06 
k1:16.08  
3%IPA  
Warfarin α: 1 
k1:11.75  
10%IPA & 
1% 
AcOH  
α: 1 
k1:13.91  
10%IPA & 
1% 
AcOH 
α: 1 
k1:14.12  
25%IPA  
α: 1.11 
k1:10.57  
10%IPA & 
1% 
AcOH  
Sec-Phenethyl  
alcohol 
α: 1 
k1:5.35  
1%IPA  
α: 1 
k1:6.67  
1%IPA  
α: 1 
k1:5.79  
1%IPA  
α: 1.02 
k1:11.3  
1%IPA 
α-Methyl-2-  
Naphalenemethanol 
α: 1 
k1:8.98  
1%IPA  
α: 1 
k1:13.36  
1%IPA  
α: 1 
k1:12.69  
1%IPA  
α: 1 
k1:22.36  
1%IPA 
1-Acenaphthenol α: 1 
k1:5.74  
2%IPA  
α: 1 
k1:7.83  
3%IPA  
α: 1 
k1:7.45 
3%IPA  
α: 1 
k1:13.36  
3%IPA 
3-Phenyl-Glycidol α: 1 
k1:5.73  
3%IPA  
α: 1 
k1:5.23  
3%IPA  
α: 1 
k1:7.31  
3%IPA  
α: 1 
k1:5.64  
3%IPA  
1,1'-Bi-2-naphthol α: 1 
k1:3.23  
75%IPA  
α: 1.04 
k1:11.48  
75%IPA  
α: 1.13 
k1:7.39  
75%IPA  
α: 1.16 
k1:32.80  
75%IPA  
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Table 2-2 continued. 
 
 
a. separation  factor; b. retention factor of the first eluted enantiomer; c. IPA percentage in hexane 
of the mobile phase 
 
2,2'-Dihydroxy- 
5,5',6,6',7,7',8,8'- 
Octahydro-1,1'-
binaphthyl 
α: 1 
k1:5.16  
10%IPA  
α: 1.14 
k1:12.58  
10%IPA  
α: 1.10 
k1:8.38  
10%IPA  
α: 1.17 
k1:11.10  
10%IPA  
1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinecarboxylic 
acid ethyl ester 
α: 1.07 
k1:9.28  
10%IPA  
α: 1.05 
k1:14.81  
15%IPA  
α: 1 
k1:9.00  
15%IPA  
α: 1.18 
k1:18.68  
15%IPA  
1,2,3,4-Tetrahydro-4- 
(4-hydroxyphenyl)- 
6-methyl-2-thioxo-, 5-
Pyrimidinecarboxylic 
acid ethyl ester 
α: 1 
k1:10.93 
30%IPA  
α: 1.12 
k1:44.66  
30%IPA  
α: 1 
k1:24.00  
30%IPA  
α: 1.20 
k1:27.80  
50%IPA  
1-[1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinyl]ethanone 
α: 1 
k1:10.63  
10%IPA  
α: 1 
k1:27.03  
15%IPA  
α: 1 
k1:21.76  
15%IPA  
α: 1.20 
k1:40.60  
15%IPA  
Hexobarbital α: 1 
k1:13.86  
1%IPA  
α: 1 
k1:28.86  
1%IPA  
α: 1 
k1:13.5  
1%IPA  
α: 1 
k1:22.28  
1%IPA  
Temazepam α: 1 
k1:23.23 
2%IPA  
α: 1.09 
k1:22.03  
2%IPA 
α: 1 
k1:22.71  
2%IPA  
α: 1 
k1:25.54  
2%IPA  
5-Methyl- 
5-(2,5-dichloro) 
phenylhydantoin 
α: 1 
k1:9.96  
15%IPA  
α: 1 
k1:11.21  
15%IPA  
α: 1 
k1:7.34  
15%IPA  
α: 1.16 
k1:14.6  
15%IPA 
5-Methyl-5-phenyl 
hydantoin 
α: 1 
k1:8.65  
8%IPA  
α: 1 
k1:16.24  
8%IPA  
α: 1 
k1:12.79  
8%IPA  
α: 1.10 
k1:25.00  
8%IPA  
Mephentoin α: 1 
k1:4.12  
2%IPA  
α: 1 
k1:5.86  
2%IPA  
α: 1 
k1:5.81  
2%IPA  
α: 1.14 
k1:7.86  
2%IPA 
sec-Butyl carbanilate α: 1 
k1:4.18  
1%IPA  
α: 1 
k1:3.62  
1%IPA  
α: 1.20 
k1:4.00  
1%IPA  
α: 1 
k1:7.30  
1%IPA  
Methyl Mandelate α: 1 
k1:5.72  
1%IPA  
α: 1.02 
k1:7.97  
1%IPA  
α: 1.15 
k1:6.41  
1%IPA  
α: 1.10 
k1:10.8  
1%IPA  
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(3). Number of L-Proline units 
  Four CSPs with 1, 2, 4 and 6 L-proline units in their structures were evaluated with 
the 22 analytes. The structures of these four CSPs are shown on Figure 2-3. And the 
separation results for these CSPs are summarized on Table 2-3. 
From the results, as number of L-proline units increased from 1 to 2, then to 4, big 
difference was found in versatility and enantio-selectivity of these three CSPs. For 
versatility, CSP-4(Fmoc-Pro-N(Me)-Ahx-APS) resolved only 6 analytes, while CSP-
6(Fmoc-Pro-Pro-N(Me)-Ahx-APS) separated 16 and CSP-7(Fmoc-Pro-Pro-Pro-Pro-
N(Me)-Ahx-APS) separated 17 out of 22 analytes. For enantio-selectivity, lowest 
separation factors were found for CSP-4. For the 16 analytes resolved by both CSP-6 and 
CSP-7, bigger separation factors were achieved for CSP-7 in most cases.  
 30 
 
Figure 2-3 Structures of CSPs with different number of L-proline units
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    Table 2-3 Comparison results for CSPs with different number of L-proline units 
Analyte name CSP-4 CSP-6 CSP-7 CSP-8 
Benzoin α: 1a 
k1:5.78 
b 
3%IPAc 
α: 1.07 
k1:8.22  
3%IPA  
α: 1.09 
k1:6.35  
3%IPA  
α: 1.12 
k1:16.0  
5%IPA  
Hydrobenzoin α: 1 
k1:17.71  
4%IPA  
α: 1.12 
k1:21.15  
4%IPA 
α: 1.13 
k1:17.98  
4%IPA  
α: 1.15 
k1:25.79  
8%IPA 
Benzoin oxime α: 1 
k1:12.28  
20%IPA  
α: 1.09 
k1:16.08  
20%IPA  
α: 1.13 
k1:15.36  
20%IPA 
α: 1.20 
k1:41.45  
30%IPA  
2,2,2-Trifluoro-1- 
(9-anthryl) 
ethanol 
α: 1 
k1:16.40  
10%IPA  
α: 1.28 
k1:23.44  
10%IPA  
α: 1.56 
k1:18.48  
10%IPA 
α: 1.78 
k1:22.58  
25%IPA  
 a-(pentafluoroethyl)- 
a-(trifluoromethyl)- 
Benzenemethanol 
α: 1 
k1:19.31  
3%IPA  
α: 1.06 
k1:16.08  
3%IPA  
α: 1.10 
k1:8.91  
3%IPA  
α: 1.10 
k1:8.62  
5%IPA 
Warfarin α: 1 
k1:13.91  
10%IPA & 
1% 
AcOH 
α: 1.11 
k1:10.57  
10%IPA & 
1% 
AcOH  
α: 1.08 
k1:11.19  
10%IPA & 
1% 
AcOH 
α: 1.18 
k1:17.50  
10%IPA & 
1% 
AcOH 
Sec-Phenethyl  
alcohol 
α: 1 
k1:6.67  
1%IPA  
α: 1.02 
k1:11.3  
1%IPA 
α: 1.02 
k1:8.07  
1%IPA  
α: 1.04 
k1:19.42  
1%IPA 
α-Methyl-2-  
Naphalenemethanol 
α: 1 
k1:13.36  
1%IPA  
α: 1 
k1:22.36  
1%IPA 
α: 1.04 
k1:17.62  
1%IPA  
α: 1 
k1:18.81  
3%IPA  
1-Acenaphthenol α: 1 
k1:7.83  
3%IPA  
α: 1 
k1:13.36  
3%IPA 
α: 1 
k1:10.28 
3%IPA  
α: 1 
k1:28.06  
3%IPA 
3-Phenyl-Glycidol α: 1 
k1:5.23  
3%IPA  
α: 1 
k1:5.64  
3%IPA  
α: 1 
k1:6.77  
3%IPA 
α: 1 
k1:10.38  
5%IPA  
1,1'-Bi-2-naphthol α: 1.04 
k1:11.48  
75%IPA  
α: 1.16 
k1:32.80  
75%IPA  
α: 1.29 
k1:23.83  
75%IPA  
α: 1.42 
k1:9.94  
90%IPA  
2,2'-Dihydroxy-
5,5',6,6',7,7',8,8'-
Octahydro-1,1'-
binaphthyl 
α: 1.14 
k1:12.58  
10%IPA  
α: 1.17 
k1:11.10  
10%IPA  
α: 1.32 
k1:10.95  
10%IPA  
α: 1.67 
k1:19.75  
25%IPA  
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Table 2-3 continued. 
 
 
a. separation  factor; b. retention factor of the first eluted enantiomer; c. IPA percentage in 
hexane of the mobile phase 
 
1,2,3,4-Tetrahydro-4-(4-
methoxyphenyl)-6- 
methyl-2-thioxo-5-
pyrimidinecarboxylic 
acid ethyl ester 
α: 1.05 
k1:14.81  
15%IPA  
α: 1.18 
k1:18.68  
15%IPA  
α: 1.24 
k1:12.60  
15%IPA  
α: 1.20 
k1:23.53  
15%IPA  
1,2,3,4-Tetrahydro-4-(4-
hydroxyphenyl)- 
6-methyl-2-thioxo-, 5-
Pyrimidinecarboxylic 
acid ethyl ester 
α: 1.12 
k1:44.66  
30%IPA  
α: 1.20 
k1:27.80  
50%IPA  
α: 1.41 
k1:25.07  
30%IPA  
α: 1.32 
k1:30.13  
70%IPA  
1-[1,2,3,4-Tetrahydro-4-
(4-methoxyphenyl)-6-
methyl-2-thioxo-5-
pyrimidinyl]ethanone 
α: 1 
k1:27.03  
15%IPA  
α: 1.20 
k1:40.60  
15%IPA  
α: 1.21 
k1:25.72  
15%IPA 
α: 1.34 
k1:33.90  
25%IPA 
Hexobarbital α: 1 
k1:28.86  
1%IPA  
α: 1 
k1:22.28  
1%IPA  
α: 1 
k1:16.98  
1%IPA  
α: 1 
k1:11.26  
3%IPA  
Temazepam α: 1.09 
k1:22.03  
2%IPA 
α: 1 
k1:25.54  
2%IPA  
α: 1 
k1:20.24  
2%IPA  
α: 1 
k1:25.52  
5%IPA  
5-Methyl- 
5-(2,5-dichloro) 
phenylhydantoin 
α: 1 
k1:11.21  
15%IPA  
α: 1.16 
k1:14.6  
15%IPA 
α: 1.17 
k1:8.55  
15%IPA  
α: 1.34 
k1:11.64  
25%IPA 
5-Methyl-5-phenyl 
hydantoin 
α: 1 
k1:16.24  
8%IPA  
α: 1.10 
k1:25.00 
8%IPA  
α: 1.15 
k1:15.6  
8%IPA 
α: 1.32 
k1:10.7  
20%IPA  
Mephentoin α: 1 
k1:5.86  
2%IPA  
α: 1.14 
k1:7.86  
2%IPA 
α: 1.14 
k1:6.93  
2%IPA 
α: 1.27 
k1:9.85  
3%IPA  
sec-Butyl carbanilate α: 1 
k1:3.62  
1%IPA  
α: 1 
k1:7.30  
1%IPA  
α: 1 
k1:7.64  
1%IPA  
α: 1 
k1:15.34  
3%IPA  
Methyl Mandelate α: 1.02 
k1:7.97  
1%IPA  
α: 1.10 
k1:10.8  
1%IPA  
α: 1.17 
k1:8.31  
1%IPA  
α: 1 
k1:17.49  
3%IPA  
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The number of L-proline units proved important. L-proline peptides are necessary to 
achieve better enantio-selectivity and versatility. With more L-proline units in the 
structure of CSPs, the rigidity of chiral selector is improved. And because of more 
carbonyl groups available in the structure, hydrogen bond interaction between analytes 
and chiral selectors is improved. And better chiral discrimination and versatility can be 
achieved.  
However, as number of L-proline units increased from 1 to 2, then to 4, the retention 
factors did not change much for most analytes. It can be concluded that the achiral 
interaction is not improved much with increasing of number of L-proline units into 4. 
When number of L-proline units increased into 6, more polar mobile phases were 
needed to make sure that analytes could be eluted from the column efficiently and even 
with more polar mobile phase systems retention factors increased greatly. CSP-8(Fmoc-
Pro-Pro-Pro-Pro-Pro-Pro-N(Me)-Ahx-APS) resolved 15 analytes. The versatility 
decreases a little but the separation factors of most analytes increase impressively 
compared with CSP-7. So when number of L-proline units becomes 6, there is 
improvement for both the chiral and achiral interaction between analytes and CSP. 
 
(4) Modification of L-proline structure 
In our study, t-butyl-trans-4-L-Hydroxyproline was chosen to replace the L-proline 
structure for the CSPs. Two CSPs containing t-butyl-trans-4-L-Hydroxyproline structure 
were prepared and evaluated with 22 analytes. The separation results were compared with 
those of CSPs with only L-proline structures. The structures of the four CSPs are shown 
on Figure 2-4. The separation results are summarized on Table 2-4. 
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Figure 2-4 Structures of CSP-5, CSP-6, CSP-9 and CSP-10 
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Table 2-4. Comparison results of CSP-5, CSP-6, CSP-9 and CSP-10 
 
Analyte name CSP-5 CSP-9 CSP-6 CSP-10 
Benzoin α: 1 
k1:3.93  
3%IPA  
α: 1.25 
k1:3.21  
3%IPA  
α: 1.07 
k1:8.22  
3%IPA  
α: 1.08 
k1:6.42  
3%IPA  
Hydrobenzoin α: 1 
k1:27.45  
4%IPA  
α: 1 
k1:13.04  
4%IPA  
α: 1.12 
k1:21.15  
4%IPA 
α: 1.04 
k1:17.95  
4%IPA  
Benzoin oxime α: 1 
k1:7.69 
20%IPA  
α: 1 
k1:6.82 
20%IPA  
α: 1.09 
k1:16.08  
20%IPA  
α: 1 
k1:11.42  
20%IPA  
2,2,2-Trifluoro-1- 
(9-anthryl) 
ethanol 
α: 1 
k1:9.66  
10%IPA  
α: 1 
k1:8.72  
10%IPA  
α: 1.28 
k1:23.44  
10%IPA  
α: 1.34 
k1:10.28  
10%IPA  
 a-(pentafluoroethyl)- 
a-(trifluoromethyl)- 
Benzenemethanol 
α: 1 
k1:6.83  
3%IPA  
α: 1 
k1:5.68  
3%IPA  
α: 1.06 
k1:16.08  
3%IPA  
α: 1 
k1:6.35  
3%IPA  
Warfarin α: 1 
k1:14.12  
25%IPA  
α: 1 
k1:12.61  
25%IPA  
α: 1.11 
k1:10.57  
10%IPA & 
1% 
AcOH  
α: 1 
k1:11.05  
10%IPA & 
1% 
AcOH  
Sec-Phenethyl  
alcohol 
α: 1 
k1:5.79  
1%IPA  
α: 1 
k1:5.79  
1%IPA  
α: 1.02 
k1:11.3  
1%IPA 
α: 1 
k1:7.82  
1%IPA  
α-Methyl-2-  
Naphalenemethanol 
α: 1 
k1:12.69  
1%IPA  
α: 1 
k1:9.88  
1%IPA  
α: 1 
k1:22.36  
1%IPA 
α: 1 
k1:15.28  
1%IPA  
1-Acenaphthenol α: 1 
k1:7.45 
3%IPA  
α: 1 
k1:6.04 
3%IPA  
α: 1 
k1:13.36  
3%IPA 
α: 1 
k1:8.30  
3%IPA  
3-Phenyl-Glycidol α: 1 
k1:7.31  
3%IPA  
α: 1 
k1:7.63  
3%IPA  
α: 1 
k1:5.64  
3%IPA  
α: 1 
k1:8.70 
3%IPA  
1,1'-Bi-2-naphthol α: 1.13 
k1:7.39  
75%IPA  
α: 1 
k1:4.68  
75%IPA  
α: 1.16 
k1:32.80  
75%IPA  
α: 1 
k1:45.07  
25%IPA  
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Table 2-4 continued. 
 
 
a. separation  factor; b. retention factor of the first eluted enantiomer; c. IPA percentage in 
hexane of the mobile phase 
2,2'-Dihydroxy- 
5,5',6,6',7,7',8,8'- 
Octahydro-1,1'-
binaphthyl 
α: 1.10 
k1:8.38  
10%IPA  
α: 1 
k1:6.77  
10%IPA  
α: 1.17 
k1:11.10  
10%IPA  
α: 1.05 
k1:11.07  
10%IPA  
1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinecarboxylic 
acid ethyl ester 
α: 1 
k1:9.00  
15%IPA  
α: 1 
k1:5.22  
15%IPA  
α: 1.18 
k1:18.68  
15%IPA  
α: 1.15 
k1:13.30  
15%IPA  
1,2,3,4-Tetrahydro-4- 
(4-hydroxyphenyl)- 
6-methyl-2-thioxo-, 5-
Pyrimidinecarboxylic 
acid ethyl ester 
α: 1 
k1:24.00  
30%IPA  
α: 1 
k1:15.14  
30%IPA  
α: 1.20 
k1:27.80  
50%IPA  
α: 1.21 
k1:42.56 
50%IPA  
1-[1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinyl]ethanone 
α: 1 
k1:21.76  
15%IPA  
α: 1 
k1:14.79  
15%IPA  
α: 1.20 
k1:40.60  
15%IPA  
α: 1 
k1:29.70  
15%IPA  
Hexobarbital α: 1 
k1:13.5  
1%IPA  
α: 1 
k1:10.95  
1%IPA  
α: 1 
k1:22.28  
1%IPA  
α: 1 
k1:12.02  
1%IPA  
Temazepam α: 1 
k1:22.71  
2%IPA  
α: 1.10 
k1:22.16  
2%IPA  
α: 1 
k1:25.54  
2%IPA  
α: 1.08 
k1:20.56  
2%IPA  
5-Methyl- 
5-(2,5-dichloro) 
phenylhydantoin 
α: 1 
k1:7.34  
15%IPA  
α: 1 
k1:5.47  
15%IPA  
α: 1.16 
k1:14.6  
15%IPA 
α: 1.08 
k1:8.87  
15%IPA  
5-Methyl-5-phenyl 
hydantoin 
α: 1 
k1:12.79  
8%IPA  
α: 1 
k1:11.28  
8%IPA  
α: 1.10 
k1:25.00  
8%IPA  
α: 1.09 
k1:15.84  
8%IPA  
Mephentoin α: 1 
k1:5.81  
2%IPA  
α: 1 
k1:4.44  
2%IPA  
α: 1.14 
k1:7.86  
2%IPA 
α: 1.36 
k1:4.44  
2%IPA  
sec-Butyl carbanilate α: 1.20 
k1:4.00  
1%IPA  
α: 1 
k1:4.02  
1%IPA  
α: 1 
k1:7.30  
1%IPA  
α: 1 
k1:4.86  
1%IPA  
Methyl Mandelate α: 1.15 
k1:6.41  
1%IPA  
α: 1 
k1:7.53  
1%IPA  
α: 1.10 
k1:10.8  
1%IPA  
α: 1 
k1:9.81  
1%IPA  
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By comparison of results of CSP-5 and CSP-9, and results of CSP-6 and CSP-10, it is 
quite clear that modification of  one residue of L-proline into  t-butyl-trans-4-L-
Hydroxyproline in the CSP structure has negative effects on the versatility of CSPs: 
Fmoc-Pro-Pro-NH-Ahx-APS(CSP-5) resolved 4 analytes while Fmoc-(tBu)Hyp-Pro-NH-
Ahx-APS(CSP-9) could resolve 2, and Fmoc-Pro-Pro-N(Me)-Ahx-APS(CSP-6) 
separated 16 analytes while Fmoc-(tBu)Hyp-Pro-N(Me)-Ahx-APS(CSP-10) could only 
separate 10 ones. So addition of the steric group of t-Bu-O- to L-proline in the CSP 
structure does not improve the chiral interaction between analytes and CSPs.  
 
(5.) End group 
9 CSPs with different end groups or with no end group were chosen to investigate the 
influence of end group in the structure of CSP on the enantio-selectivity towards the 22 
analytes. The structure of these 9 CSPs are shown on Figure2-5. 
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Figure 2-5, continued. 
 
 
Figure 2-5 Structures of CSPs with different end groups 
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The comparison results are summarized on Table 2-5. All these 9 CSPs have APS as 
the support, -N(Me)-Ahx- group as the linker and two L-proline units in their structures. 
The only difference is that they have different end groups or no end group. 
For CSP-11(Pro-Pro-N(Me)-Ahx-APS) without any end group in its structure, it has 
worst versatility among the 9 CSPs: only 4 analytes were resolved. So end group is a key 
factor to achieve good versatility for CSPs. 
Among these 9 CSPs, CSP-6 with Fmoc end group has the best versatility. CSP-6 
resolved 16 analytes out of 22 while CSP-1 with Piv group separated 15, CSP-16 with 
Dmb group separated 14, CSP-12 with Boc and CSP-13 with Cbz both resolved 13, CSP-
14 with Aca group and CSP-17 with Tpa group showed separation for 12, and CSP-15 
with Tapa only resolved 8 analytes. 
 For the enantio-selectivity, CSP-1 with Piv group achieved highest separation factors 
for most analytes among these 9 CSPs. By comparing CSP-1 and CSP-12, obviously 
CSP-1 has better versatility and enantio-selectivity. The only difference between the 
structures of these two CSPs is that Boc end group in CSP-12 has oxycarbonyl group 
connected with t-butyl group while Piv in CSP-1 has carbonyl group connected with t-
butyl. Piv increases the rigidity of CSP structure. Rigid structure is helpful to achieve 
better versatility and separation results.  
But versatility and enantio-selectivity are also determined by other factors besides 
rigidity of the structure of CSP. CSP-14 and CSP-17 have rigid structures but they did not 
achieve good versatility and separation results. The Fmoc end group in CSP-6 is not very 
rigid but CSP-6 has the best versatility and good enantio-discrimination.   
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Among these 9 CSPs, CSP-1 does not have aromatic group in its structure but it has 
best enantio-selectivity and good versatility while CSP-14, CSP-15 and CSP-17 possess 
strong aromatic groups but do not achieve good separation results and versatility. So it 
can be concluded that pi-pi interaction is not a key factor to achieve good versatility and 
enantio-selectivity for the proline-based CSPs in our study.  Hydrogen bonding 
interaction and steric hindrance are factors which have greater influence on chiral 
recognition ability of these proline-based CSPs. 
   The separation results of CSP-1 with Piv end group are very promising. CSP-1 
achieved great enantio-selectivity towards most of the analytes. Although versatility of 
CSP-1 is not as good as CSP-6 with Fmoc group, CSP-1 has great potential to separate a 
wider range of analytes and have better durability because Piv group has a more stable 
structure compared with Fmoc group. Fmoc group is  unstable in basic mobile phases or 
in the presence of basic analytes.  
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Table 2-5. Comparison results of CSPs with different end groups 
 
 
 
Analyte name CSP-11 CSP-1 
 
CSP-6 
 
CSP-
12 
CSP-13 CSP-
14 
CSP-
15 
CSP-16 CSP-17 
Benzoin α: 1 
k1:5.84  
3%IPA  
α: 1.12 
k1:6.34  
3%IPA  
α: 1.07 
k1:8.22  
3%IPA  
α: 1.07 
k1:4.45  
3%IPA  
α: 1.08 
k1:6.63  
3%IPA  
α: 1 
k1:7.71  
3%IPA  
α: 1 
k1:19.02  
3%IPA  
α: 1.10 
k1:7.76  
3%IPA  
α: 1.07 
k1:6.00  
3%IPA  
Hydrobenzoin α: 1.07 
k1:16.71  
4%IPA  
α: 1.22 
k1:17.00  
4%IPA  
α: 1.12 
k1:21.15  
4%IPA 
α: 1.11 
k1:10.7
1  
4%IPA  
α: 1.11 
k1:13.33  
4%IPA  
α: 1.10 
k1:16.81  
4%IPA  
α: 1.14 
k1:26.41  
4%IPA  
α: 1.13 
k1:18.09  
4%IPA  
α: 1.16 
k1:15.17  
4%IPA  
Benzoin oxime α: 1 
k1:11.44 
20%IPA  
α: 1.12 
k1:14.65 
20%IPA  
α: 1.09 
k1:16.08  
20%IPA  
α: 1 
k1:10.0
9 
20%IP
A  
α: 1 
k1:12.23 
20%IPA  
α: 1 
k1:13.44 
20%IPA  
α: 1 
k1:16.03 
20%IPA  
α: 1.10 
k1:15.00 
20%IPA  
α: 1.08 
k1:11.71 
20%IPA  
2,2,2-Trifluoro-1- 
(9-anthryl) 
ethanol 
α: 1 
k1:17.23  
10%IPA  
α: 1.58 
k1:22.4  
10%IPA  
α: 1.28 
k1:23.44  
10%IPA  
α: 1.28 
k1:15.0
8  
10%IP
A  
α: 1.33 
k1:15.82  
10%IPA  
α: 1.16 
k1:20.02  
10%IPA  
α: 1.28 
k1:31.59  
40%IPA  
α: 1.30 
k1:20.47  
10%IPA  
α: 1.40 
k1:16.03  
10%IPA  
 a-(pentafluoroethyl)- 
a-(trifluoromethyl)- 
Benzenemethanol 
α: 1 
k1:9.72  
3%IPA  
α: 1.14 
k1:8.89  
3%IPA  
α: 1.06 
k1:16.08  
3%IPA  
α: 1.11 
k1:7.55  
3%IPA  
α: 1.10 
k1:5.76  
3%IPA  
α: 1.06 
k1:6.18  
3%IPA  
α: 1.10 
k1:8.13  
1%IPA  
α: 1.09 
k1:13.80  
3%IPA  
α: 1.09 
k1:5.75  
3%IPA  
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Table 2-5 continued. 
 
Warfarin α: 1 
k1:41.10  
90%IPA  
α: 1.20 
k1:12.41  
10%IPA 
& 
1% 
AcOH  
α: 1.11 
k1:10.57  
10%IPA 
& 
1% 
AcOH  
α: 1 
k1:19.5
3  
25%IP
A  
α: 1.16 
k1:11.55  
10%IPA 
& 
1% 
AcOH  
α: 1.12 
k1:14.34  
10%IPA 
& 
1% 
AcOH  
α: 1 
k1:28.61  
10%IPA 
& 
1% 
AcOH  
α: 1.16 
k1:13.41  
25%IPA  
α: 1.14 
k1:12.68  
10%IPA 
& 
1% 
AcOH  
Sec-Phenethyl  
alcohol 
α: 1 
k1:6.47  
1%IPA  
α: 1.08 
k1:8.42  
1%IPA  
α: 1.02 
k1:11.3  
1%IPA 
α: 1.03 
k1:6.30  
1%IPA  
α: 1 
k1:6.02  
1%IPA  
α: 1 
k1:6.84  
1%IPA  
α: 1 
k1:9.37  
1%IPA  
α: 1 
k1:19.34  
1%IPA  
α: 1 
k1:1.90  
1%IPA  
α-Methyl-2-  
Naphalenemethanol 
α: 1 
k1:15.30  
1%IPA  
α: 1 
k1:17.31  
1%IPA  
α: 1 
k1:22.36  
1%IPA 
α: 1 
k1:13.0
7  
1%IPA  
α: 1.02 
k1:12.96  
1%IPA  
α: 1.10 
k1:14.89  
1%IPA  
α: 1 
k1:17.15  
5%IPA  
α: 1.04 
k1:7.65  
1%IPA  
α: 1 
k1:1.19  
1%IPA  
1-Acenaphthenol α: 1 
k1:8.12  
3%IPA  
α: 1 
k1:10.78  
3%IPA  
α: 1 
k1:13.36  
3%IPA 
α: 1 
k1:7.34 
3%IPA  
α: 1 
k1:8.45 
3%IPA  
α: 1 
k1:11.04  
3%IPA  
α: 1 
k1:21.41 
7%IPA  
α: 1 
k1:13.90 
3%IPA  
α: 1 
k1:8.95 
3%IPA  
3-Phenyl-Glycidol α: 1 
k1:9.54  
3%IPA  
α: 1 
k1:11.13  
3%IPA  
α: 1 
k1:5.64  
3%IPA  
α: 1 
k1:10.7
5  
3%IPA  
α: 1 
k1:9.12  
3%IPA  
α: 1 
k1:11.29  
3%IPA  
α: 1 
k1:20.85  
3%IPA  
α: 1 
k1:15.49  
3%IPA  
α: 1 
k1:9.78  
3%IPA  
1,1'-Bi-2-naphthol α: 1.05 
k1:13.31  
75%IPA  
α: 1.34 
k1:20.90  
75%IPA  
α: 1.16 
k1:32.80  
75%IPA  
α: 1.17 
k1:13.2
1  
75%IP
A  
α: 1.17 
k1:17.07  
75%IPA  
α: 1.35 
k1:15.73  
75%IPA  
α: 1 
k1:28.63  
75%IPA  
α: 1.18 
k1:21.89  
75%IPA  
α: 1.30 
k1:19.51  
75%IPA  
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Table 2-5 continued. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2,2'-Dihydroxy-
5,5',6,6',7,7',8,8'-
Octahydro-1,1'-
binaphthyl 
α: 1 
k1:13.03  
10%IPA  
α: 1.08 
k1:17.92  
10%IPA  
α: 1.17 
k1:11.10  
10%IPA  
α: 1.06 
k1:8.80  
10%IPA  
α: 1.14 
k1:12.16  
10%IPA  
α: 1.33 
k1:12.33  
10%IPA  
α: 1.34 
k1:7.83  
10%IPA  
α: 1.24 
k1:13.54  
10%IPA  
α: 1 
k1:12.73  
10%IPA  
1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinecarboxylic 
acid ethyl ester 
α: 1 
k1:11.52  
10%IPA  
α: 1.30 
k1:11.34  
15%IPA  
α: 1.18 
k1:18.68  
15%IPA  
α: 1.19 
k1:7.91  
15%IPA  
α: 1.15 
k1:12.93  
15%IPA  
α: 1.22 
k1:13.36  
15%IPA  
α: 1.48 
k1:23.07  
15%IPA  
α: 1.19 
k1:14.24  
15%IPA  
α: 1.26 
k1:9.61  
15%IPA  
1,2,3,4-Tetrahydro-4- 
(4-hydroxyphenyl)- 
6-methyl-2-thioxo-, 5-
Pyrimidinecarboxylic 
acid ethyl ester 
α: 1.07 
k1:36.72  
70%IPA  
α: 1.49 
k1:39.00  
30%IPA  
α: 1.20 
k1:27.80  
50%IPA  
α: 1.40 
k1:23.11  
30%IPA  
α: 1.36 
k1:31.14  
30%IPA  
α: 1.37 
k1:27.18  
30%IPA  
α: 1.26 
k1:28.56  
40%IPA  
α: 1.40 
k1:24.64  
40%IPA  
α: 1.36 
k1:16.80  
30%IPA  
1-[1,2,3,4-Tetrahydro-
4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinyl]ethanone 
α: 1 
k1:26.54  
10%IPA  
α: 1.29 
k1:26.27  
15%IPA  
α: 1.20 
k1:40.60  
15%IPA  
α: 1.24 
k1:19.00  
15%IPA  
α: 1.11 
k1:32.93  
15%IPA  
α: 1.34 
k1:31.72  
15%IPA  
α: 1 
k1:50.85  
15%IPA  
α: 1.34 
k1:34.45  
15%IPA  
α: 1.23 
k1:17.30  
15%IPA  
Hexobarbital α: 1 
k1:29.92  
1%IPA  
α: 1 
k1:11.51  
1%IPA  
α: 1 
k1:11.88  
1%IPA  
α: 1.22 
k1:7.21  
1%IPA  
α: 1.10 
k1:13.11  
1%IPA  
α: 1 
k1:15.02  
1%IPA  
α: 1 
k1:9.74  
2%IPA  
α: 1 
k1:14.94  
1%IPA  
α: 1 
k1:15.27  
1%IPA  
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Table 2-5 continued. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a. 
separation  factor; b. retention factor of the first eluted enantiomer; c. IPA percentage in hexane of the mobile phase 
Temazepam α: 1 
k1:20.77  
2%IPA  
α: 1 
k1:17.73  
2%IPA  
α: 1 
k1:25.54  
2%IPA  
α: 1 
k1:12.52  
2%IPA  
α: 1 
k1:17.34  
2%IPA  
α: 1 
k1:27.75  
2%IPA  
α: 1 
k1:25.44  
10%IPA  
α: 1 
k1:20.24  
2%IPA  
α: 1 
k1:27.30  
2%IPA  
5-Methyl- 
5-(2,5-dichloro) 
phenylhydantoin 
α: 1 
k1:9.35  
10%IPA  
α: 1.30 
k1:10.00  
15%IPA  
α: 1.16 
k1:14.6  
15%IPA  
α: 1 
k1:12.39  
15%IPA  
α: 1 
k1:15.78  
15%IPA  
α: 1 
k1:8.27  
15%IPA  
α: 1 
k1:7.52  
15%IPA  
α: 1.22 
k1:9.91  
15%IPA  
α: 1.16 
k1:7.30  
15%IPA  
5-Methyl-5-phenyl 
hydantoin 
α: 1 
k1:18.12  
8%IPA  
α: 1.18 
k1:17.91  
8%IPA  
α: 1.10 
k1:10.44  
8%IPA  
α: 1.08 
k1:12.93  
8%IPA  
α: 1.16 
k1:14.71  
8%IPA  
α: 1 
k1:13.54  
8%IPA  
α: 1.16 
k1:13.44  
8%IPA  
α: 1.10 
k1:19.00  
8%IPA  
α: 1 
k1:14.25  
8%IPA  
Mephentoin α: 1 
k1:7.42  
2%IPA  
α: 1 
k1:5.73  
2%IPA  
α: 1.14 
k1:7.86  
2%IPA  
α: 1 
k1:5.43  
2%IPA  
α: 1 
k1:5.43  
2%IPA  
α: 1 
k1:6.27  
2%IPA  
α: 1.10 
k1:9.74  
2%IPA  
α: 1 
k1:8.09  
2%IPA  
α: 1.07 
k1:9.00  
2%IPA  
sec-Butyl carbanilate α: 1.47 
k1:4.09  
1%IPA  
α: 1 
k1:9.04  
1%IPA  
α: 1 
k1:7.30  
1%IPA  
α: 1.04 
k1:5.91  
1%IPA  
α: 1 
k1:5.91  
1%IPA  
α: 1 
k1:7.74  
1%IPA  
α: 1 
k1:11.89  
1%IPA  
α: 1 
k1:9.64 
1%IPA  
α: 1 
k1:9.61  
1%IPA  
Methyl Mandelate α: 1 
k1:9.24  
1%IPA  
α: 1.23 
k1:9.00  
1%IPA  
α: 1.10 
k1:10.8  
1%IPA  
α: 1 
k1:6.50  
1%IPA  
α: 1 
k1:8.46  
1%IPA  
α: 1.10 
k1:6.27  
1%IPA  
α: 1 
k1:19.37  
1%IPA  
α: 1 
k1:19.00  
1%IPA  
α: 1 
k1:17.64  
1%IPA  
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2 Mobile phase 
   Two kinds of mobile phase system: IPA/Hexane and DCM/Hexane/MeOH were 
chosen to investigate the influence of mobile phase conditions on the separation of 
analytes of CSPs. Two CSPs: CSP-7(Fmoc-Pro-Pro-Pro-Pro-N(Me)-Ahx-APS)and CSP-
2(PIV-Pro-Pro-N(Me)-Ahx-PRP-1) were tested using these two mobile phase systems. 
The comparison results are summarized on Table 2-6. 
For CSP-7 with APS as the support, better versatility was achieved in IPA/hexane 
mobile phase system: 17 analytes were separated in IPA/hexane while 15 were resolved 
in the other system. For CSP-2 with PRP-1 as the support, better versatility was got in 
DCM/Hexane/MeOH system: 6 analytes were resolved in IPA/hexane while 8 were 
separated in DCM/Hexane/MeOH.  
By comparison of chromatograms, peak shape in chromatograms of 
DCM/Hexane/MeOH system are better for most analytes. The peaks seem to be sharper 
and narrower in DCM/Hexane/MeOH system for the two CSPs. 
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Table 2-6. Comparison results of CSP-7 and CSP-2 in two types of mobile phase systems 
 
Table 2-6, continued. 
CSP-7 CSP-2 Analyte name 
IPA/Hex DCM/Hex/MeOH IPA/Hex DCM/Hex/MeOH 
Benzoin α: 1.09a 
k1:6.35
b 
3%IPAc  
α: 1.07 
k1:11.61 
5%DCM 
in Hexane  
α: 1.41 
k1:6.40  
3%IPA  
α: 1 
k1:5.04 
10%DCM 
in Hexane 
Hydrobenzoin α: 1.13 
k1:17.98  
4%IPA  
α: 1.12 
k1:12.93  
40%DCM 
in Hexane   
α: 1 
k1:21.40  
4%IPA  
α: 1.16 
k1:5.06  
40%DCM 
in Hexane 
Benzoin oxime α: 1.13 
k1:15.36  
20%IPA 
α: 1.08 
k1:15.85 
100%DCM 
α:1 
k1:13.04 
20%IPA  
α:1 
k1:4.92 
100%DCM 
 
2,2,2-Trifluoro-1- 
(9-anthryl) 
ethanol 
α: 1.56 
k1:18.48  
10%IPA 
α: 1.20 
k1:9.54  
100%DCM 
 
α: 1.61 
k1:17.40  
10%IPA  
α: 1.50 
k1:3.35  
100%DCM 
 a-(pentafluoroethyl)- 
a-(trifluoromethyl)- 
Benzenemethanol 
α: 1.10 
k1:8.91  
3%IPA  
α: 1.06 
k1:28.23  
30%DCM 
in Hexane 
α: 1.18 
k1:6.80  
3%IPA  
α: 1.15 
k1:7.96  
5%DCM 
in Hexane 
Warfarin α: 1.08 
k1:11.19  
10%IPA & 
1% 
AcOH 
α: 1.08 
k1:8.30  
40%DCM 
in Hexane& 
1%AcOH 
α: 1 
k1:11  
10%IPA & 
1% 
AcOH  
α: 1 
k1:7.18 
50%DCM 
in Hexane 
Sec-Phenethyl  
alcohol 
α: 1.02 
k1:8.07  
1%IPA  
α: 1.02 
k1:13.08 
10%DCM 
in Hexane 
α: 1 
k1:9.44  
1%IPA  
α: 1 
k1:5.82 
10%DCM 
in Hexane 
α-Methyl-2-  
Naphalenemethanol 
α: 1.04 
k1:17.62  
1%IPA  
α: 1 
k1:23.66  
10%DCM 
in Hexane 
α: 1 
k1:21.54  
1%IPA  
α: 1 
k1:12.92  
10%DCM 
in Hexane   
1-Acenaphthenol α: 1 
k1:28.46  
3%IPA  
α: 1 
k1:7.31 
30%DCM 
in Hexane   
α: 1 
k1:14  
3%IPA  
α: 1 
k1:3.29  
10%DCM 
in Hexane   
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3-Phenyl-Glycidol α: 1 
k1:6.77  
3%IPA 
α: 1 
k1:7.39  
30%DCM 
in Hexane   
α: 1 
k1:15.4  
3%IPA  
α: 1 
k1:3.80 
10%DCM 
in Hexane 
1,1'-Bi-2-naphthol α: 1.29 
k1:23.83  
75%IPA  
α: 1.06 
k1:12.21  
1%MeOH 
in Hexane   
α: 1.19 
k1:21  
75%IPA  
α: 1.20 
k1:7.51  
30%DCM 
in Hexane 
2,2'-Dihydroxy- 
5,5',6,6',7,7',8,8'- 
Octahydro-1,1'-binaphthyl 
α: 1.32 
k1:10.95  
10%IPA  
α: 1 
k1:12.08  
50%DCM 
in Hexane   
α: 1 
k1:10.9  
10%IPA  
α: 1 
k1:10.67  
50%DCM 
in Hexane 
1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinecarboxylic acid 
ethyl ester 
α: 1.24 
k1:12.60  
15%IPA  
α: 1.18 
k1:6.26  
60%DCM 
in Hexane 
α: 1.21 
k1:24  
15%IPA  
α: 1.26 
k1:22.53  
50%DCM 
in Hexane   
1,2,3,4-Tetrahydro-4- 
(4-hydroxyphenyl)- 
6-methyl-2-thioxo-, 5-
Pyrimidinecarboxylic acid 
ethyl ester 
α: 1.41 
k1:25.07  
30%IPA  
α: 1.19 
k1:12.72  
3%MeOH 
in Hexane   
α: 1.46 
k1:35.00  
30%IPA  
α: 1.40 
k1:3.82  
3%MeOH 
in Hexane 
1-[1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinyl]ethanone 
α: 1.21 
k1:25.72  
15%IPA 
α: 1.22 
k1:12.20  
60%DCM 
in Hexane 
α: 1 
k1:27.00  
15%IPA  
α: 1.31 
k1:8.47  
50%DCM 
in Hexane 
Hexobarbital α: 1 
k1:5.96  
1%IPA  
α: 1 
k1:8.08  
30%DCM 
in Hexane   
α: 1 
k1:13.80  
1%IPA  
α: 1 
k1:1.14  
10%DCM 
in Hexane 
Temazepam α: 1 
k1:20.24  
2%IPA  
α: 1 
k1:4.62  
10%DCM 
in Hexane 
α: 1 
k1:16.20  
2%IPA  
α: 1 
k1:4.24  
30%DCM 
in Hexane 
5-Methyl- 
5-(2,5-dichloro) 
phenylhydantoin 
α: 1.17 
k1:8.55  
15%IPA  
α: 1.12 
k1:13.56  
100%DCM 
α: 1 
k1:9.4  
15%IPA  
α: 1.25 
k1:5.72  
100%DCM 
5-Methyl-5-phenyl 
hydantoin 
α: 1.15 
k1:15.6  
8%IPA\ 
α: 1.11 
k1:18.51 
100%DCM 
 
α: 1 
k1:17.40  
8%IPA  
α: 1 
k1:8.80  
100%DCM 
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Table 2-6 continued. 
 
 
a. separation  factor; b. retention factor of the first eluted enantiomer; c. IPA percentage in 
hexane of the mobile phase. 
 
3. Comparison of CSP-7 with commercial CSPs              
The CSP with best separation results and versatility in the study: CSP-7(Fmoc-Pro-
Pro-Pro-Pro-N(Me)-Ahx-APS) was compared with three commercial CSPs: 
CHIRALPAK OD-H, CHIRALPAK AD-H and Whelk-O2. These three commercial 
CSPs are the most widely used in pharmaceutical industries and research labs. The 
comparison results are shown on Table 2-7. 
Among the 4 CSPs, CSP-7 resolved 17 analytes while CHIRALPAK OD-H separated 
18, CHIRALPAK AD-H resolved 17 and Whelk-O2 resolved 15 out of 22 analytes. So 
the versatility of CSP-6 is comparable with these commercial CSPs. Considering the fact 
that column size of  CSP-7 is 50×4.6 mm and  columns sizes of commercial CSPs are  
150×4.6 mm or 250×4.6 mm, these results are very encouraging.  
For enantio-selectivity, CSP-7 got comparable separation factors for most analytes 
with the three commercial CSPs. For some analytes, CSP-7 even achieved better 
Mephentoin α: 1.14 
k1:6.93  
2%IPA 
α: 1.17 
k1:17.10 
20%DCM 
in Hexane  
α: 1 
k1:6.80  
2%IPA  
α: 1 
k1:10.18  
20%DCM in 
Hexane 
sec-Butyl carbanilate α: 1 
k1:7.64  
1%IPA  
α: 1.12 
k1:4.16  
10%DCM 
in Hexane 
α: 1 
k1:7.00  
1%IPA  
α: 1 
k1:8.27  
10%DCM in 
Hexane 
Methyl Mandelate α: 1.17 
k1:8.31  
1%IPA  
α: 1 
k1:8.18 
10%DCM 
in Hexane 
α: 1 
k1:13.40  
1%IPA  
α: 1 
k1:6.84  
10%DCM in 
Hexane   
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separations: it resolved TFAE with α of 1.56 , 1,1'-Bi-2-naphthol with α of 1.29, 2,2'-
Dihydroxy-5,5',6,6',7,7',8,8'-Octahydro-1,1'-binaphthyl  with α of 1.32 and  1,2,3,4-
Tetrahydro-4- (4-hydroxyphenyl)- 6-methyl-2-thioxo-, 5-Pyrimidinecarboxylic acid ethyl 
ester with α of 1.41. CSP-7 shows great potential to be developed into a commercial CSP. 
The chromatograms of TFAE separated by these 4 CSPs are shown on Figure 2-6. 
For CSP-7, the retention factors are bigger for most analytes compared with 
commercial CSPs. And peak shapes of analytes in chromatograms are broader for CSP-7. 
So preparation process needs to be improved to increase the column efficiency and 
decrease the retention factor. 
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Table 2-7. Comparison results of CSP-7 and three commercial CSPs 
Analyte name CSP-7 CHIRALPAK 
OD-H 
CHIRALPAK 
AD-H 
Whelk-O2 
Benzoin α: 1.09a 
k1:6.35
b  
3%IPAc 
α: 1.61 
k1:4.68  
15%IPA  
α: 1.32 
k1:3.46  
15%IPA  
α: 2.12 
k1:1.83  
5%IPA  
Hydrobenzoin α: 1.13 
k1:17.98  
4%IPA  
α: 1 
k1:7.35  
4%IPA  
α: 1.08 
k1:5.15  
8%IPA  
Α1.33 
k1:4.18  
4%IPA  
Benzoin oxime α: 1.13 
k1:15.36  
20%IPA  
α: 1.13 
k1:2.82  
10%IPA  
α: 1.24 
k1:4.55  
15%IPA  
α: 1.31 
k1:1.40  
10%IPA  
2,2,2-Trifluoro-1- 
(9-anthryl) 
ethanol(TFAE) 
α: 1.56 
k1:18.48  
10%IPA  
α: 1.13 
k1:1.26  
15%IPA  
α: 1.47 
k1:1.99  
10%IPA  
α: 1.13 
k1:0.62  
10%IPA  
 a-(pentafluoroethyl)- 
a-(trifluoromethyl)- 
Benzenemethanol 
α: 1.10 
k1:8.91  
3%IPA  
α: 1.16 
k1:0.90  
1%IPA  
α: 1.11 
k1:0.79  
3%IPA  
α: 1 
k1:0.70  
3%IPA  
Warfarin α: 1.08 
k1:11.19  
10%IPA & 
1% 
AcOH  
α: 2.49 
k1:6.40  
15%IPA  
α:3.94 
k1:5.02  
20%IPA  
α: 1.97 
k1:10.06  
20%IPA  
Sec-Phenethyl  
alcohol 
α: 1.02 
k1:8.07  
1%IPA  
α: 1.37 
k1:8.30  
1%IPA  
α: 1 
k1:4.12  
2%IPA  
α: 1.03 
k1:3.64  
2%IPA  
α-Methyl-2-  
Naphalenemethanol 
α: 1.04 
k1:17.62  
1%IPA  
α: 1 
k1:6.25  
3%IPA  
α: 1.05 
k1:1.98  
10%IPA  
α: 1.02 
k1:4.39  
3%IPA  
1-Acenaphthenol α: 1 
k1:28.46  
3%IPA  
α: 1.16 
k1:5.46  
3%IPA  
α: 1.08 
k1:6.58  
3%IPA  
α: 1.28 
k1:4.96  
3%IPA  
3-Phenyl-Glycidol α: 1 
k1:6.77  
3%IPA  
α: 1.15 
k1:16.87  
10%IPA  
α: 1 
k1:8.01  
8%IPA  
α: 1.37 
k1:8.74  
10%IPA  
1,1'-Bi-2-naphthol α: 1.29 
k1:23.83  
75%IPA  
α: 1.16 
k1:4.49  
8%IPA  
α: 1.13 
k1:3.58  
25%IPA  
α: 1 
k1:1.26  
5%IPA  
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Table 2-7 continued. 
 
 
 
a. separation  factor; b. retention factor of the first eluted enantiomer; c. IPA percentage in 
hexane of the mobile phase 
2,2'-Dihydroxy-5,5',6,6',7,7',8,8'-
Octahydro-1,1'-binaphthyl 
α: 1.32 
k1:10.95  
10%IPA  
α: 1.32 
k1:3.98  
5%IPA  
α:1 
k1:8.53  
10%IPA  
α: 1 
k1:4.47  
5%IPA  
1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinecarboxylic acid ethyl 
ester 
α: 1.24 
k1:12.60  
15%IPA  
α: 1.15 
k1:2.13  
15%IPA  
α:1.40 
k1:3.44  
15%IPA  
α: 1.16 
k1:2.27  
15%IPA  
1,2,3,4-Tetrahydro-4- 
(4-hydroxyphenyl)- 
6-methyl-2-thioxo-, 5-
Pyrimidinecarboxylic acid ethyl 
ester 
α: 1.41 
k1:25.07  
30%IPA  
α: 1.30 
k1:2.87  
15%IPA  
α:1.36 
k1:4.62  
15%IPA  
α: 1 
k1:2.23  
15%IPA  
1-[1,2,3,4-Tetrahydro-4- 
(4-methoxyphenyl)- 
6-methyl-2-thioxo- 
5-pyrimidinyl]ethanone 
α: 1.21 
k1:25.72  
15%IPA  
α: 1.18 
k1:2.62 
15%IPA  
α:1.70 
k1:3.62  
15%IPA  
α: 1 
k1:1.83  
15%IPA  
Hexobarbital α: 1 
k1:5.96  
1%IPA  
α: 1.12 
k1:6.26  
5%IPA  
α:1.46 
k1:2.42  
8%IPA  
α: 1 
k1:1.95  
5%IPA  
Temazepam α: 1 
k1:20.24  
2%IPA  
α: 1 
k1:3.39  
25%IPA  
α:1 
k1:4.12  
25%IPA  
α: 1.19 
k1:3.40  
25%IPA  
5-Methyl- 
5-(2,5-dichloro) 
phenylhydantoin 
α: 1.17 
k1:8.55  
15%IPA  
α: 1.08 
k1:4.29  
8%IPA  
α:1 
k1:4.80  
8%IPA  
α: 1.11 
k1:1.96  
10%IPA  
5-Methyl-5-phenyl 
hydantoin 
α: 1.15 
k1:15.6  
8%IPA  
α: 1.09 
k1:4.06  
8%IPA  
α:1 
k1:3.24  
8%IPA  
α: 1.46 
k1:1.67  
10%IPA  
Mephentoin α: 1.14 
k1:6.93  
2%IPA  
α: 1.10 
k1:5.20  
4%IPA  
α:1.37 
k1:3.56  
4%IPA  
α: 1 
k1:3.35  
4%IPA  
sec-Butyl carbanilate α: 1 
k1:7.64  
1%IPA  
α: 1 
k1:6.18  
2%IPA  
α:1.04 
k1:3.35  
2%IPA  
α: 1.05 
k1:3.36  
1%IPA  
Methyl Mandelate α: 1.17 
k1:8.31  
1%IPA  
α: 1.25 
k1:2.82  
3%IPA  
α:1.08 
k1:1.85  
10%IPA  
α: 1.07 
k1:1.12  
10%IPA  
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(a) CSP-7 
 
 
(b) CHIRALPAK AD-H 
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(c) CHIRALPAK OD-H 
 
(d) Whelk-O2 
 
Figure 2-6. Chromatograms of TFAE separated by CSP-7 and three commercial CSPs 
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Conclusion 
17 new L-proline based CSPs were designed, prepared and evaluated. The influence of 
structural components of these CSPs, including support, linker, number of L-proline units, 
modification of L-proline unit and end group, and mobile phase system on the enatio-
selectivity and versatility of CSPs was investigated.  
To achieve better versatility and enantio-selectivity, APS support is much better than 
PRP-1 in IPA/Hexane mobile phase and  -N(Me)-Ahx- linker capable of accepting 
hydrogen bond is more adaptable than  -NH-Ahx- linker capable of donating hydrogen 
bond. 
The increase of number of  L-proline units in the structure of CSP can improve the 
enantio-selectivity and versatility but the achiral retention of analytes is also increased 
and versatility decreased slightly if the number of L-proline units reaches 6. 
Modification of L-proline into t-butyl-trans-4-L-Hydroxyproline structure has negative 
effects on the separation abilities of CSPs. 
End groups in the structure have great influence on the enantio-discrimination and 
versatility of CSPs. CSP with Piv group has great enantio-selectivity towards the 22 
analytes and CSP with Fmoc group shows good versatility. Piv and Fmoc groups seem to 
be good choices for end group. 
The mobile phase also has effects on the separation abilities of CSPs. CSP-7 with APS 
as the support got better versatility in IPA/Hexane system while CSP-2 with PRP-1 as the 
support had better versatility in DCM/Hexane/MeOH system. 
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Separation ability of the best CSP among the 17 ones  CSP-7(Fmoc-Pro-Pro-Pro-
Pro-N(Me)-Ahx-APS) were  also compared with those of three popular commercial CSPs  
The enantio-selectivity and versatility of this CSP is comparable with commercial ones. 
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CHAPTER III 
 
SPECTROSCOPIC RATIONALIZATION OF THE SEPARATION ABILITIES OF 
DECAPROLINE CHIRAL SELECTOR IN DICHLOROMETHANE-ISOPROPANOL 
SOLVENT MIXTURE 
 
 
Introduction 
A series of chiral columns, with proline oligomers as chiral selectors, have been 
developed recently1-3. These columns have relatively broad chiral selectivity and their 
separation performance is comparable to some popular commercial columns. To 
understand the separation mechanism of these oligoproline-based chiral columns, it is 
necessary to understand the conformations of proline oligomers in the mobile phase. 
Because of the cyclic structure of proline, the oligomers of proline form unique helical 
conformations, namely polyproline Ι (PPI)4 and polyproline II (PPII)5, which are 
distinctly different from standard α-helix and β-sheet structures6. The PPI helix is a right 
handed helix with an axial translation of 1.90Å composed of 3.3 residues per turn, and its 
all peptide bonds are in cis configuration with backbone dihedral angles of φ=-75°, 
ψ=+160°, ω=0°.4 The PPII helix is a left-handed helix with an axial translation of 3.20Å 
composed of 3.0 residues per turn, and its all peptide bonds are in trans configuration 
with φ=-75°, ψ=+145°, ω=180°.5  
 The conformations of some proline oligopeptides have been previously studied 
using different spectroscopic techniques7-12. Most of the literature work dealt with the 
conformation of proline oligopeptides in aqueous solutions although some papers also 
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reported the conformation of proline oligomers in pure organic solvents, such as 
chloroform10, methanol8b and 1-propanol8b.  
 Using infrared (IR) absorption spectral measurements on KBr disks, Isemura and 
coworkers7a did not see differences for the peptide carbonyl absorption bands of PPI and 
PPII conformations. However, Strassmair and coworkers7b studied poly-O-acetyl-L-
hydroxyproline in solution and found that for PPI conformation in dichloromethane 
(DCM), the position of peptide carbonyl absorption band remains almost unchanged 
when alcohol (benzyl alcohol or n-butanol) is added to DCM. But for PPII conformation, 
the peptide carbonyl absorption band continuously shifted to lower frequencies as the 
percent alcohol added is increased. Based on this observation they have concluded7b that 
the peptide carbonyl groups bind to alcohol solvent molecules much stronger in PPII 
conformation than in PPI conformation. Swenson and Formanek have reported7c that the 
peptide carbonyl absorption band of PPII in D2O appears at 1624 cm
-1 and this band 
shifts to a higher frequency at elevated temperature. They suggested that conformational 
change resulting from rotation around Cα-C(=O) could be one explanation for the 
observed spectral changes. Dukor and Keiderling reported9b that the peptide carbonyl 
absorption band for PPII in D2O solution appears at 1623 cm
-1 and that for PPI appears at 
1635 cm-1.  
 Using electronic circular dichroism (ECD)8 spectral measurements in H2O, 
Okabayashi and coworkers indicated that proline oligopetides, containing three or more 
proline units adopt PPII conformation which gives a weak positive ECD in the 221-225 
nm range and a strong negative ECD in the 200-210 nm range.  Kakinoki and coworkers 
have indicated8b that proline oligopeptides adopt PPII conformation in water and 
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trifluoroethanol solvents. They reported that PPII conformation is characterized by an 
ECD spectrum with a strong negative band at 202-206nm and a weak positive band at 
225-229nm and that PPI is characterized by an ECD spectrum with a medium intensity 
negative band at 198-200nm, a strong positive band at 214-215nm, and a weak negative 
band at 231-232nm. For the oligopeptide containing 13 proline residues, they also noted a 
transition from PPII to PPI conformation in pure aliphatic alcohols, such as methanol and 
propanol.   
 Dukor and Keiderling used vibrational circular dichroism (VCD) measurements 
on unblocked proline oligomers, (Pro)n, with n=3-7, in D2O and indicated
9a that PPII 
structure is favored. The PPII structure is characterized by a negative VCD couplet, with 
positive VCD on the higher frequency side and negative VCD on the lower frequency 
side of the absorption band center at 1623 cm-1. Conversion between PPII and PPI 
conformations has also been studied9b in D2O for poly-L-proline using VCD. The VCD 
of PPI conformation was found to be similar to that of PPII, namely a negative VCD 
couplet, but the absorption maximum of PPI at 1635 cm-1 and its associated VCD is 
shifted to higher frequency compared to that of PPII at 1623 cm-1.  
 From NMR studies, Blout and coworkers have concluded10a that for t-
butyloxycarbonyl-(L-Pro)n benzyl esters in chloroform, a random distribution of cis and 
trans peptide bonds appears for n=2-4, but a PPII conformation is favored when n = 5 and 
6. But Zhang and Madalengoitia10b concluded that for these oligomers PPII conformation 
is favored in CDCl3 solvent, without any limit for critical chain length.  Walton et al
11 
presented Raman spectra for three proline oligomers (trimer, tetramer and pentamer) with 
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tert-amyloxycarbonyl blocking group and found that all these three oligomers have PPII 
structures in aqueous solution.  
Optical rotation was one of the earliest techniques applied to study the conformation of 
proline polypeptides4a,12.  Kurtz et al12a found that, in acetic acid or water, PPΙ exhibits a 
specific rotation [α]D =+50° while PPΙI exhibits a very different specific rotation [α]D =-
540° and that PPΙ mutarotates in water to PPΙI over a period of several days.   
Recently, a liquid chromatographic column with decaproline oligomer as the chiral 
selector has been developed1 and this column has demonstrated even better separation 
abilities than the proline-based columns described in CHAPTER II. The decaproline 
oligomer (see Figure 3-1), with t-butoxy carbonyl (Boc) group replaced by trimethyl 
acetyl (TMA) group, was connected to the support of 3-methylaminopropyl silica gel (see 
Figure 3-2), and was used as the stationary phase. This column could resolve more than 
40, out of 53, analytes chosen randomly for testing. In normal-phase HPLC experiments, 
the commonly used solvent mixtures for the mobile phase are isopropanol(IPA)/DCM 
and IPA/hexane. In this manuscript we investigate the conformation of decaproline 
oligomer with Boc end group (Figure 3-1), in the IPA/DCM solvent mixtures using 
multiple spectroscopic techniques, namely optical rotation, ECD, IR and VCD. The 
conformational information obtained for the decaproline oligomer is then related to the 
separation results of the chiral column. 
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Figure 3-1. Structure of the decaproline oligomer (Boc-(Pro)10-OBn). 
 
 
Figure 3-2. The chemical structure of the CSP with the decaproline oligomer as chiral 
selector. 
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Experimental 
  N-Boc O-benzyl protected decaproline oligomer (Boc-(Pro)10-OBn) was synthesized 
according to the reported method10a. The solvents, IPA and DCM were purchased from 
Aldrich. 
  For IR, VCD and ECD measurements, six sample solutions of the same concentration 
(3.5 mg/mL), but with varying proportions of IPA and DCM were prepared from a stock 
solution with 35 mg Boc-(Pro)10-OBn dissolved in 1 mL of DCM. For 0% IPA solution, 
200 µL of the stock solution was added to 800 µL of DCM; for 20% IPA solution, 200 
µL of the stock solution was added to 600 µL of DCM and 200 µL of IPA; for 40% IPA 
solution, 200 µL of the stock solution was added to 400 µL of DCM and 400 µL of IPA; 
for 60% IPA solution, 200 µL of the stock solution was added to 200 µL of DCM and 
600 µL of IPA; for 80% IPA solution, 200 µL of the stock solution was added to 800µL 
of IPA. For 100% IPA solution, 3.5 mg decaproline oligomer was dissolved in 1mL of 
IPA. For optical rotation measurements also six sample solutions were prepared using the 
same procedure as that mentioned above, except that the concentration of each sample 
solution was 1.0 mg/mL and 2 mL solution was prepared for each sample. 
An Autopol IV polarimeter with a resolution of 0.001° (reproducibility of 0.002°) was 
used for optical rotation measurements. Sodium D line was used to measure the optical 
rotation at the wavelength of 589 nm. Each of the sample solutions (1.5 mL) was 
transferred to a 1.0 dm cell and optical rotation was measured three different times (by 
removing the cell from and reinserting the cell into the sample compartment) to check for 
consistency. The averages of these measurements were used to calculate specific rotation. 
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  All ECD measurements were made on a JASCO J720 spectropolarimeter at room 
temperature, using a resolution of 1 nm, and sensitivity of 100 mdeg. All spectra reported 
in this study were averages of 3 individual scans. The spectra were recorded at a scan 
speed of 100 nm/min and a time constant of 0.125 s. The sample solutions (100 µL) were 
held in a circular quartz cell with a path length of 100 µm.  The corresponding solvent 
spectrum was subtracted from the ECD spectrum of the decaproline oligomer. For ease in 
comparison of spectra, all ECD spectra presented are normalized so that their positive 
bands have the same intensity. 
All IR absorption and VCD spectra were recorded on a commercial Chiralir 
spectrometer (Bomem-Biotools, Canada). The absorption spectra were recorded at 4 cm-1 
resolution with 225 scans, while VCD spectra were recorded at 8 cm-1 resolution with a 
spectral collection time of 3h. The sample solutions were held in a demountable cell with 
BaF2 windows and 500 µm spacer. The absorption and VCD spectra of solvents were 
subtracted from the corresponding spectra of the decaproline oligomer. 
    The HPLC experiments for the separation of 2,2,2-Trifluoro-1-[10-(2,2,2-trifluoro-1-
hydroxy-ethyl-anthracen-9-yl]-ethanol (DiTFAE) by the decaproline column in 
IPA/DCM mobile phase were conducted with the following conditions: UV detection at 
254 nm; flow rate at 1 mL/min; mobile phase: IPA/DCM; dead time t0 was measured 
with 1,3,5-tri-t-butylbenzene.  
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Results and discussion 
  The optical rotation, ECD, IR and VCD spectral measurements were obtained by 
varying the composition of IPA/DCM solvent mixture from 0% IPA (pure DCM) to 
100% IPA. 
 
1. Optical rotation  
The specific rotations of the decaproline oligomer in IPA/DCM solvent mixture (0% 
IPA ~100% IPA) are shown in Figure 3-3. 
 
Figure 3-3. Specific rotation, [α]D, of the decaproline oligomer in IPA/DCM solvent 
mixtures. 
 
As the composition of the solvent is changed from 0% IPA to 20% IPA, the 
magnitude of specific rotation, [α]D of the decaproline oligomer increases slightly. As the 
percentage of IPA in solvent system increases from 20% to 40%, then to 60%, the 
specific rotation of this oligomer remains the same. When the solvent system is changed 
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from 60% IPA to 80% IPA and then to 100% IPA, the magnitude of specific rotation of 
this oligomer increases again. In the entire range of IPA/DCM solvent mixture, from 0% 
to 100% IPA, the sign of [α]D remained negative and the specific rotation changed from -
140° in 0% IPA to -210° in 100% IPA.  
In the literature studies on [α]D of PPΙ and PPII conformations, PPΙ is 
characterized4a,12  by a slightly positive [α]D in water or acetic acid solvents.  PPII is 
characterized4a,12 by a large negative [α]D in water or acetic acid solvents. But [α]D of PPΙ 
or PPII conformation in pure DCM, pure IPA or IPA/DCM mixture was not reported 
before. From the observed behavior of [α]D of this decaproline oligomer, there are two 
possibilities for the conformation of this oligmer in IPA/DCM solvent system.  Since 
PPII conformation was characterized by negative [α]D, it is possible that the decaproline 
oligomer in IPA/DCM mixture may also have a PPII conformation.  Then the change in 
magnitude of optical rotation with solvent composition may have to be attributed to 
solvent related effects. The second possibility is that both PPII and PPΙ conformations 
may be present in IPA/DCM mixture for this oligomer, with population of one conformer 
decreasing and that of second conformer increasing as the percentage of IPA in the 
solvent mixture increases. Additional evidence is needed to establish one of these two 
possibilities.   
 
2. Electronic circular dichroism spectra 
The literature studies have used ECD to distinguish PPI and PPII conformations.  PPI 
is generally characterized by an ECD spectrum with a medium intensity negative band at 
198-200 nm, a strong positive band at 214-215 nm, and a weak negative band at 231-232 
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nm.8b PPII is generally characterized by a ECD spectrum with a strong negative band at 
202-206nm and a weak positive band at 225-229nm.8b  
The present ECD spectra of the decaproline oligomer in varying IPA/DCM solvent 
mixtures are shown at Figure 3-4.  All these spectra exhibit the same pattern of ECD 
bands: a strong negative band at lower wavelength and a weak positive band at higher 
wavelength. As the percentage of IPA in the solvent system increases from 0% to 100%, 
the position of the positive band remains unchanged at 226 nm. The position of the 
negative band shifts from 209 nm gradually to 205 nm when the percentage of IPA 
increases from 0% to 60%. Beyond this point, as the percentage of IPA increases from 
60% to 100%, the position of the negative band remains almost unchanged at 205 nm. 
The ECD patterns observed here are those assigned to PPII conformation, and we did not 
see strong positive ECD at 215 nm that is characteristic of PPI conformation. Thus it 
appears that the decaproline oligomer is in PPII conformation in IPA/DCM solvent 
system (0% IPA ~ 100% IPA).  
The blue shift of the negative ECD band, as the percent of IPA increased from 0 to 
60%, is considered to be caused by hydrogen bonding of C=O groups of the decaproline 
oligomer with IPA molecules. Previously8b the blue shift of negative ECD band, with a 
decrease in the number of residues, was attributed to the decreased stability of standard 
PPII helix. Then it is possible that some changes in dihedral angle around Cα-C(=O) 
occur as the percent of IPA is increased in the solvent mixture.  Overall the shift of the 
negative band is very small (from 209 nm to 205 nm). Infrared and VCD spectra are 
expected to be more sensitive to hydrogen bonding influence and therefore we have 
undertaken these studies. 
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Figure 3-4. ECD spectra of the decaproline oligomer in IPA/DCM solvent mixtures. 
 
3. Infrared absorption spectra 
The decaproline oligomer (Figure 3-1) contains three different types of carbonyl 
groups: the peptide carbonyl groups, the Boc carbonyl groups and the carbonyl group 
connected to the benzyloxy protecting group.  In the preparation of chiral stationary 
phase, the decaproline oligomer is connected to a linker molecule by removing the 
benzyloxy group and forming another amide bond. As a result, vibrational bands 
originating from the peptide carbonyl groups and Boc carbonyl groups are of interest here. 
In presenting the infrared absorption bands of the peptide C=O groups (Figure 3-5), 
the bands are normalized to Amax = 1.0 for the ease in comparison of spectra. As the 
solvent composition changes from 0% IPA to 60% IPA, there is a significant shift in band 
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position (Figure 3-6) for the carbonyl absorption band. As the composition of IPA 
increases further only a small frequency shift is found. 
Figure 3-5. Infrared absorption spectra of the peptide C=O groups of decaproline 
oligomer in IPA/DCM solvent system. 
 
Figure 3-6. Frequencies of peptide carbonyl band of the decaproline oligomer in 
IPA/DCM solvent system. 
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Strassmair et al reported7b that for poly-O-acetyl-L-hydroxyproline in PPI 
conformation, the position of carbonyl absorption band remained almost unchanged in 
DCM when alcohol (benzyl alcohol or n-butanol) was added to DCM, but in PPII 
conformation, there was a significant shift of carbonyl absorption band to lower 
frequencies when alcohol was added.  For the decaproline oligomer here in IPA/DCM 
system, a clear shift to lower frequencies (compared with that in pure DCM) is observed 
for the peptide carbonyl absorption band as the content of IPA increases. This offers 
further evidence that the decaproline oligomer is in PPII conformation in IPA/ DCM 
system. The IPA molecules can form hydrogen bonding to the peptide C=O groups, 
influence the dihedral angle around Cα-C(=O), and cause the peptide C=O band to shift 
to lower frequency. The DCM molecules on the other hand do not participate in hydrogen 
bonding. In pure DCM solvent (0% IPA), the peptide C=O groups of decaproline 
oligomer can be regarded as free CO groups. When the percentage of IPA in the solvent 
increases from 60% to 100%, the shift of the peptide C=O band becomes small indicating 
that the hydrogen bonding with the solvent, and concomitant changes in the dihedral 
angle around Cα-C(=O), are near saturation when the content of IPA in the solvent 
mixture reaches 60%. 
The infrared absorption bands of the Boc carbonyl group are shown in Figure 3-7. As 
the solvent composition changes from 0% IPA to 60% IPA, there is a large shift in the 
band position (from 1689 cm-1 to 1678 cm-1). Also the intensity of this band decreases. 
As the percentage of IPA in the solvent increases from 60% to 100%, the position of the 
band remains unchanged at 1678 cm-1 and the intensity of the band increases. 
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Figure 3-7. IR spectra of the C=Os of Boc groups of the decaproline oligomer in 
IPA/DCM solvent system. 
 
 
4. Vibrational circular dichroism spectra 
Among the three kinds of carbonyl groups in the decaproline oligomer, only the 
peptide carbonyl groups exhibit measurable VCD at the concentration and pathlength 
used. There is not enough absorption to measure VCD for the other two kinds of carbonyl 
groups and therefore much higher concentration or pathlength is needed to measure the 
corresponding VCD. The solubility limits and interfering absorption from solvent 
mixture, prevent VCD measurements for the other two kinds of C=O groups.  
The VCD associated with the peptide carbonyl groups in different IPA/DCM solvent 
mixtures are shown in Figure 3-8. All these VCD spectra exhibit a negative couplet, with 
positive VCD band at the higher frequency and negative VCD band at the lower 
frequency, which is a characteristic of the PPII conformation. As the percentage of IPA in 
the solvent system increases from 0% to 60%, the position of the positive band shifts 
from 1660 cm-1 to 1654 cm-1 and that of the negative band shifts from 1643 cm-1 to 1635 
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cm-1, gradually. As the percentage of IPA increases further from 60% to 100%, the 
position of the negative band remains almost unchanged at 1635 cm-1, but that of positive 
band continues to decrease to 1652 cm-1. The negative VCD couplet, which is a 
characteristic of the PPII conformation, remained in the entire range of solvent mixtures 
(0%-100% IPA). As mentioned earlier, ECD spectra also indicated decaproline oligomer 
is in PPII conformation in the entire range of solvent mixtures (0%-100% IPA).  
 
 
Figure 3-8. VCD spectra of the peptide C=O groups of the decaproline oligomer in 
IPA/DCM solvent system. 
 
5. Rationalization of separation abilities of the decaproline chiral selector  
The representations of PPI and PPII structures constructed from six proline residues 
are shown in Figure 3-9. It is obvious that PPI is a more crowded structure with stronger 
steric effects. The C=O groups in PPII are much more exposed to the solvent than those 
in PPI structure. For these proline-based chiral columns, the key factors to achieve good 
separation towards a wide range of analytes include a rigid structure and chiral 
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interaction sites. Both PPII and PPI conformations are rigid structures. Interactions 
between chiral selector and analytes include hydrogen bonding, pi-pi interaction and steric 
effects. For the decaproline oligomer, there are no aromatic rings, so pi-pi interactions are 
not available. Then the interactions between the oligomer and analytes are mainly 
hydrogen bonding and steric effects. The C=O groups in PPІ structure are much less 
exposed to solvent so the hydrogen bonding with solvent molecules or anlaytes is not 
significant. For PPII structure, the C=O groups in PPII structure are much more exposed, 
so the hydrogen bonding with solvent molecules or analytes is much easier.  It appears 
that hydrogen bonding is a more important factor for the decaproline column to achieve 
broad separation abilities.  Differences in the ability of forming hydrogen bonds with 
solvent molecules for PPІ and PPII structures can be used to explain why there is a large 
shift of infrared absorption band of PPII structure when alcohol is added to DCM while 
there is almost no change7b in the position of infrared absorption band of PPІ structure 
with the addition of alcohol into DCM.   
 
Figure 3-9. Representations of PPI (left) and PPII (right) structures constructed from six 
proline residues. 
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2,2,2-Trifluoro-1-[10-(2,2,2-trifluoro-1-hydroxy-ethyl-anthracen-9-yl]-ethanol 
(DiTFAE) is a useful compound for the evaluation of chiral columns1. Its structure is 
shown in Figure 3-10. The separation of racemic DiTFAE by the decaproline column was 
studied in IPA/DCM solvent system (20% IPA ~ 100% IPA). The separation of DiTFAE 
by the decaproline column was not done in pure DCM system (0% IPA) because it takes 
very long time(more than 3 hr) to wash out the two enantiomers of DiTFAE from this 
column in pure DCM and their chromatographic peaks are so flat that they can not be 
used for data analysis. The separation results are shown in Figure 3-11, where the 
changes of retention factor (k) and separation factor (α) of DiTFAE with the change of 
percentage of IPA in the solvent are presented. Retention factor (k) equals (tr - t0)/t0, in 
which tr is the retention time and t0 is the dead time. Separation factor(α) equals k2/k1, in 
which k1 and k2 are the retention factors of two enantiomers. In this case k1 is the 
retention factor of (R)-enantiomer of DiTFAE and k2 is the retention factor of (S)-
enantiomer of DiTFAE. As the percentage of IPA increases in solvent mixture, the 
retention factors of the two enantiomers, and also the separation factor, decrease first and 
then increase when the percentage of IPA reach 60%. This has a good correlation with 
the changes in optical rotation, ECD, IR and VCD properties, where the composition of 
60% IPA is also seen as the turning point for hydrogen bonding interactions with the 
solvent, and associated changes in the dihedral angle around Cα-C(=O). 
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Figure 3-10. Structure of 2,2,2-Trifluoro-1-[10-(2,2,2-trifluoro-1-hydroxy-ethyl -
anthracen-9-yl] – ethanol (DiTFAE). 
 
Figure 3-11. Retention factors (left panel) and separation factor (right panel) of DiTFAE 
achieved in the decaproline column in IPA/DCM solvent system. k1 is the retention factor 
of R enantiomer of DiTFAE and k2 is the retention factor of S enantiomer of DiTFAE. 
 
The present spectroscopic results provide an explanation for the observed changes in 
retention time and separation factor in the decaproline column. It appears that the 
competition between solvent and analyte molecules for interaction with decaproline CSP 
column is changing with the percent composition of IPA. The hydrogen bonding 
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interactions between decaproline and IPA are less significant at lower composition of 
IPA (<20%), and are saturated at higher composition (>60%) of IPA. At lower 
composition of IPA, the analyte molecules have direct interactions with the column. In 
the 0-20% IPA range, as the percent IPA increases IPA molecules compete successfully 
with analyte molecules for interaction with decaproline CSP, leading to a decrease in the 
separation factor and retention times for the analyte.  In this process, there may have been 
some amount of distortion of dihedral angles around Cα-C(=O) in the decaproline 
structure from the standard PPII helix. When the percent IPA comes to 60%, the 
hydrogen bonding interactions between IPA and decaproline come to a saturation point. 
From this point onwards, the analyte molecules interact directly with IPA bound 
decaproline column leading to an increase in the separation factor and retention times for 
the analyte. Thus it appears that decaproline column saturated with hydrogen bonding 
with IPA is more effective in separations than the one with limited amount of IPA. 
 
Conclusions 
  The conformation of the decaproline oligomer, the chiral selector of a newly 
developed chiral column, was investigated in IPA/DCM solvent system using multiple 
spectroscopic techniques including optical roation, ECD, IR and VCD. Based on these 
studies, this oligomer is suggested to be in the PPII conformation in IPA/DCM solvent 
system (0% IPA ~ 100% IPA). The C=O groups in the decaproline oligomer become 
saturated with hydrogen bonding to IPA molecules when the content of IPA in the 
solvent mixture reaches 60%. Based on separation results of racemic DiTFAE by the 
decaproline column, the 60% IPA is also seen to be the turning point for the change of 
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retention factors and separation factor of DiTFAE with the change of content of IPA in 
the solvent mixture. 
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 CHAPTER IV 
 
VIBRATIONAL ABSORPTION, VIBRATIONAL CIRCULAR DICHROISM AND 
SPECIFIC ROTATION STUDY ON DIALKYL TARTRATES AND THEIR 
CYCLODEXTRIN COMPLEXES 
 
 
Introduction 
Vibrational circular dichroism (VCD) technique has been successfully used for 
determining the absolute configuration and predominant conformations of chiral 
molecules in the solution phase.1 The utility of VCD for structural elucidation is 
facilitated by two advances: (a) improvements in VCD instrumentation have made it 
possible to obtain the VCD spectra with enhanced signal-to-noise ratio and (b) ab initio 
applications using density functional theory (DFT)2 have become state-of-the-art in 
recent years. The DFT theory, which provides vibrational frequencies and intensities that 
are comparable to the post-SCF calculations employing electron correlation, has also 
been extended to the VCD intensity calculations3 and implemented in standard software4.  
 Recently VCD technique was also applied to the study of cyclodextrin complexes.5  
VCD is becoming a useful tool to investigate the host/guest interactions in the complexes. 
   Specific rotation is an age-old technique that has experienced a renaissance in the past 
few years, following the first prediction6 of specific rotation using ab initio methods. 
Recent implementation of DFT for predicting specific rotation has led to accurate 
predictions of specific rotation.7 The specific rotations measured in the gas phase are 
ideal for comparison with predictions on isolated molecules; however, such 
measurements require special instrumentation and are not routine. Because the 
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condensed-phase experimental specific rotations (often reported for neat liquids or in 
some convenient solvent at some convenient concentration) can be influenced by solute-
solute interactions, a quantitative comparison of predicted and condensed-phase 
experimental specific rotations may not be reliable. This drawback can be alleviated with 
the measurement of intrinsic rotation (specific rotation in the limit of zero concentration)8, 
which is devoid of solute-solute interactions. The combined use of experimental intrinsic 
rotations and predicted specific rotations is another approach to study the conformations 
of chiral molecules in solutions. 
Tartaric acid and its derivatives play an important role in organic and pharmaceutical 
chemistry9. Dialkyl tartrates are a category of tartaric acid derivatives which have wide 
applications in both academic laboratories and chemical industries. They can be used as 
good asymmetric synthesis catalysts and they are also chiral intermediates for several 
pharmaceuticals and agrochemicals10.  
Dialkyl tartrates have been studied by VA and VCD techniques before. Keiderling et 
al11 found bisignate VCD associated with the O-H stretching vibrations of dimethyl 
(R,R)-tartrate in CCl4 solution. They carried out further VCD measurements in the O-H 
stretching region by varying the temperature and found out the restricted conformational 
mobility of this molecule in dilute CCl4 solution. They also did the VCD measurements 
in the C=O stretching region and found bisignate VCD for the C=O stretching vibrations 
in CCl4.  
Our group also did some research on VA and VCD spectra of dialkyl tartrates12. VCD 
spectra of dimethyl tartrate, diethyl tartrate and diisopropyl tartrate were measured in the 
1600-900 cm-1 region in different solvents (CCl4, DMSO and CS2) and different 
 79 
concentrations. It was found that VCD associated with the C-O stretching vibrations in 
the region of 1250-1000 cm-1 is identical for all these molecules in all three solvents. But 
in the 1600-1250 cm-1 region absorption and VCD spectra are quite different in CCl4 and 
DMSO solvents. Absorption spectra were also studied in the C=O stretching region 
(1850-1600 cm-1). It is found that in DMSO solvent the spectra show two absorption 
bands as opposed to one in CCl4. Intermolecular hydrogen bonding in DMSO was 
thought to cause the difference. But there was no further investigation of this issue. 
In this article we report further investigations of VA and VCD spectra in the mid-
infrared region in different solvents (CCl4, DMSO-d6 and D2O) for three dialkyl tartrates. 
VA and VCD spectra in CCl4 and CS2 were found to be quite similar
12. DMSO-d6 and 
D2O are used instead of DMSO and H2O to avoid solvent absorption interference in the 
Mid-infrared region. Intrinsic rotations of dialkyl tartrates were not reported before. We 
measured the intrinsic rotations of dimethyl D-tartrate (with the configuration of S,S) in 
different solvents(CCl4, DMSO and H2O).  The DFT calculations for dimethyl (S,S)-
tartrate, a representative compound among these tartrates, were performed in isolated 
state and in different solvents to study the conformational change of this molecule in 
different solvents. 
 Dialkyl tartrate-cyclodextrin complexes were also prepared for the first time. VA and 
VCD spectra in the mid-IR region, intrinsic rotations, and binding constants of these 
complexes were also measured to investigate the intercation between guest and host 
molecules in these complexes. 
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Experimental 
  Dimethyl D-tartrate, dimethyl L-tartrate, diethyl D-tartrate, diethyl L-tartrate 
diisopropyl D-tartrate, and diisopropyl L-tartrate were all purchased from Aldrich 
Chemicals; α and β-cyclodextrins were purchased from Sigma Chemicals. 
  Preparation of dialkyl tartrate-cyclodextrin complexes 
  These complexes were prepared using coprecipation method13. Take diethyl D-tartrate 
β-CD complex as an example. The mixture of β-CD (1mmole) and diethyl D-tartrate 
(10mmol) was dissolved in hot H2O (5mL) at 90°C. Then the solution was allowed to 
cool down slowly and crystals were obtained after filtration. α-CD complex of diethyl L-
tartrate and β-CD complexes of diethyl D-tartrate, diethyl L-tartrate,diisopropyl D-
tartrate, and diisopropyl L-tartrate were prepared using the same procedure. And these 
complexes were characterized by 1H NMR: 
for diethyl L-tartrate α-CD complex complex: 
  1H NMR δ (D2O): 1.2 (t, 6H), 3.4-3.5 (m, 6H), 3.7-3.8 (m, 6H), 3.8-3.9 (m, 6H), 4.2 (m, 
4H) and 5.0(s, 6H). 
for diethyl D-tartrate β- CD complex complex: 
  1H NMR δ (D2O): 1.2 (t, 6H), 3.4-3.5 (m, 7H), 3.7-3.8 (m, 7H), 3.8-3.9 (m, 7H), 4.2 (m, 
4H) and 5.0(s, 7H). 
for diethyl L-tartrate β- CD complex complex: 
  1H NMR δ (D2O): 1.2 (t, 6H), 3.4-3.5 (m, 7H), 3.7-3.8 (m, 7H), 3.8-3.9 (m, 7H), 4.2 (m, 
4H) and 5.0(s, 7H). 
for diisopropyl D-tartrate β- CD complex complex: 
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  1H NMR δ (D2O): 1.2 (d, 12H), 3.4-3.5 (m, 7H), 3.7-3.8 (m, 7H), 3.8-3.9 (m, 7H), 4.5 
(m, 2H) and 5.0(s, 7H). 
for diisopropyl L-tartrate β- CD complex complex: 
  1H NMR δ (D2O): 1.2 (d, 12H), 3.4-3.5 (m, 7H), 3.7-3.8 (m, 7H), 3.8-3.9 (m, 7H), 4.5 
(m, 2H) and 5.0(s, 7H). 
  Determination of binding constants of dialkyl tartrate-cyclodextrin complexes 
  The binding constants of diethyl L-tartrate complexes of α-CD and β-CD were 
determined in both H2O and DMSO solvents by isothermal titration calorimetry(ITC)
14.   
An isothermal calorimeter (Microcal Inc., MA), was used in all microcalorimetric 
experiments. For microcalorimetric experiments in H2O, 20 injections of 5µL of diethyl 
L-tartrate in H2O (100mM) were added at an interval of 5 min into the α-CD or β-CD 
solution in H2O (2mM) in the reaction cell (cell volume = 1.4mL) while stirring at 300 
rpm at 298K.  The duration time of each injection is 20 sec.  For microcalorimetric 
experiments in DMSO, 20 injections of 10µL of diethyl L-tartrate in DMSO were added 
at an interval of 5 min into the α-CD or β-CD solution in DMSO (20mM) in the cell with 
the stirring speed at 550 rpm at 298K. The concentrations of diethyl L-tartrate were 
150mM for the titration with β-CD and 450mM for the titration with α-CD respectively. 
For each injection the duration time is 7.1 sec. 
   Dilution effects were determined by identical injections of the diethyl L-tartrate 
solutions into the pure solvents and were subtracted from the raw titration to produce the 
final binding curve. The ORIGIN software (Microcal), used for the calculation of K, ∆H 
and ∆S from the titration curve, gave the relevant standard deviations based on the scatter 
of the data points in a single titration curve. 
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   VA and VCD measurements 
The VA and VCD spectra were recorded on a commercial Fourier transform VCD 
spectrometer, Chiralir (Bomem-BioTools, Canada) with a ZnSe beam splitter, BaF2 
polarizer, optical filter (transmitting below 2000 cm-1) and a 2 × 2 mm HgCdTe detector. 
One difference from the standard Chiralir instrument is that the photo elastic modulator 
used was a PEM-80 model (Hinds Instruments) without AR coating on the ZnSe optical 
element. The VCD spectra were recorded, using the supplied Chiralir software, with 3 h 
data collection time at 4 cm-1 resolution. The transmission properties of optical filter and 
BaF2 substrates used in the instrument restrict the range of measurements to 2000-900 
cm-1. 
 In the CCl4 solvent spectra were measured for diethyl D-tartrate and diethyl L-tartrate 
at the concentration of 0.017 M at path length of 600 µm in a variable path length cell 
with BaF2 windows. In the DMSO-d6 solvent spectra were measured for dimethyl D-
tartrate, diethyl D-tartrate, diisopropyl D-tartrate and diisopropyl L-tartrate. Their 
concentrations were 0.046, 0.040, 0.035 and 0.035M, respectively.  Spectra were also 
measured for β-CD complexes of diethyl D-tartrate, diethyl L-tartrate diisopropyl D-
tartrate and diisopropyl L-tartrate at the concentrations of 0.040M in the DMSO-d6. The 
samples were held in a demountable path length cell (200 µm) with BaF2 windows. In the 
D2O solvent spectra were measured for dimethyl D-tartrate, diethyl D-tartrate and α-CD 
complex of diethyl L-tartrate at the concentration of 0.048, 0.041M and 0.044M 
respectively in a demountable path length cell (100µm) with BaF2 windows. In the 
presented VA and VCD spectra, the solvent absorption and VCD spectra were subtracted 
out respectively.  
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Optical rotation measurement 
  For optical rotation measurement, an Autopol Ⅳ polarimeter with a resolution of 
0.001° (reproducibility of 0.002°) and analytical balances with accuracy of 0.00001 g 
were used. Optical rotations were measured at the wavelength of 589 nm. Optical 
rotations of dimethyl D-tartrate were measured in CCl4 at the concentration range of 
0.0028-0.0010M, in DMSO at 0.0570-0.013M and in H2O at 0.0590-0.0037M 
respectively. Optical rotations of diethyl D-tartrate, diethyl L-tartrate, diisopropyl D-
tartrate, diisopropyl L-tartrate,  α-CD and  β-CD were also measured in H2O with the 
concentration ranges of 0.0439-0.0027M, 0.0614-0.0038M, 0.0521-0.0016M, 0.0408-
0.0026M, 0.0083-0.0003M and 0.0077-0.0002M respectively. Optical rotations of α-CD 
complex of diethyl L-tartrate were measured in H2O at the concentration range of 0.0031-
0.0001M. And optical rotations of β-CD complexes of diethyl L-tartrate, diethyl D-
tartrate, diisopropyl L-tartrate and diisopropyl D-tartrate were also measured in H2O with 
the concentration ranges of 0.0058-0.0002M, 0.0058-0.0002M, 0.0031-0.00008M and 
0.0031-0.00008M respectively. Optical rotations of dimethyl D-tartrate were also 
measured at other wavelengths besides 589nm. Optical rotations of dimethyl D-tartrate 
were measured at 0.0014M in CCl4 and at 0.0064M in DMSO respectively at the 
wavelengths of 633, 589, 546, 436, 405, and 365nm.  For experiments to measure the 
intrinsic rotations for dimethyl D-tartrate in DMSO, optical rotations were also measured 
at the wavelength of 365nm at the concentration range of 0.027-0.008M.  
Each time the solution was transferred to a 1.0 dm cell and optical rotation was 
measured three different times to check for consistency. The averages of these 
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measurements were used to calculate specific rotation. This procedure ensured that no 
unusual data scatter was present in the measurements. 
 Based on experimental results for dialkyl tartrates, cyclodextrins and the complexes, 
plots of c(concentration) Vs. α(observed rotation) and c(concentration) Vs. [α](specific 
rotation) are made and equation fittings are performed for each case. Normal least-
squares fitting is appropriate for α vs. c data, weighted least-squares fitting is needed for 
fitting the [α] vs. c data. Intrinsic rotation ([α]c=0 or {α}) can be obtained from these 
equations. For example, if the measured specific rotation as a function of concentration 
follows the equation [α] = A1c + B1, then the observed rotation α must follow the 
quadratic equation, as α = A2c
2 + B2c. Then {α} equals B1. It is to be noted that the linear 
relation, [α] = A1c + B1, may not apply in all situations; in some cases [α] may be 
constant, or follow quadratic, cubic, or some other complicated relation. 
DFT calculations 
The DFT geometry optimization, vibrational frequencies, absorption, and VCD 
intensities, specific-rotation calculations for isolated dimethyl (S,S)-tartrate were 
calculated using Gaussian 98 or 03 program4. The calculations used DFT with B3LYP 
functional (6-31G* and aug-cc-pVDZ basis sets).  The DFT geometry optimization, VCD 
and specific-rotation calculations for dimethyl (S,S)-tartrate in CCl4 were calculated using 
Gaussian 03 program4. The solvent influence was investigated with a polarizable 
continuum model (PCM) that was incorporated in Gaussian 03 program. The DFT 
geometry optimization, vibrational frequencies, absorption, and VCD intensities, 
specific-rotation calculations for clusters of dimethyl (S,S)-tartrate with DMSO molecules 
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were also calculated using the DFT method with B3LYP functional(6-31G* basis set) in 
Gaussian 98 or 03 program. 
The theoretical absorption and VCD spectra were simulated with Lorentzian band 
shapes and 5 cm-1 full width at half-height. Since the predicted band positions with 6-
31G* basis set are higher than the experimental values, the predicted frequencies have 
been scaled with 0.96.  
 
Results and discussion 
 
  1. VA and VCD study of dialkyl tartrate 
  Because of solvent inference, VCD spectra of dialkyl tartrate can only be obtained in the 
regions of 2000-1600 cm-1 and 1500-900 cm-1in CCl4, in the region of 2000-1100 cm
-1 in 
DMSO-d6 and in the region of 2000-1250 cm
-1 in D2O. The vibrational absorption and 
VCD spectra of dialkyl tartrates, measured in CCl4, DMSO-d6 and D2O solvents in the 
mid-infrared region, are shown in Figures 4-1 ~ 4-3. The VCD spectra of both 
enantiomers of diethyl tartrate were shown in Figure 4-1. The absorption and VCD 
spectra of dimethyl L-tartrate in the mid-infrared region in CCl4 have been reported by 
Buffeteau et al17 before. The absorption and VCD spectra in the mid-infrared region in 
the same solvent system remain almost unaffected for these esters as the alkyl group in 
their structures changes from methyl to ethyl and isopropyl. Difference is found for only 
absorption spectra in the region of 1500-1400 cm-1 as the alkyl group changes. For a 
given tartrate, the absorption and VCD signs are affected significantly when the solvent is 
changed from CCl4 to DMSO-d6 and D2O. Several VCD bands are seen in the mid-
infrared region in both CCl4 and DMSO-d6 solvent while no VCD bands are found in 
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D2O. In the C=O stretching region (1850-1600 cm
-1), one absorption band and bisignate 
VCD signs (negative-positive for D enantiomer) are found in CCl4 and two absorption 
bands and three VCD bands (negative-positive-negative triplet for D enantiomers) are 
seen in DMSO-d6 while one broader absorption band and no VCD signals are found in 
D2O. In the 1500-900 cm
-1 region, three positive couplets (positive at lower frequency 
and negative at higher frequency for D enantiomer) are observed at the 1400-1240 cm-1, 
1240-1150 cm-1 and 1150-1050 cm-1 regions respectively in the VCD spectra in CCl4 
while a pattern of a negative couplet (negative at higher frequency and positive at lower 
frequency for D enantiomers) is seen in the 1250-1100 cm-1 region in DMSO-d6. No 
VCD signals are observed in D2O.      
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Figure 4-1. Vibrational absorption(bottom) and VCD(top) spectra in the Mid IR region  
in CCl4 solution of both enantiomers of diethyl tartrate(0.017M), L enantiomer is labeled 
with L. 
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Figure 4-2. Vibrational absorption(bottom) and VCD(top) spectra in the Mid IR region in 
DMSO-d6 solution of: (a) dimethyl D-tartrate(0.046M), (b) diethyl D-tartrate(0.040M), 
(c)both enantiomers of  diisopropyl tartrate(0.035M), L enantiomer is labeled with L. 
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Figure 4-3. Vibrational absorption(bottom) and VCD(top) spectra in the C=O stretching 
region  in D2O solution of: (a) dimethyl D-tartrate(0.048M), (b) diethyl D-
tartrate(0.041M). 
 
 
  2.Optical rotation study of dialkyl tartrates 
The intrinsic rotations of dimethyl D-tartrate were measured in three solvents: CCl4, 
DMSO and H2O. The specific rotation, [α]D, and observed rotation, αD, as a function of 
concentration in different solvents are displayed in Figure 4-4. The intrinsic rotations, 
{α}D are derived from these data. The {α}D for dimethyl D-tartrate is 43.0 in CCl4. In 
DMSO, the intrinsic rotation is -3.1 while this value changes to -20.3 in H2O solvent. So 
the intrinsic rotation of dimethyl D-tartrate is significantly affected when the solvent is 
changed from CCl4 to DMSO and H2O. 
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Figure 4-4. Optical rotation (αD) and specific rotation ([α]D) of dimethyl  D-tartrate, as a 
function of concentration in CCl4, DMSO and H2O solutions. In CCl4, a plot of αD versus 
concentration was fit to αD =43.02c; a plot of [α]D versus concentration was fit to [α]D 
=43.0. In DMSO, a plot of αD versus concentration was fit to αD = -3.13c and a plot of 
[α]D versus concentration was fit to [α]D = -3.1. In H2O, a plot of αD versus concentration 
was fit to αD = -20.75c and a plot of [α]D versus concentration was fit to [α]D = -20.8. 
Fitting of the specific rotation versus concentration required the weighted least-squares 
method. 
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  3. DFT calculations 
Different absorption and VCD spectra and different optical rotations in different 
solvents are usually caused by conformational change of molecules in different solvents. 
DFT calculations were performed to study the conformation of dialkyl tartrate molecules 
in different solvents. Based on previous VCD and NMR studies, T conformer(shown on 
Figure 4-5) is the favored structure for dialkyl tartrate.12,15 Rychlewska et al analyzed the 
conformation of isolated dimethyl (R,R)-tartrate by ab-initio quantum calculations and 
proposed five lowest energy conformers. Among them, two T conformers( T(ss) and 
T(as)) are the lowest energy forms.16 
 
 
 
Figure 4-5. The three principle conformations of dialkyl (R,R)-tartrate around the C*-C* 
bond. 
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    In our study, DFT calculations were done first for isolated dimethyl (S,S)-tartrate. 22 
conformers of the isolated molecules were considered and B3LYP/6-31G* and B3LYP/ 
COOR
H OH
COOR
OHH
T
COOR
H OH
OH
HROOC
COOR
H OH
H
COORHO
G- G
+
 92 
aug-cc-pVDZ basis sets were both used for calculations. VA and VCD spectra in the 
mid-infrared region and specific rotation for isolated dimethyl (S,S)-tartrate were both 
predicted. 
22 geometries for isolated dimethyl (S,S)-tartrate molecule were optimized with the 
B3LYP/6-31G* basis set in Gaussian 98 program. These geometries and their electronic 
energies are listed in Table 4-1. The five most stable conformations (see Figure 4-6) are 
found and they were further examined at aug-cc-pVDZ basis set. Four among these five 
conformers correspond well with most stable ones in Rychlewska’s study. The most 
stable conformer is trans-COOCH3-1 with two internal hydrogen bonds between the 
hydrogen atoms of OH groups and their nearest C=O groups.  Trans-COOCH3-1 
corresponds to T(ss) in Rychlewska’s study. The only exception is the second lowest 
energy conformer: trans-COOCH3-2. Trans-COOCH3-2 has one internal hydrogen bond 
between the hydrogen atom of OH group and its nearest C=O and the hydrogen atom of 
second OH group is approximately in between the oxygen atom of first OH group and the 
nearest ester oxygen atom. In Rychlewska’s study, the second lowest one is T(as) with 
two internal hydrogen bonds: one between the hydrogen atom of OH group and its 
nearest ester oxygen and the other between the hydrogen atom of the other OH group and 
its nearest C=O. Actually in our study, the geometry of T(as) was considered and it was 
converted into the geometry of trans-COOCH3-2 in the optimization calculation. Trans-
COOCH3-2 matches well with the second lowest energy conformer in Buffeteau’s 
study.17 
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Table 4-1. Geometries and electronic energies of the 22 conformers at B3LYP/6-31G* 
level 
Conformer intramolecular hydrogen bonding energy(hartrees) 
trans-COOCH3-1 Both: OH…..C=O attached to the same chiral carbon -685.995246 
trans-COOCH3-2 1 OH…..C=O attached to the same chiral carbon; 
1 OH: between the oxygen atom of first OH group and the 
nearest ester oxygen atom 
-685.993571 
trans-COOCH3-3 Both: OH…..C=O attached to the adjacent chiral carbons -685.986590 
trans-COOCH3-4 Both: OH…..ester oxygen attached to the same chiral 
carbon 
-685.960518 
trans-COOCH3-5 Both: OH…..ester oxygen attached to the adjacent chiral 
carbons 
-685.975453 
trans-COOCH3-6 1 OH…..C=O attached to the adjacent chiral carbons; 
1 OH……OH 
-685.988945 
trans-COOCH3-7 1 OH…..ester oxygen attached to the same chiral carbons; 
1 OH: between the oxygen atom of first OH group and the 
nearest ester oxygen atom 
-685.988838 
trans-COOCH3-8 1 OH…..ester oxygen attached to the adjacent chiral 
carbons; 
1 OH……OH 
-685.984855 
trans-COOCH3-9 1 OH…..C=O attached to the same chiral carbons; 
1 OH…..ester oxygen attached to the same chiral carbons; 
-685.993571 
(converted to trans-
COOCH3-2) 
trans-OH-1 Both: OH…..C=O attached to the same chiral carbon -685.992120 
trans-OH-2 Both: OH…..C=O attached to the adjacent chiral carbons -685.993837 
trans-OH-3 1 OH…..C=O attached to the same chiral carbons; 
1 OH…..ester oxygen attached to the adjacent chiral 
carbons; 
-685.992194 
trans-OH-4 Both: OH…..ester oxygen attached to the same chiral 
carbon 
-685.993837 
(converted to trans-
OH-2) 
trans-OH-5 Both: OH…..ester oxygen attached to the adjacent chiral 
carbons 
-685.992126 
(converted to trans-
OH-1) 
trans-OH-6 1 OH…..C=O attached to the same chiral carbon; 
1 OH…..ester oxygen attached to the same chiral carbon; 
-685.986085 
trans-OH-7 Both: OH free Can not be 
optimized 
trans-OH-8 1 OH…..C=O attached to the adjacent chiral carbons; 
1 OH…..ester oxygen attached to the adjacent chiral 
carbon; 
-685.989258 
trans-H-1 Both: OH…..C=O attached to the same chiral carbon -685.987905 
trans-H-2 Both: OH…..ester oxygen attached to the same chiral 
carbon 
-685.982640 
trans-H-3 1 OH…..C=O attached to the same chiral carbon; 
1 OH……OH 
-685.989018 
trans-H-4 1 OH…..ester oxygen attached to the same chiral carbon; 
1 OH……OH 
-685.985202 
trans-H-5 1 OH…..ester oxygen attached to the same chiral carbon; 
1 OH……C=O attached to the same chiral carbon; 
-685.985739 
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Figure 4-6. The five lowest energy conformers of dimethyl (S,S)-tartrate at B3LYP/6-
31G* level in our study  
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Gaussian 98 program are listed in Table 4-2. Trans-COOCH3-1 is the predominant 
conformer for isolated dimethyl (S,S)-tartrate. For the specific rotations, only Trans-
COOCH3-2 has a negative value. The predicted specific rotations, obtained as population 
weighted sum of specific rotations of different conformers, are 50.4 at the 6-31G* basis 
and 38.8 at the aug-cc-pVDZ basis. These two predicted values are close to the 
experimental intrinsic rotation of dimethyl D-tartrate in CCl4 (see Table 4-8), especially 
in the case at the aug-cc-pVDZ basis. (Aug-cc-pVDZ is a higher level basis set compared 
with 6-31G*).  Our group18a also predicted the theoretical optical rotatory dispersion 
(ORD18b, optical rotation as a function of wavelength) for dimethyl (S,S)-tartrate at the  
aug-cc-pVDZ basis set. The predicted ORD was obtained as population weighted data 
from the two lowest energy conformers of isolated dimethyl (S,S)-tartrate: Trans-
COOCH3-1  and Trans-COOCH3-2. The predicted ORD is compared with experimental 
ORD of dimethyl D-tartrate in CCl4 in Figure 4-10. A good correlation is found between 
the predicted ORD and the experimental one. 
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Table 4-2. B3LYP calculated Gibbs energies; populations, and specific rotations of five 
conformers of isolated dimethyl (S, S)-tartrate 
 Trans-COOCH3-1 Trans-COOCH3-2 Trans-OH-1 Trans-OH-2 Trans-OH-3 
 Gibbs Energy (in hartrees) 
6-31G* -685.86466 -685.86270 -685.86158 -685.86160 -685.86066 
aug-cc-pVDZ -685.98342 -685.98113 -685.97953 -685.97774 -685.97799 
 Population(%)     
6-31G* 82.1 10.4 3.1 3.2 1.2 
aug-cc-pVDZ 90.2 7.9 1.4 0.2 0.3 
 Specific rotation, 
[α]D 
    
6-31G* 65.2 -109.7 222.9 53.5 102.9 
aug-cc-pVDZ 47.9 -120.8 209.9 42.2 103.4 
 
  The absorption and VCD intensities were calculated for the five conformations at the 
B3LYP/6-31G* and B3LYP/aug-cc-pVDZ levels, and all of these conformations were 
found to have potential energy minima (i.e., all vibrational frequencies are real). The 
absorption and VCD spectra for all five conformations of dimethyl (S,S)-tartrate were 
simulated with 5 cm-1 half widths and Lorentzian band shapes. The absorption and VCD 
spectra at the B3LYP/6-31G* and B3LYP/aug-cc-pVDZ levels for these five individual 
conformers and for the isolated molecule, obtained as population weighted sum of the 
absorption and VCD spectra of individual conformers,  are shown in Figures 4-7 ~ 4-8.  
The calculated frequencies (νi), dipole strengths (Di) and rotation strengths (Ri) of five 
conformers of isolated dimethyl (S, S)-tartrate at the B3LYP/6-31G* and B3LYP/aug-cc-
pVDZ levels are listed in Table 4-3 and Table 4-4 respectively. The predicted absorption 
and VCD spectra for the isolated dimethyl (S,S)-tartrate (population weighted sum of 
conformer spectra) at both the B3LYP/6-31G* and B3LYP/aug-cc-pVDZ levels are 
compared in the Mid IR region with experimental spectra of diethyl D-tartrate in CCl4 in 
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Figures 4-9. Experimental absorption and VCD band positions of diethyl D-tartrate in 
CCl4 and their corresponding B3LYP predicted values of isolated dimethyl (S, S)-tartrate 
are shown in Table 4-7. The predicted absorption and VCD spectra at the B3LYP/6-31G* 
level are identical with those at the B3LYP/aug-cc-pVDZ level except that frequencies of 
absorption and VCD  bands of predicted spectra at the B3LYP/aug-cc-pVDZ level are 
higher by about 10 cm-1 than those of the corresponding bands of predicted spectra at the 
B3LYP/6-31G* level. Overall, these predicted absorption and VCD spectra have good 
correspondence with the experimental spectra of dialkyl tartrates in CCl4 in band 
positions and relative peak intensities. There is just a small disagreement in the VCD 
spectra: a weak negative-positive doublet is seen in the 1450-1350 cm-1 region in the 
predicted VCD spectrum while it does not show up in the experimental spectrum. 
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Figure 4-7. The simulated absorption (top) and VCD (bottom) spectra with B3LYP/6-
31G* for individual conformers of isolated dimethyl (S, S)-tartrate and for the isolated 
molecule (population weighted sum of conformer spectra). The 6-31G* frequencies were 
scaled by 0.96, and a bandwidth of 5 cm-1 was used in the spectral simulation. 
Populations determined from the Gibbs energies (Table 2) are used to obtain the 
predicted spectrum. 
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Figure 4-8. The simulated absorption (top) and VCD (bottom) spectra with B3LYP/aug-
cc-pVDZ for individual conformers of isolated dimethyl (S, S)-tartrate and for the 
isolated molecule (population weighted sum of conformer spectra). A bandwidth of 5 cm-
1 was used in the spectral simulation. Populations determined from the Gibbs energies 
(Table 4-2) are used to obtain the predicted spectrum. 
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Table 4-3. Calculated frequenciesa (νi), dipole strengths (Di) and rotation strengths (Ri) of five conformers of isolated dimethyl (S, S)-
tartrate at B3LYP/6-31G* levelb 
Trans-COOCH3-1 Trans-COOCH3-2 Trans-OH-1 Trans-OH-2 Trans-OH-3 
νi Di Ri νi Di Ri νi Di Ri νi Di Ri νi Di Ri 
1750 619.6 -277.6 1750 379.1 11.4 1731 145.9 -290.1 1704 814.4 -139.6 1749 443.5 -172.1 
1748 272.9 310.2 1740 480.3 -30.3 1730 720.0 402.0 1401 514.6 36.9 1737 413.1 256.6 
1415 79.7 -98.0 1388 206.4 11.8 1410 129.0 113.4 1330 208.3 20.7 1407 188.5 112.3 
1399 98.9 239.2 1266 113.8 67.6 1315 441.9 -331.7 1290 500.9 -331.9 1349 306.3 -174.2 
1277 52.1 -99.1 1250 2042.8 -75.9 1288 247.4 280.0 1275 133.7 125.9 1292 223.4 -68.0 
1276 378.3 -436.6 1225 473.9 -32.7 1240 858.2 -461.6 1243 1533.8 235.3 1218 363.2 285.3 
1251 2150.1 416.5 1200 85.3 -64.1 1231 285.6 222.0 1094 598.8 36.6 1214 677.1 -62.7 
1225 236.8 -51.7 1102 472.1 -199.6 1213 789.4 -67.3 1048 281.3 50.4 1190 851.9 -155.5 
1107 553.2 -367.7 1062 360.9 123.7 1096 212.1 175.5 989 201.4 -93.3 1097 308.1 34.4 
1083 509.3 175.4 1014 174.8 0.6 1088 672.9 -93.1 947 26.7 32.5 1062 452.0 -4.1 
974 175.5 31.6 981 135.8 -9.0 971 42.4 60.7 903 166.0 -44.4 1035 109.6 -93.1 
a Calculated frequencies with B3LYP/6-31G* level were scaled with 0.96.  b Frequencies are in cm-1, dipole strengths are in 10-40 
esu2cm2, and rotational strengths are in 10-44 esu2cm2. 
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Table 4-4. Calculated frequencies (νi), dipole strengths (Di) and rotation strengths (Ri) of five conformers of isolated dimethyl (S, S)-
tartrate at B3LYP/ aug-cc-pVDZ levela 
Trans-COOCH3-1 Trans-COOCH3-2 Trans-OH-1 Trans-OH-2 Trans-OH-3 
νi Di Ri νi Di Ri νi Di Ri νi Di Ri νi Di Ri 
1781 659.5 -332.6 1778 413.9 41.4 1762 167.4 -338.7 1738 24.2 137.7 1779 522.3 -292.8 
1778 373.6 362.9 1770 596.9 -64.4 1761 835.7 450.3 1737 906.1 -195.8 1770 453.5 394.6 
1431 31.7 -57.8 1413 165.6 56.4 1458 78.0 79.1 1437 41.5 -92.2 1374 259.4 -174.8 
1410 60.6 167.3 1298 106.6 157.6 1431 52.0 53.9 1423 390.4 68.6 1312 248.3 -71.8 
1299 403.1 -551.4 1278 1431.0 -75.0 1342 338.0 -326.7 1359 272.6 44.3 1278 107.3 89.6 
1271 2063.6 456.2 1254 887.7 -114.1 1309 241.6 309.1 1318 392.6 -296.0 1238 467.6 -0.5 
1242 208.4 -10.7 1223 39.7 -40.7 1263 1057.9 -540.5 1290 94.6 106.2 1237 414.6 170.9 
1212 105.4 42.9 1135 476.8 -223.1 1253 237.3 170.5 1265 1456.5 156.2 1216 913.6 -148.8 
1138 554.6 -411.7 1093 430.4 125.5 1235 642.9 1.0 1117 573.5 32.5 1190 219.8 -32.8 
1113 607.9 192.2 1038 183.5 1.8 1123 266.7 198.3 1012 235.1 -93.6 1087 453.9 -5.1 
995 176.9 35.3 1003 142.7 -3.3 1113 662.2 -124.8 927 162.0 -49.8 1071 114.2 -91.0 
a Frequencies are in cm-1, dipole strengths are in 10-40 esu2cm2, and rotational strengths are in 10-44 esu2cm2. 
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  Using the PCM model that was implemented in the Gaussian 03 program, optimization 
calculation of the five geometries was performed in CCl4 solvent. The geometry of Trans-
OH-2 is found unstable in CCl4. Buffeteau et al
17 also reported that this conformer can 
not be stabilized in the presence of a solvent before. The specific rotations and absorption 
and VCD intensities for the other four conformers were calculated at the B3LYP/6-31G* 
level with the PCM model.  
  The Gibbs energies, relative populations and specific rotations predicted for the four 
conformers of the molecule in CCl4 using 6-31G* basis set in the Gaussian 03 program 
are listed in Table 4-5. Trans-COOCH3-1 is still the predominant conformer for dimethyl 
(S,S)-tartrate in CCl4. For the specific rotations, only small difference (less than 10%) is 
found for the value of each conformer in CCl4 compared with calculation results for 
isolated molecule. Trans-COOCH3-2 still has a negative value. The population-weighted 
predicted specific rotation is 53.2 at the 6-31G* basis. This predicted value is close to the 
experimental intrinsic rotation of dimethyl D-tartrate in CCl4 and predicted values for the 
isolated molecule (see Table 4-8). 
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Table 4-5. B3LYP/ 6-31G* calculated Gibbs energies; populations, and specific rotations 
of conformers of dimethyl (S, S)-tartrate in CCl4 
 
 Trans-COOCH3-1 Trans-COOCH3-2 Trans-OH-1 Trans-OH-3 
Gibbs Energy 
(in hartrees) 
-685.87308 -685.87104 -685.86890 -685.86066 
Population(%) 88.4 10.1 1.1 0.4 
Specific 
rotation, [α]D 
70.0 -111.5 241.1 91.2 
 
 
  From the absorption and VCD results of the molecule in CCl4, all the four conformers 
were found to have potential energy minima. The population-weighted predicted 
absorption and VCD spectra for dimethyl (S,S)-tartrate in CCl4 are shown in Figure 4-9.  
Experimental absorption and VCD band positions of diethyl D-tartrate in CCl4 and their 
corresponding B3LYP Predicted values of dimethyl (S, S)-tartrate in CCl4 are shown in 
Table 4-7. The predicted absorption and VCD spectra of dimethyl (S,S)-tartrate in CCl4  
have a good agreement with predicted spectra of the isolated molecule and correspond 
well with the experimental spectra of dialkyl tartrate in CCl4 except that a weak negative-
positive doublet is seen in the 1450-1350 cm-1 region in the predicted VCD spectrum in 
CCl4 while it does not show up in the experimental spectrum. 
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Table 4-6. Calculated frequenciesa (νi), dipole strengths (Di) and rotation strengths (Ri) of four conformers of dimethyl (S, S)-tartrate 
in CCl4 at B3LYP/6-31G* level
b 
Trans-COOCH3-1 Trans-COOCH3-2 Trans-OH-1 Trans-OH-3 
νi Di Ri νi Di Ri νi Di Ri νi Di Ri 
1740 819.2 
-
326.8 
1734 338.3 208.5 1724 237.6 
-
313.5 
1739 611.7 
-
198.3 
1737 355.9 364.5 1731 789.2 
-
235.9 
1721 872.4 417.2 1729 476.9 280.5 
1402 58.7 -55.7 1376 227.1 62.0 1400 117.3 142.6 1400 209.1 104.6 
1383 87.9 197.6 1262 266.3 145.6 1309 434.4 
-
290.5 
1344 337.1 
-
168.2 
1266 452.1 
-
425.9 
1247 1969.9 -67.7 1275 302.6 325.6 1291 236.5 -75.9 
1242 2345.8 499.8 1224 757.7 -27.5 1233 1199.0 
-
573.1 
1214 488.2 214.8 
1222 306.5 -79.4 1193 163.2 -70.3 1230 326.7 218.2 1213 655.4 64.0 
1185 105.3 47.7 1099 672.1 
-
258.3 
1210 834.0 -52.7 1187 1087.1 
-
180.0 
1099 766.1 
-
447.6 
1059 469.6 154.1 1091 279.6 217.0 1092 397.2 55.4 
1075 659.8 228.1 1008 209.8 2.8 1080 936.2 
-
117.4 
1054 544.5 3.2 
968 196.1 41.0 974 152.8 -11.7 966 55.2 78.4 1034 233.4 -143.0 
a Calculated frequencies with B3LYP/6-31G* level were scaled with 0.96.  b Frequencies are in cm-1, dipole strengths are in 10-40 
esu2cm2, and rotational strengths are in 10-44 esu2cm2. 
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Figure 4-9. Comparison of the experimental absorption (top) and VCD (bottom)  
spectra of diethyl D-tartrate in CCl4 with predicted absorption spectra of isolated 
dimethyl (S, S)-tartrate and the molecule in CCl4. The 6-31G* frequencies were 
scaled by 0.96. A bandwidth of 5 cm-1 was used in all the spectral simulations. 
1800 1600 1400 1200 1000
0
2000
4000
6000
8000
2
2
2
2
1
1
1
8
8
8
8
7
7
7
7
6
6
6
5
5
5
5
6
4
4
4
4
3
3
3
3
1
6-31G
*
for molecule in CCl
4
aug-cc-pVDZ for isolated molecule
6-31G
*
for isolated molecule
Experimental
 
 
εε εε(
L
*
m
o
l-
1
*
cm
-1
)
Wavenumber(cm
-1
)
1800 1600 1400 1200 1000
0
2000
4000
6000
8000
10000
1b
1b
1b
1b
8
8
8
7
7
7
6
6
6
5
5
4
5
4
3
3
3
1a
1a
2
2
2
1a
7
6
4
53
1a
2
6-31G
*
for molecule in CCl
4
aug-cc-pVDZ for isolated molecule
6-31G
*
for isolated molecule
Experimental
 
 
∆ε∆ε ∆ε∆ε
 X
1
0
4
(L
*
m
o
l-
1
*
cm
-1
)
Wavenumber(cm
-1
)
 106 
Table 4-7. Experimental absorption and VCD band positionsa of diethyl D-tartrate in CCl4 and their correlation to B3LYP predicted values of 
isolated dimethyl (S, S)-tartrate and the molecule in CCl4 
 
Predicted Experimental 
6-31G* for isolated 
moleculeb 
aug-cc-pVDZ for 
isolated molecule 
6-31G* for  molecule 
in CCl4
b 
 
 
No 
absorption VCD absorption VCD absorption VCD absorption VCD 
1750 (-)c 1750 (-) 1781 (-) 1740 (-) 1 1746 
1744(+)c 
1749 
1748(+) 
1780 
1778(+) 
1739 
1737(+) 
2 1285 1285(-) 1276 1276(-) 1299 1299(-) 1266 1266(-) 
3 1252 1252(+) 1251 1251(+) 1271 1271(+) 1242 1242(+) 
4 1226 1226(-) 1225 1225(-) 1242 … 1222 1222(-) 
5 1200 1200(+) 1200 1200(+) 1212 1212(+) 1185 1185(+) 
6 1124 1124(-) 1107 1107(-) 1138 1138(-) 1099 1099(-) 
7 1092 1092(+) 1083 1083(+) 1113 1113(+) 1075 1075(+) 
8 1019 …d 974 974(+) 995 995(+) 968 968(+) 
a band positions are in cm-1; bpredicted band positions at B3LYP/6-31G* level were scaled with 0.96; c(+) refers to the positive sign of VCD 
band and (-) refers to the negative sign of VCD band; d”…” means that no corresponding VCD band is found.   
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Table 4-8. B3LYP predicted specific rotation([α]D) of dimethyl (S, S)-tartrate and 
experimental intrinsic rotation({α}D) of dimethyl D-tartrate 
Method Value 
Predicted Specific Rotation[α]D for isolated 
molecule 
6-31G* 50.4 
aug-cc-pVDZ 38.8 
Predicted Specific Rotation[α]D in CCl4 
6-31G* 53.2 
Experimental intrinsic rotation{α}D 
CCl4 43.0±1.6 
 
 
Figure 4-10 Comparison of experimental ORD of dimethyl D-tartrate in CCl4 and 
predicted ORD for isolated dimethyl (S,S)-tartrate. The predicted ORD was obtained as 
population weighted data from the two lowest energy conformers of isolated dimethyl 
(S,S)-tartrate: Trans-COOCH3-1  and Trans-COOCH3-2 at B3LYP/aug-cc-pVDZ basic 
set. 
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DFT calculations of dimethyl (S,S)-tartrate were continued in DMSO solvent. PCM 
model in the Gaussian 03 program was used to do the calculation but it turned out 
conformers of dimethyl (S,S)-tartrate can not be optimized in DMSO with PCM model. 
Then clusters of dimethyl (S,S)-tartrate with the solvent molecules were considered to 
perform the calculation.  Proniewicz et al19 have reported structural study of several 
hydroxamic acids in DMSO solutions based on the DFT calculations of NMR spectra. In 
their study they used clusters of the compounds with DMSO molecules in DFT 
calculation and the computed chemical shifts of these clusters are in good agreement with 
experimental data. 
Dimethyl (S,S)-tartrate molecule has two –OH groups which are capable to form 
hydrogen bonds with DMSO molecules. 
  Two geometries of clusters of trans-COOCH3 conformers of dimethyl (S,S)-tartrate 
with 2 DMSO were considered first. Their structures are shown in Figure 4-11. The only 
difference between these 2 geometries is: in Trans-COOCH3-(DMSO)2-0, the 2 hydrogen 
bonds are between OH group and C=O group, which are connected to the same chiral 
carbon; while in Trans-COOCH3-(DMSO)2-1, the 2 hydrogen bonds are between OH 
groups and S=O groups of solvent molecules. Based on their energies after optimization 
with B3LYP/6-31G* basis set (shown in Figure 4-11), Trans-COOCH3-(DMSO)2-1, is 
much more stable than Trans-COOCH3-(DMSO)2-0. That means that in DMSO, dimethyl 
(S,S)-tartrate prefers to forming intermolecular hydrogen bonds with solvent molecules 
compared with forming internal hydrogen bonds. 
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Figure 4-11. Structures and electronic energies(with B3LYP/6-31G* basis set) of 
TransCOOCH3-(DMSO)2-)-0 and TransCOOCH3-(DMSO)2-1 
 
Another 5 geometries of clusters of dimethyl (S,S)-tartrate with 2 DMSO molecules 
were considered. Their structures are shown in Figure 4-12. For each of these 5 clusters, 
the hydrogen bonds are between OH groups and S=O groups of solvent molecules. Based 
on geometry of dimethyl (S,S)-tartrate in the clusters, these clusters can be divided into 
three groups: trans-COOCH3, trans-OH and trans-H conformers of clusters. With Trans-
COOCH3-(DMSO)2-1 included, two geometries of clusters with 2 DMSO were chosen 
for each group of clusters. For each group of clusters, the only difference between the 
two geometries is the position of ester groups and C=O groups for dimethyl (S,S)-tartrate. 
The electronic energies and Gibbs energies were calculated for the 6 conformers of 
clusters of dimethyl (S,S)-tartrate with 2 DMSO molecules at the B3LYP/6-31G* level. 
The results are listed in Table 4-9. The absorption and VCD intensities were also 
calculated for these 6 conformations at the B3LYP/6-31G* level. All of these 
conformations except Trans-COOCH3-(DMSO)2-2 are found to have potential energy 
minima. For Trans-COOCH3-(DMSO)2-2, negative vibrational frequencies are found. 
The absorption and VCD spectra for the 5 conformations with potential energy minima 
Trans-COOCH3-(DMSO)2-0 
E(energy): -1792.3926 hartrees 
Trans-COOCH3-(DMSO)2-1 
E: -1792.3966 hartrees 
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were simulated with 5 cm-1 half widths and Lorentzian band shapes (shown in Figure 4-
13). Based on Gibbs energies, Trans-OH-(DMSO)2-1 is the most dominant conformers. 
But the predicted absorption and VCD spectra  (see Figure 4-13) and the predicted optical 
rotation  (150.1 at 589 nm) based on the populations of conformers calculated from Gibbs 
energies of these conformers (listed in Table 4-9) are far from matching with the 
experimental ones. A different approach based on the experimental intrinsic rotation and 
experimental VCD spectrum was used to determine the dominant conformers and 
populations of the conformers. 
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Figure 4-12. Structures of 6 conformers of clusters of dimethyl (S,S)-tartrate with 2 
DMSO molecules with hydrogen bonds between OH and S=O  
Trans-COOCH3-(DMSO)2-1 
Trans-COOCH3-(DMSO)2-2 
Trans-OH-(DMSO)2-1 
Trans-OH-(DMSO)2-2 
Trans-H-(DMSO)2-1 Trans-H-(DMSO)2-2 
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Table 4-9 B3LYP/ 6-31G* calculated Gibbs energies; and specific rotations of conformers of clusters of dimethyl (S, S)-tartrate with 
DMSO 
 
 Gibbs 
Energy (in 
hartrees) 
Population 
(%) 
Specific 
rotation, [α] 
(633nm) 
Specific 
rotation, [α] 
(589nm) 
Specific 
rotation, [α] 
(546nm) 
Specific 
rotation, [α] 
(436nm) 
Specific 
rotation, [α] 
(405nm) 
Specific 
rotation, [α] 
(365nm) 
Trans-COOCH3-(DMSO)2-1 -1792.1258 20.7 14.1 18.0 23.8 59.1 81.5 135.2 
Trans-COOCH3-(DMSO)2-2
*         
Trans-OH-(DMSO)2-1 -1792.1269 66.2 154.2 181.2 215.3 369.3 446.1 591.2 
Trans-OH-(DMSO)2-2 -1792.1243 4.2 126.2 148.8 177.5 309.8 377.4 508.0 
Trans-H-(DMSO)2-1 -1792.1250 8.8 194.1 229.0 273.5 479.7 586.0 793.4 
Trans-H-(DMSO)2-2 -1792.1207 0.1 13.8 17.2 22.0 49.0 65.8 103.7 
*: Trans-COOCH3-(DMSO)2-2 has no potential energy minima. 
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Figure 4-13. The simulated absorption (top) and VCD (bottom) spectra for conformers of 
cluster of dimethyl (S, S)-tartrate with 2 DMSO and for the molecule in DMSO 
(population weighted sum of conformer spectra) with B3LYP/6-31G*. The 6-31G* 
frequencies were scaled by 0.96, and a bandwidth of 5 cm-1 was used in the spectral 
simulation.  
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The experimental intrinsic rotation of dimethyl D-tartrate in DMSO solvent is -3.1±0.2 
at 589nm. This value is very close to zero. When comparing predicted specific rotation 
value with this experimental intrinsic rotation value, it is really hard to determine they 
correspond well or not because even with a small difference of 4 between them the sign 
of optical rotation may change from negative to positive. So it is necessary to measure the 
experimental intrinsic rotation of dimethyl D-tartrate in DMSO at other wavelengths. So 
we first measured the specific rotations of dimethyl D-tartrate at 6 wavelengths (633nm ~ 
365nm) at the concentration of 0.0064M in DMSO (see Figure 4-15). Specific ration of 
dimethyl D-tartrate changes from negative into positive as the wavelength decreases. 
Dimethyl D-tartrate has anomalous optical rotatory dispersion18c in DMSO. It is 
necessary to measure the intrinsic rotation of dimethyl D-tartrate at a lower wavelength. 
So intrinsic rotation of dimethyl D-tartrate was also measured at 365nm in DMSO and 
the intrinsic rotation is 42.7±0.4.  
    Specific rotations of these 5 conformations were predicted at 6 wavelengths (633nm ~ 
365nm) at the B3LYP/6-31G* level. The results are shown in Table 4-9. Trans-
COOCH3-(DMSO)2-1 and Trans-H-(DMSO)2-2 have the closest specific rotations to the 
experimental intrinsic rotation both at 589nm and 365nm. When the predicted absorption 
spectra of these 2 conformers are combined, two bands are formed in the C=O stretching 
region. These two bands correspond well with the experimental absorption bands in this 
region for dialkyl D-tartrates in DMSO-d6. When the predicted VCD spectra of these 2 
conformers are combined, a negative-positive-negative triplet is formed in the C=O 
stretching region, which has also a good agreement with the experimental VCD sign in 
this region. Based on the fact that the intensities of two negative bands of this triplet are 
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almost the same in the experimental VCD spectra of dialkyl tartrates, populations of these 
two conformers were predicted. It is found that when populations of Trans-COOCH3-
(DMSO)2-1 and Trans-H-(DMSO)2-2 are 62.5% and 37.5% respectively, the two 
negative bands of predicted VCD spectrum of dimethyl (S,S)-tartrate are almost the same. 
The empirically predicted absorption and VCD spectra of dimethyl (S,S)-tartrate 
(population weighted sum of  spectra of Trans-COOCH3-(DMSO)2-1 and Trans-H-
(DMSO)2-2) are compared with the experimental spectra of dimethyl D-tartrate in 
DMSO-d6 solvent and shown on Figure 4-14. Experimental absorption and VCD band 
positions of dimethyl D-tartrate in DMSO-d6 and their corresponding values in the 
empirically predicted spectra are shown in Table 4-10. For the absorption spectra, a good 
agreement is seen for major bands in the comparison between the empirically predicted 
and the experimental spectra. Overall the bands in the experimental absorption spectrum 
are broader than those in the empirically predicted spectrum and several small bands 
which show up in the 1300-1180 cm-1 region in the empirically predicted spectrum have 
not been observed in the experimental spectra possibly because of their overlapping with 
other bands. For the VCD spectra, there is a good agreement in the C=O stretching region 
(1850-1600 cm-1) and the C-O stretching region (1250-1100 cm-1) between the VCD 
bands in the empirically predicted spectrum and those in experimental spectrum. Several 
bands with relatively low intensities are observed in the 1500-1250 cm-1 region in the 
empirically predicted VCD spectrum but these VCD bands did not show up in the 
experimental spectrum. A similar discrepancy was also seen for the spectra in 
CCl4(Figure 4-9). The empirically predicted specific rotations (population weighted sum 
of specific rotations of Trans-COOCH3-(DMSO)2-1 and Trans-H-(DMSO)2-2) are listed 
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on Table 4-11. At 589 nm, the experimental intrinsic rotation is close to zero. Even 
though the empirically predicted value (17.7) is close to the experimental one (-3.1±0.2), 
they differ in the sign. At 365 nm, the difference between the empirically predicted 
optical rotation and experimental intrinsic rotation is bigger than that at 589nm but the 
empirically predicted optical rotation and experimental value match in the sign. The 
empirically predicted optical rotatory dispersion (ORD) for dimethyl (S,S)-tartrate in 
DMSO , which was obtained as population weighted data from Trans-COOCH3-
(DMSO)2-1 and Trans-H-(DMSO)2-2) , is compared with experimental ORD of dimethyl 
D-tartrate in DMSO in Figure 4-15. There is a gap between empirically predicted ORD 
and experimental ORD. But overall there is a good correlation between the predicted 
ORD and the experimental one. 
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Figure 4-14. Comparison of the experimental absorption (top) and VCD (bottom) spectra 
of dimethyl D-tartrate in DMSO-d6 with the simulated absorption spectra of Trans-
COOCH3-(DMSO)2-1 and Trans-H-(DMSO)2-2 conformers and the predicted absorption 
spectra of dimethyl (S,S)-tartrate in DMSO (population weighted sum of conformer 
spectra). The 6-31G* frequencies were scaled by 0.96, and a bandwidth of 5 cm-1 was 
used in the spectral simulation. 
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Table 4-10. Experimental absorption and VCD band positionsa of dimethyl D-tartrate in 
DMSO-d6 and their correlation to predicted values of dimethyl (S, S)-tartrate in DMSO 
 
Experimental Predictedb No 
absorption VCD absorption VCD 
1763 (-)c 1750 (-) 1 1753 
1747(+)c 
1748 
1745(+) 
2 1736 1736(-) 1737 1737 (-) 
1447(+) 3 1457 …d 1445 
1437(-) 
1422(-) 4 1437 … 1420 
1410(+) 
1313(+) 5 1324 … 1311 
1306(-) 
1248(+) 6 1273 … 1246 
1234(-) 
1224(-) 1207(-) 7 1207 
1201(+) 
1188 
1186(+) 
8 1146 1146(-) 1142 1142(-) 
a band positions are in cm-1; bpredicted band positions at B3LYP/6-31G* level were 
scaled with 0.96; c(+) refers to the positive sign of VCD band and (-) refers to the 
negative sign of VCD band; d”…” means that no corresponding VCD band is found.   
 
 
Table 4-11. B3LYP/6-31G* empirically predicted specific rotation([α]D) of dimethyl (S, 
S)-tartrate and experimental intrinsic rotation({α}D) of dimethyl D-tartrate in DMSO 
Wavelength Value 
Empirically predicted specific rotation[α]D for 
isolated molecule 
589 nm 17.7 
365 nm 123.4 
Experimental intrinsic rotation{α}D 
589 nm -3.1±0.2 
365 nm 42.7±0.4 
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Figure 4-15 Comparison of experimental ORD of dimethyl D-tartrate in DMSO and 
predicted ORD for dimethyl (S,S)-tartrate in DMSO. The predicted ORD was obtained as 
population weighted data from the two conformers of cluster of dimethyl (S,S)-tartrate 
with 2 DMSO: Trans-COOCH3-(DMSO)2-1 and Trans-H-(DMSO)2-2 at B3LYP/6-31G* 
basic set. 
 
We could not perform calculation about dimethyl (S, S)-tartrate in H2O successfully 
because great difficulties exist in the prediction of absorption and VCD spectra and 
optical rotation for dimethyl (S, S)-tartrate in H2O. Hydrogen bonding between dimethyl 
(S, S)-tartrate and solvent molecules is a very important factor in investigation of 
conformations of dimethyl (S, S)-tartrate in H2O. PCM model in the Gaussian 03 program 
does not considerate hydrogen bonding in the calculation. Clusters of dimethyl (S, S)-
tartrate with H2O molecules were also tried in the calculation but the number of H2O 
molecules in the clusters is hard to determine because H2O molecules are both hydrogen 
bond donors and acceptors while DMSO molecules are just hydrogen bond acceptors.  
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4. Study of dialkyl tartrate cyclodextrin complexes 
Dialkyl tartrate cyclodextrin complexes were prepared using coprecipitation method 
and characterized by 1H NMR. From the integration result in the NMR spectra, the 
complexation ratios for these complexes are confirmed to be 1:1. 
The vibrational absorption and VCD spectra of dialkyl tartrate-cyclodextrin complexes 
were measured in DMSO-d6 and D2O solvents in the Mid IR region(see Figures 4-16 ~ 4-
17). The absorption and VCD bands in the region below 1600 cm-1 originate from 
vibrational modes of both dialkyl trate and cyclodextrin molecules in the complex while 
bands in the C=O stretching region (1850-1600 cm-1) only come from ester groups in 
dialkyl tartrate. By direct comparison between absorption and VCD bands the C=O 
region of dialkyl tartrates and those of their corresponding complexes, effects of 
complexation with cyclodextrin on dialkyl tartrate can be investigated. The absorption 
and VCD signs in the C=O region for these complexes are identical with those shown in 
the spectra of dialkyl tatrates:  in DMSO-d6, there are two absorption bands and three 
VCD bands(negative-positive-negative triplet for D enantiomer complexes); in D2O, one 
broader absorption band and no VCD signs are found. The frequencies of these bands for 
the complexes in the C=O region are almost the same as those for dialkyl tartrates. 
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Figure 4-16. Vibrational absorption(bottom) and VCD(top) spectra in the C=O region in 
D2O solution of diethyl L-tartrate α-CD complex(0.044M).  
Figure 4-17. Vibrational absorption(bottom) and VCD(top) spectra in the C=O stretching 
region in DMSO-d6 solution of (a)diethyl tartrate β -CD complex(0.040M); 
(b)diisopropyl tartrate β-CD complex(0.040M ). L enantiomer complexes are labeled 
with L. 
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   The intrinsic rotations of dialkyl tartrates-cyclodextrin complexes were measured in 
H2O. They were compared with the intrinsic rotations of 1:1 ratio mixtures of dialkyl 
tartrate and cyclodextrin in Table 4-12. The intrinsic rotations of these 1:1 ratio mixtures 
were calculated using equation 4-1, which is derived in CHAPTER VI. 
{α}mixture = {α}guest *
Mguest
(Mguest +Mhost)
+ {α}host *
Mhost
(Mguest +Mhost)  
{α}:  intrinsic rotaton; M: molar mass; dialkyl tartrate molecules are guest molecules and 
cyclodextrin molecules are host molecules. 
 
Table 4-12. Comparison of intrinsic rotations between dialkyl tartate- cyclodextrin 
complexes and their corresponding 1:1 ratio mixtures 
Guest Host Intrinsic 
rotation({α}D for the 
complex 
Intrinsic 
rotation({α}D of 1:1 
ratio mixture 
Diethyl L-tartrate α-CD 120.9±0.7 129.5±0.4 
Diethyl D-tartrate β-CD 126.0±0.9 130.6±0.4 
Diethyl L-tartrate β-CD 128.1±1.2 138.9±0.4 
Diisopropyl D-tartrate β-CD 126.0±0.9 126.7±0.4 
Diisopropyl L-tartrate β-CD 132.4±1.2 136.9±0.4 
 
 
The intrinsic rotations of dialkyl tartrate-cyclodextrin complexes are close to the values 
of 1:1 ratio mixtures of dialkyl tartrates and cyclodextrin in H2O. The differences 
between intrinsic rotation of the complexes and their corresponding mixtures are less than 
10% in all cases.  
From the comparison between VA and VCD spectra of dialkyl tartrate-cyclodextrin 
complexes and those of dialkyl tartrate in the C=O stretching region and the comparison 
 (4-1) 
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of intrinsic rotations of dialkyl tartrate-cyclodextrin complexes with  those of 1:1 ratio 
mixtures of dialkyl tartrates and cyclodextrin, it is indicated that in the solution of DMSO 
and H2O, the interaction between dialkyl tartrates and cyclodextrin is very weak and 
cyclodextrin does not change the VA, VCD and intrinsic rotation properties of dialkyl 
tartrates significantly. 
To prove the weak interaction between dialkyl tartrates and cyclodextrin in solutions, it 
is very important to measure the binding constants of dialkyl tartrates and cyclodextrin in 
solutions. Quantitative NMR method20 was tried to measure the binding constants of 
dialkyl tartrates in DMSO and H2O, but big errors are found from the results. Isothermal 
titration calorimetry (ITC) is a thermodynamic technique that allows the study of the 
interactions of two species. 14 When these two species interact, heat is either generated or 
absorbed. By measuring these interaction heats, binding constants (K), reaction 
stoichiometry (n), and thermodynamic parameters including enthalpy (∆H) and entropy 
(∆S) can be accurately determined. ITC is a direct, accurate and highly sensitive method 
to measure binding constants and other thermodynamic parameters. ITC has found 
widespread applicability in the study of biological systems21 involving protein-ligand, 
protein-nucleic acid and protein-protein interactions and also in supramolecular 
chemistry, most notably for cyclodextrins (CDs)22 and crown ethers23. 
For each titration, a curve of heat pulse (dQ/dt) over time was recorded as raw data. 
Heat pulse (dQ/dt) can be calculated by equation 4-224, where ∆T is the temperature 
difference between sample cell and reference cell, and k is the calibration constant. 
TkdtdQ ∆=/                (4-2) 
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 Then a binding curve between integrated heat (Q) and mole ratio of two species 
(ligand : macromolecules) can be obtained from raw data. The integrated heat (Q) is 
related to the molar ratio as shown in equation 4-314, where V is the reaction volume, and 
[LB], [L] and [M] are molarities of bound ligand, total ligand and total macromolecules in 
the sample cell respectively. Molar ratio of ligand to macromolecules is equal to [L]/[M]. 
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For single site interaction cases, n is equal to 1. With ORIGIN software, best fits can 
be found for binding curves based on equation 4-3 and ∆H and K and be obtained. ∆G 
(free energy) and ∆S can be obtained from equation 4-4 and 4-5 respectively. 
KRTG ln−=∆  
TGHS /)( ∆−∆=∆  
 
Calorimetric titrations were made for α-CD and β-CD with diethyl L-tartrate in both 
H2O and DMSO. The calorimetric titrations of diethyl L-tartrate with α-CD and β-CD in 
H2O and DMSO are shown in Figure 4-18. The binding constants of diethyl L-tartrate 
complexes of α-CD and β-CD in H2O and DMSO solvents are listed in Table 4-13. 
(4-5) 
 
(4-4) 
 
(4-3) 
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(c) 
(d) 
Figure 4-18. Calorimetric titrations of  (a) diethyl L-tartrate (100 mM) with α-CD (2 mM) 
in H2O;  (b) diethyl L-tartrate (100 mM) with β-CD (2 mM) in H2O; (c) diethyl L-tartrate 
(450 mM) with α-CD (20 mM) in DMSO;  (d) diethyl L-tartrate (150 mM) with β-CD 
(20 mM) in DMSO. Raw data (top) was obtained for 20 ejections with each of 5 µL of 
diethyl L-tartrate solution in H2O or with each of 10 µL of diethyl L-tartrate solution in 
DMSO; the binding curves (bottom) were obtained in best fit with binding constants and 
other thermodynamic parameters shown in the window. 
(a) (b) 
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Table 4-13. Binding constants of diethyl L-tartrate and cyclodextrin in solutions 
Host  Solvent Binding constant(K, M-1)* 
α-CD H2O 62.2±1.4 
α-CD DMSO 30.2±6.1 
β-CD H2O 39.0±1.7 
β-CD DMSO 23.6±6.9 
 
  
The binding constants between diethyl L-tartrate and cyclodextrin (α-CD or β-CD) in 
DMSO are smaller than their corresponding binding constants in H2O. Generally, these 
binding constants are very small (＜ 100 M-1)  in both H2O and DMSO. It can be 
concluded that in the solutions of H2O and DMSO, interaction between diethyl L-tartrate 
and cyclodextrin(α-CD or β-CD) is very weak. This can explain why absorption and 
VCD spectra, and optical rotation properties of dialkyl tartrate are not affected 
significantly by cyclodextrin in solution states. 
 
Conclusion 
Dialkyl tartrates show different VA and VCD spectra in the Mid IR region and 
different intrinsic rotation values in different solvents. The DFT calculations for dimethyl 
(S,S)-tartrate, a representative compound among these tartrates, were performed in 
isolated state and in different solvents. The trans COOR conformer with hydrogen 
bonding between OH and C=O groups attached to the same chiral carbon is dominant 
(population is more than 80%) for isolated dimethyl (S,S)-tartrate and the molecule in 
CCl4. The population weighted VA and VCD spectra and specific rotations for isolated 
dimethyl (S,S)-tartrate and the molecule in CCl4 correspond well with the experimental 
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spectra and intrinsic rotations in CCl4. In DMSO, dimethyl (S,S)-tartrate molecules are in 
favor of forming intermolecular hydrogen bonding with DMSO solvent molecules and  
clusters of dimethyl (S,S)-tartrate with 2 DMSO molecules were used to perform DFT 
calculation of dimethyl (S,S)-tartrate in DMSO. Based on experimental results, there are 
two dominant conformers of cluster including a Trans COOR cluster conformer and a 
Trans H one in DMSO solvent and the corresponding predicted VA and VCD spectra and 
specific rotations are in good agreement with experimental spectra and intrinsic rotations 
of dimethyl D-tartrate in DMSO solvent. 
For dialkyl tartrate-cyclodextrin complexes, cyclodextrin does not change the VA, 
VCD and intrinsic rotation properties of dialkyl tartrates significantly in the complexation 
because of weak interaction between cyclodxtrin and dialkyl tartrate molecules in the 
solution state. 
Combined use of VA, VCD, optical rotation techniques with DFT calculations is a 
powerful tool to study chiral molecules in solutions. VA, VCD and optical rotation 
techniques are also quite useful to study the effects of cyclodextins on guest molecules in 
cyclodextrin complexes. 
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CHAPTER V 
 
VIBRATIONAL CIRCULAR DICHROISM OF MATRIX ASSISTED AMINO ACID 
FILMS IN THE MID-INFRARED REGION 
 
 
Introduction 
Vibrational Circular Dichroism (VCD) is the measurement of differential absorbance 
of left and right circularly polarized light in the infrared region resulting from molecular 
vibrational transitions.1 In recent years, VCD is being used extensively for determining 
the absolute configuration and predominant conformations of chiral molecules.2   
Furthermore, VCD has also been used successfully in the conformational analysis of 
biological molecules, such as proteins, peptides, nucleic acids, and even viruses.3  
  The conformations of amino acids in aqueous solutions are of considerable interest 
owing to the role that these molecules play in the determination of structure and function 
of peptides and proteins. Nafie and coworkers4 have reported VCD spectra in the C-H 
stretching region (3100-2800 cm-1) for several amino acids in D2O.
  But in the mid 
infrared region (2000-900 cm-1), VCD spectra were reported for only two amino acids in 
aqueous solution. VCD spectra of L-alanine were reported5 by Diem in D2O in the 1700-
1500 cm-1, 1500-1250 cm-1and 1150-900 cm-1 regions; VCD spectra of L-alanine were 
also measured5 by Diem in H2O in the 1500-1250 cm
-1 and 1250-1000 cm-1 regions.  
Nafie and coworkers reported4c the VCD spectra of L-alanine in the methine bending 
region (1400-1250 cm-1) both in D2O and H2O. They have also measured
4c the VCD 
spectra of L-proline in D2O in the 1400-1250 cm
-1 region. Although the strong absorption 
of H2O in the C-H stretching and C=O stretching regions is avoided by substituting D2O 
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for H2O, Diem found
5 that in D2O, the frequencies and VCD intensities can be 
significantly altered because of the exchange of N-H protons with deuterium. 
 Nafie and coworkers adapted4a the mull sampling technique in halocarbon oil and 
reported the VCD spectra in the 3600-1900 cm-1 region for alanine and serine. They have 
also reported4d the VCD spectra for solid state samples in the mid-infrared region. 
However, a direct correlation between the solid- and solution-phase VCD data was not 
observed because of significant perturbations for crystalline samples. 
 VCD measurements in the mid-infrared region for simple amino acids in aqueous 
solution are difficult to undertake because of two reasons. First, interfering water 
absorption requires the use of high concentrations and low pathlengths; second, the 
solubilities of most simple amino acids in water at neutral pH are not sufficient enough 
for undertaking VCD measurements in solution. The interfering water absorption can be 
avoided if the measurements can be undertaken on films prepared from aqueous solutions. 
Film technique was successfully used in our laboratory to measure the VCD spectra of 
peptides6, proteins7, carbohydrates8a, nucleic acids8b and viruses3e.  VCD spectra of these 
peptide, protein, carbohydrate and nucleic acid films compared well with the 
corresponding spectra measured for aqueous solutions. Also, VCD spectra of films were 
found to have better signal to noise ratio than those of corresponding aqueous solutions.   
However, when aqueous solutions of amino acids are dried to make films, amino acids 
tend to form microcrystalline deposits which are not suitable for artifact free VCD 
measurements. For such cases, investigations in our laboratory revealed that the matrix 
assisted film formation9,8b can avoid crystalline deposits. Since different samples work 
better with different matrices, it is necessary to investigate and find a suitable matrix for 
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the samples of interest.  For amino acid films we found that α-cyclodextrin (α-CD) 
serves as a suitable matrix.  Even though α-CD provides a chiral environment, the 
interaction between α-CD and amino acids is weak10 and therefore the VCD spectra of 
parent amino acids are unlikely to be perturbed. Furthermore, α-CD is water-soluble, 
chemically stable and does not have strong interfering absorption bands in the region of 
2000-1200 cm-1.  Utilizing these advantages, we report here VCD measurements for 
matrix assisted amino acid films, with α-CD serving as the matrix to facilitate the film 
formation. Wherever possible, VCD spectra for aqueous solutions were also measured 
and compared to the film state measurements. For those amino acids whose VCD spectra 
could not be measured in solution, the absorption spectra of films and solutions are 
compared. Advantages and limitations of the film method are also discussed. 
 
Experimental 
  The samples of L-alanine, L-proline, L-methionine, DL-methionine, and L-valine 
were obtained from Mann Research Lab. L-tyrosine and DL-valine were obtained from 
Nutritional Biochemical Corp. Racemic alanine was obtained from Sigma. The remaining 
amino acids and α-cyclodextrin were obtained from Acros Chemicals. These samples 
were used as received. The amino acids studied, their solubilities11 and concentrations 
used in the present measurements are listed in Table 5-1. 
All VCD spectra were recorded on a commercial ChiralIr spectrometer (Bomem-
Biotools, Canada) modified as described previously6-9 to minimize the artifacts using the 
double polarization modulation method12. All VCD spectra were recorded at 4 cm-1 
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resolution. The data collection time was 3 hr, except for the solution state VCD spectra of 
methionine, histidine, and valine where 6 hr data collection time was used. 
  For the absorption and VCD measurements on films, stock solutions containing 
amino acid and α-CD with molar ratio of 1:1 or 2:1 were prepared. The concentration of 
α-CD in these stock solutions is between 9.7 mg/mL (0.010 M) and 48.5 mg/mL (0.050 
M). The concentration of amino acids in these stock solutions is between 1.6 mg/mL and 
11.5 mg/mL (see Table 5-1). For stock solution containing tyrosine (L or racemic) and α-
CD, the concentration of α-CD is about 0.01M but the concentration of tyrosine is much 
less than 0.01M because of low solubility of tyrosine in water at neutral pH. A portion, 
usually in the range of 100-660 µL, of stock solution (containing the desired amino acid 
and α-CD) was cast onto a 2.5 cm diameter BaF2 window. Evaporation was continued at 
room temperature in a fume hood until dry films were formed. VCD spectra were 
measured for these dried films. The absorption spectrum of α-CD film was subtracted 
from those of the films containing amino acid and α-CD. The VCD spectra of films 
containing racemic amino acid + α-CD were subtracted from the corresponding spectra 
of films containing L-amino acid and α-CD. In the case of alanine, however, the VCD 
spectra were also obtained for D-alanine + α-CD. By subtracting the VCD spectrum of 
racemic alanine + α-CD from the individual VCD spectra of L-alanine + α-CD and D-
alanine + α-CD, the required mirror image features for L-alanine and D-alanine have 
been verified.  For the amino acids investigated here, the film VCD measurements were 
repeated with different levels of absorbance (by varying the solution amount deposited) 
and the VCD features were reproduced in these measurements except for the films of L-
valine + α-CD. 
 134 
For the solution state absorption and VCD measurements, spectra were measured for 
water solutions, using either a demountable cell with ~6 (or ~15) µm spacer or a variable 
pathlength cell set to give a minimum of ~6 µm pathlength. Both cells used BaF2 
windows. The concentrations of solutions and the solution volumes used are summarized 
in Table 5-1. The absorption spectra of H2O solvent were subtracted from the 
corresponding spectra of amino acid solutions. The presented VCD spectra in H2O 
solution are the raw spectra as obtained, except for L-proline in the 1800-1550 cm-1 
region where VCD of racemic proline was subtracted. 
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Table 5-1. Amino acids, their solubilities, concentrations and volumes of stock solutions 
used for solution and film VCD studies 
Concentration and volume used for 
solution VCD studiesb 
Concentration and volume used 
for film VCD studies 
Concentration Concentration 
amino acid Solubility
a 
(g/100g, 
H2O, 25°C) 
mg/mL mol/L 
Volume 
(μL) 
mg/mL mol/L 
Volume 
(μL) 
Alaninec 16.65 151 1.7 600 1.6 0.018 400 
230 2.0 25 2.9 0.025 200 
Proline 162.30 
115 1.0 600 11.5 0.10 200 
Valinec 8.85 84 0.71 25 2.1 0.018 330 
400  
Methioninec 3.38 30 0.20 25 2.0 0.014 
660 
1.9 0.012 200 
Histidinec 4.19 40 0.26 25 
3.8 0.024 200 
100 
Phenylalaninec 2.96 28 0.17 25 4.0 0.024 
200 
160 
Tryptophanc 1.14 11 0.05 25 3.8 0.019 
420 
Tyrosined 0. 04 saturated saturated 25 saturated saturated 540 
a Solubility data was obtained from reference 11; bvariable pathlength cell with ~6 µm 
pathlength whenever 600 µL volume was used; demountable cell with ~6 or 15 µm 
spacer in other cases; cnearly saturated solutions were used for solution state VCD 
measurement; dSaturated solutions (after filtration) were used for both solution and film 
state measurements. 
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Results and discussion 
For α-CD film (Figure 5-1), its characteristic absorption originating from C-O/C-C 
stretching modes appear in the 1200-900 cm-1 region. Three major absorption bands at 
1152 cm-1, 1078 cm-1 and 1034 cm-1 can be noted for α-CD in this region. For films of L-
proline + α-CD, the absorption spectra (Figure 5-1) in the 1200-900 cm-1 region are 
similar to the corresponding spectra of α-CD film. This observation indicates that the 
absorption signals originating from proline in the 1200-900 cm-1 region are very weak 
and also that L-proline has very weak interaction with α-CD in the film state. These 
observations, illustrated in Figure 5-1 for proline as an example, also apply for other 
simple amino acids studied here, except valine. The absorption spectra of L-proline + α-
CD film are also compared to those of racemic proline + α-CD film in Figure 5-1. The 
absorption spectra of racemic amino acid + α-CD films are quite similar to the 
corresponding spectra of L-amino acid + α-CD films. For the reasons mentioned above, 
the absorption spectra of α-CD films were subtracted from those of amino acid + α-CD 
films to obtain the absorption spectra of amino acids in the film state (see Figure 5-1). 
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Figure 5-1. Absorption and VCD spectra of L-proline at lower absorption. α-CD film was 
prepared from 200 µL solution of α-CD (0.025M) in H2O; DL-proline + α-CD film was 
prepared from 200 µL solution of DL-proline + α-CD (molar ratio: 1:1, 0.025M for α-
CD) in H2O; L-proline + α-CD film was prepared from 200 µL solution of L-proline + α-
CD (molar ratio: 1:1, 0.025M for α-CD) in H2O.  
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Figure 5-2. Absorption and VCD spectra of L-proline at higher absorption. α-CD film 
was prepared from 200 µL solution of α-CD (0.050M) in H2O; DL-proline + α-CD film 
was prepared from 200 µL solution of DL-proline + α-CD (molar ratio: 2:1, 0.050M for 
α-CD) in H2O;  L-proline + α-CD film was prepared from 200 µL solution of L-proline + 
α-CD (molar ratio: 2:1, 0.050M for α-CD) in H2O.  
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From the comparison between the VCD spectra of racemic amino acid + α-CD films 
and L-amino acid + α-CD films, it is seen that the position, sign and intensities of VCD 
bands of α-CD in the region of 1200-900 cm-1 remain essentially unchanged (see Figure 
5-1 as an example). The VCD spectra of racemic amino acid + α-CD films were 
subtracted from those of L-amino acid + α-CD films to obtain the VCD spectra of L-
amino acids in the film state. Racemic amino acids are not expected to yield any VCD 
signals, and accordingly racemic amino acid + α-CD films give the same VCD patterns 
as α-CD films. The VCD spectra of racemic amino acid + α-CD films match better (than 
α-CD films) in the baseline with the corresponding VCD spectra of L-amino acid + α-
CD films. For this reason, VCD spectra of the racemic amino acid + α-CD films, instead 
of those of α-CD films, were chosen in the subtraction process to obtain the VCD spectra 
of L-amino acids. When available, VCD spectra of D-amino acid + α-CD films are better 
choices to subtract from the spectra of L-amino acid + α-CD films because this process 
can double the magnitude of the intensities of VCD bands, thereby yielding better signal 
to noise ratio. But D-amino acids are generally more expensive than racemic amino acids. 
In the present study, VCD spectra of D-amino acid + α-CD films are also measured only 
in the case of alanine (vide infra). 
A negative VCD band at 1628 cm-1, associated with the absorption band at 1622 cm-1, 
is present for L-proline in the subtracted spectrum (Figure 5-1). However, no VCD bands 
are seen in the 1550-1200 cm-1 region because of low absorption of L-proline in this 
region. To investigate the VCD signals of L-proline in the 1550-1200 cm-1 region, the 
stock solutions of higher concentration and higher molar ratio for L-proline and α-CD 
have been prepared to obtain the films. Spectra for the films of higher absorbance are 
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shown in Figure 5-2. Since the absorbance of bands in the 1200-900 cm-1 region for films 
in Figure 5-2 is above 1.5, and therefore the corresponding VCD bands are not reliable in 
this region, the spectra in Figure 5-2 are presented only in the 1800-1200 cm-1 region. 
VCD bands in the 1550-1200 cm-1 region can now be seen in the subtracted spectra. Also 
a negative-positive doublet (Figure 5-2) in the 1650-1550 cm-1 region is clearly seen in 
the subtracted VCD spectrum for L-proline.  All these VCD signals are also seen in the 
solution spectrum (vide infra). 
For alanine, the film measurements were undertaken for both of the enantiomers as 
well as the racemic mixture (Figure 5-3). As before, the absorption spectra were obtained 
by subtracting the absorption spectrum of α-CD from those of alanine + α-CD. The 
absorption spectra obtained in this manner for both enantiomers and racemic mixture of 
alanine are identical except for a small difference in the intensity of the band at 1610 cm-1. 
The VCD spectra of enantiomers of alanine were obtained by subtracting the VCD 
spectrum of racemic alanine + α-CD from that of individual enantiomer + α-CD. VCD 
spectra obtained in this manner displayed excellent mirror image features (Figure 5-3) for 
L- and D-alanine, which supports our hypothesis that interactions of amino acids with α-
CD are weak enough for not perturbing the VCD of native amino acids. VCD spectrum 
of L-alanine was also obtained (Figure 5-3) as one-half of the difference between the raw 
VCD spectra of L-alanine + α-CD and D-alanine + α-CD, which provided better signal 
to noise ratio as expected.    
Eight amino acids of different solubilities in water (Table 5-1) were chosen for the 
present study. Among the amino acids studied, L-alanine and L-proline have high enough 
solubility in H2O to obtain the VCD spectra in solution state in the 1800-1200 cm
-1 
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region (Figure 5-3). For the remaining amino acids, which have low solubility in water, 
very low absorption intensities (less than 0.10) in the 1550-1200 cm-1 region are obtained 
for saturated or nearly saturated solutions. As a result, very weak VCD bands are found 
for L-methionine, L-histidine and L-valine and no VCD bands are seen for L-
phenylalanine, and L-tryptophan in the solution measurement. For L-tyrosine, even the 
absorption spectra could not be obtained in the solution state because of extremely low 
solubility. For four amino acids, L-alanine, L-proline, L-methionine and L-histidine, 
whose VCD spectra could be measured in solution, the absorption and VCD spectra in 
the film state are compared with their corresponding spectra in the solution state (Figures 
5-3~5-4). For L-phenylalanine and L-tryptophan, whose VCD spectra could not be 
obtained in solution, the absorption spectra of films are compared to those of 
corresponding solutions (Figure 5-5). 
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Figure 5-3. Absorption and VCD spectra of films and of aqueous solutions (Left panel: 
alanine; right panel: praline). Films of L-alanine, D-alanine and DL-alanine were 
obtained respectively from their corresponding 400 µL solutions of alanine + α-CD 
(molar ratio: 1:1, 0.018M) in H2O. Films of proline for investigating the 1550-1200 cm
-1 
region are same as those described in Figure 2; for investigating the 1800-1550 cm-1 
region, films of proline were obtained from 1:1 molar ratio mixture of proline:α-CD. 
Solution spectra of L-alanine were obtained with saturated solutions using a variable 
pathlength cell (~6 µm pathlength). Solution spectra of proline in the 1800-1550 cm-1 
region were obtained at 1.0 M using a variable pathlength cell (~6 µm pathlength), and 
those in the 1550-1200 cm-1 region were obtained at 2.0 M using a demountable cell (~6 
µm path length). For alanine, expected mirror image VCD features for the enantiomers 
are shown in both film and solution states. 
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Figure 5-4. Absorption and VCD spectra of films (left panels) and of aqueous solutions 
(right panels) for L-methionine and L-histidine. The topmost traces represent the noise 
levels in the corresponding VCD spectra. Film of L-methionine was obtained from 
400µL solution of L-methionine + α-CD (0.014M) in H2O. Film of L-histidine was 
obtained from 200 µL solution of L-histidine + α-CD (0.012M) in H2O. Solution spectra 
of L-methionine and L-histidine were obtained respectively at 0.20M and 0.26M using a 
15 µm path length demountable cell. Solution VCD spectra were obtained with 6 hr data 
collection time. 
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Figure 5-5 Absorption spectra of films (top) and of aqueous solutions (bottom) for L-
phenylalanine and L-tryptophan. 100 µL solution of L-phenylalanine + α-CD (0.024M) 
and 160 µL solution of L-tryptophan + α-CD (0.019M) in H2O were used respectively to 
make the films. The solution spectra of these two amino acids were obtained from nearly 
saturated solutions (Table 1) using a demountable cell with ~15 µm path length. 
 
The 1800-1200 cm-1 region (Figure 5-3) is the common region accessible to both film 
and solution samples of L-alanine and L-proline, while the 1550-1200 cm-1 region 
(Figure 5-4) is the common region accessible to both film and solution samples of L-
methionine and L-histidine. For L-alanine, L-proline, L-methionine and L-histidine in the 
film state, films were prepared to give comparable absorption intensity with that in 
solution measurement. For each of these four amino acids, whose VCD could be 
measured in both film and solution states, the VCD patterns observed for solutions match 
with those observed for films (see Figures 5-3~5-4). These VCD patterns for L-alanine 
(Figure 5-3) in the solution state include two weak negative bands, at ~1640 and 1581 
cm-1 in the 1650-1500 cm-1 region and a positive-negative-positive pattern at 1413, 1353, 
and 1303 cm-1 in the 1450-1250 cm-1 region.  The corresponding VCD patterns for L-
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alanine (Figure 5-3) in the film state include two weak negative bands, at ~1643 and 1583 
cm-1 in the 1650-1500 cm-1 region and a positive-negative-positive pattern at 1411, 1351, 
and 1300 cm-1 in the 1450-1250 cm-1 region. Note that the negative VCD band at ~1640 
cm-1 for L-alanine in solution is dominated by noise coming from interference of water 
absorption.  For L-proline (Figure 5-3) in the solution state, the observed VCD bands 
include a negative-positive doublet at 1621 and 1573 cm-1 in the 1650-1500 cm-1 region 
and a positive-negative-positive triplet at 1422, 1393 and 1356 cm-1 in the 1450-1300 cm-
1 region and two positive bands at 1298 and 1280 cm-1 in the 1300-1250 cm-1 region. The 
corresponding bands observed for L-proline (Figure 5-3) in the film state include a 
negative-positive doublet at 1628 and 1582 cm-1 in the 1650-1500 cm-1 region and a 
positive-negative-positive triplet at 1422, 1393 and 1356 cm-1 in the 1450-1300 cm-1 
region and two positive bands at 1297 and 1279 cm-1 in the 1300-1250 cm-1 region. For 
L-methionine (Figure 5-4) in the solution state, a positive-negative VCD doublet at 1409 
and 1356 cm-1 is seen in the 1450-1300 cm-1 region, with corresponding bands in the film 
state seen at 1404 and 1355 cm-1.  For L-histidine (Figure 5-4) in the solution state a 
negative band at 1358 cm-1 is seen in the 1400-1300 cm-1 region with the corresponding 
band in the film state at 1362 cm-1. There is a small frequency shift (of 2-12 cm-1 to lower 
frequency) for band positions in the spectra of solutions compared to those in the spectra 
of films. Overall only minor differences are found in the comparison of spectra for 
solution and film samples of these amino acids. Thus the interactions between amino 
acids and α-CD in the film state are not considered significant enough to perturb the 
native VCD of amino acids.  
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For the case of L-valine, a positive VCD band at 1416 cm-1 and a negative VCD band 
at 1356 cm-1 in the ~1450-1300 cm-1 region are found in the solution measurement (not 
shown).  However, the films L-valine formed with α-CD are cloudy and artifacts were 
found in the film VCD spectra. So a comparison could not be made between solution and 
film spectra for L-valine. For L-tyrosine, both absorption and VCD spectra could not be 
obtained in the solution state because of extremely low solubility. Also, VCD spectrum 
could not be obtained for L-tyrosine in the film state, although it was possible to obtain 
its absorption spectrum (not shown) with low intensity.  
The absorption and VCD spectra in the 1800-1200 cm-1 region for L-methionine, L-
histidine, L-phenylalanine and L-tryptophan films at higher absorption intensities than 
those shown in Figures 5-4~5-5 are shown in Figure 5-6. Here higher absorption intensity 
was obtained by depositing a larger volume of the stock solution, or using a higher 
concentration solution, during the preparation of films. We have also considered the pH 
dependence as a means to improve the solubility of tyrosine, but found14 that its solubility 
remains essentially the same in the pH range of 3-11.  In the 1800-1550 cm-1 region, two 
negative VCD bands for L-tryptophan (Figure 5-6) at 1635 and 1592 cm-1, and a positive-
negative VCD couplet for L-phenylalanine at 1627 and 1587 cm-1 (Figure 6) are found.  
No VCD bands are seen in the 1800-1550 cm-1 region for L-methionine and L-histidine. 
The vibrations responsible for the amino acids in the 1800-1550 cm-1 region are the 
stretching motions of –COO-. The weak VCD intensities of amino acids in this region 
indicate that the rotational strengths of stretching modes of –COO- in amino acids are 
small. In the 1500-1200 cm-1 region, both L-phenylalanine and L-tryptophan show one 
negative VCD band each at 1336 and 1342 cm-1 respectively. A positive VCD band at 
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1328 cm-1 for L-methionine, and at 1405 cm-1 for L-histidine, which were not as clearly 
seen in the low absorption measurements (Figure 4), are clearly seen in the higher 
absorption measurements (Figure 5-6). All of the VCD bands observed for amino acid 
films are summarized in Table 5-2. 
The amount of amino acid sample used in the present measurements for obtaining 
sufficient absorption (for VCD measurements) in the film spectra is lower than that used 
for obtaining the solution-based spectra. For example, to obtain the same level of 
absorbance in solution and film studies for L-alanine, 600μL solution at a concentration 
of saturated (~151 mg/mL) solution was used for the solution measurement (which 
amounts to 90.6 mg sample) with a variable pathlength cell, while 400μL solution at a 
concentration of 1.6 mg/mL was used for the film measurement (which amounts to 0.6 
mg sample). In the case of L-proline, 600μL solution at a concentration of 115 mg/mL 
was used for the solution measurement (which amounts to 69 mg sample) with a variable 
pathlength cell, while 200μL solution at a concentration of 11.5 mg/mL was used for the 
film measurement (which amounts to 2.3 mg sample). However, a significant portion of 
the 600 µL volume used for solution measurements with variable pathlength cell is 
wasted in dead volume (those parts of the cell that light does not probe). With special 
etched cells13, the sample volume requirement can be lowered to about 5 µL and in such 
instances the amounts of sample needed for film and solution measurements become 
comparable. 
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Table 5-2. VCD bands of amino acid films in the 1800-1200 cm-1 region 
amino acid band position a ∆A/A b 
1643 -0.9 
1583 -0.6 
1411 +1.4 
1351 -1.7 
L-Alanine 
1300 +3.0 
1628 -0.6 
1582 +0.9 
1422 +0.8 
1393 -0.4 
1356 +0.7 
1297 +1.7 
L-Proline 
1279 +1.7 
1404 +1.2 
1355 -1.3 
L-methionine 
1328 +1.6 
1405 +1.0 L-histidine 
1362 -1.7 
1627 +0.4 
1587 -0.6 
L-phenylalanine 
1336 -1.6 
1635 -0.5 
1592 -0.5 
L-tryptophan 
1342 -2.9 
a Frequencies in cm-1. b The numbers listed under ∆A/A are to be multiplied by 10-4. 
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Figure 5-6. Absorption (bottom) and VCD (top) spectra of L-methionine, L-histidine L-
phenylalanine and L-trypotophan in the film state. The topmost traces represent the noise 
levels in the VCD spectra. Films were prepared from their corresponding stock solutions 
of L-amino acid + α-CD. The spectra for methionine and histidine were obtained at 
higher absorbances than those in Figure 4. 660 µL solution of L-methionine + α-CD 
(molar ratio: 1:1, 0.014M), 200 µL solution of L-histidine + α-CD (molar ratio: 1:1, 
0.024M), 200 µL solution of L-phenylalanine + α-CD (molar ratio: 1:1, 0.024M) and 420 
µL solution of L-tryptophan + α-CD (molar ratio: 1:1, 0.019M) in H2O were used 
respectively to obtain the VCD spectra of these amino acids in the film state.  
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The matrix assisted film method, with α-CD as the matrix, improves greatly the role of 
VCD technique in the chiral analysis of amino acid samples. The film method presented 
here provides practical convenience for VCD measurements, and also avoids the 
absorption interference in the 1800- 1550 cm-1 region from water solvent. Film method is 
advantageous for obtaining the VCD spectra for amino acids, even with low solubility in 
water. The film method for VCD measurement can be applied in the field of 
environmental analysis, such as detection and analysis of samples containing low level of 
amino acids.  This film method also offers a means to obtain the VCD spectra of other 
types of compounds, such as pharmaceuticals which have limited solubility in water, or 
are only available in very limited amounts. To make a successful VCD measurement with 
the matrix assisted film method, target molecules should have either no, or only weak, 
interaction with the matrix and should form a uniform amorphous film. Another 
limitation with the matrix assisted film method is that the strong absorption bands of 
matrix can limit the useful region for measuring the VCD spectra of target molecules. 
 
Conclusion 
Matrix assisted amino acid films, with α-cyclodextrin serving as the matrix, are shown 
to be useful means for obtaining their VCD spectra.  Using this film method, VCD 
spectra in the 1800-1200 cm-1 region were successfully measured for six amino acids. 
The absorption and VCD spectra for films are found to have a good correlation with the 
corresponding spectra obtained for aqueous solutions. The film method is advantageous, 
compared to the solution measurements, in obtaining the VCD spectra for amino acids in 
the mid-IR region, especially for those with low solubility in water.  The VCD spectra of 
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L-methionine, L-histidine, L-phenylalanine and L-tryptophan are reported here in the mid 
infrared region for the first time. The matrix assisted film method greatly improves the 
role of VCD spectroscopy in the analysis of amino acids with low solubility in water and 
in obtaining the structural information of amino acids. 
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CHAPTER VI 
 
EXPERIMENTAL VERIFICATION OF THE VALIDITY OF VAN’T HOFF’S 
PRINCIPLE OF OPTICAL SUPERPOSITION 
 
 
Introduction 
 In 1875, van’t Hoff referred1 to a molecule made up of two similar asymmetric groups 
and stated that the optical rotation that each of these asymmetric carbon atoms 
contributes to the whole will be equal with either the same or opposite signs. In other 
words, the optical rotation contribution from a given asymmetric carbon atom is assumed 
to be independent of the other asymmetric carbon atom in the molecule. Thus the optical 
rotation of a molecule can be visualized as the sum of contributions from individual 
chiral centers. Later, in 1894, van’t Hoff extended this assumption to molecules with 
several different asymmetric carbon atoms.2 This concept is referred to as the principle of 
optical superposition (POS).  Several researchers3-16 have either assumed, or offered 
evidence for, the validity of POS in molecules made up of two or more asymmetric 
carbon atoms.  Rosanoff6,7, however, questioned the validity of the POS. This controversy 
was attributed to the ignorance of vicinal action8. Thus the validity of POS has not yet 
been clearly established in the literature. 
One approach to test the POS is to compare the optical rotation of a given molecule with 
the sum of the optical rotations of molecules that represent the fragments of that molecule. 
Since optical rotation is influenced by experimental conditions such as concentration and 
solvent, it is necessary to use the same experimental conditions for measuring the optical 
rotations of all different molecules involved.  However, little attention was paid in the 
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past to maintain the same experimental conditions in testing or assuming the validity of 
POS. To rectify this situation we report here the first carefully designed systematic 
investigation of the POS. 
To verify the validity of the POS we have synthesized (+)-ketoconazole 1, the 
enantiomers 2 and 3 of 3,3,3-trifluoro-2-methoxy- 2-phenyl-1-piperidin-1-yl-propan-1-
one, and the epimers 4 and 5 (see figure 6-1), which are very good candidates to examine 
the POS. Compound 4 can be thought as the assembled structure from 1 and 2 while its 
epimer 5 as the assembled structure from 1 and 3. The chiral center of 2 or 3 is far away 
from chiral carbons of 1 in the assembled structure of 4 or 5. We have chosen the same 
concentration, solvent, temperature and wavelength in the optical measurements of these 
compounds. To avoid the influence of solute-solute interactions, the limiting value of 
specific rotation at zero concentration of solute, referred as the “intrinsic rotation”, was 
measured and used for the investigation of the POS.  
 
Experimental 
  Compound 1, 2, 4 and 5 were synthesized and provided by Gal group (University of 
Colorado). These compounds were characterized by MS and NMR17. Peeters reported the 
crystal structure and absolute configuration for compound 1 and 4 recently.18 
For optical rotation measurement, an Autopol IV polarimeter with a resolution of 
0.001° (reproducibility of 0.002°) and analytic balances with accuracy of 0.00001 g were 
used. Optical rotations were measured at the wavelength of 589 nm. 
Four compounds(1, 2, 4 and 5) were dissolved in CH2Cl2 to obtain original solutions 
( [c]=5mg/mL) for measurement of optical rotations. Then series of dilutions were done 
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from the original solution (dilution factor is 0.75 for compound 1 and 0.5 for compound 2, 
4 and 5). After each dilution, optical rotation was measured. Each time the solution was 
transferred to a 1.0 dm cell and optical rotation was measured three different times to 
check for consistency. The averages of these measurements were used to calculate 
specific rotation. This procedure ensured that no unusual data scatter was present in the 
measurements.   
 Based on experimental results for compound 1, 2, 4 and 5, plots of c(concentration) 
Vs. α(observed rotation) and c(concentration) Vs. [α](specific rotation) were made and 
equation fittings were performed for each case. Normal least-squares fitting is appropriate 
for α vs. c data, weighted least-squares fitting is needed for fitting the [α] vs. c data. 
Intrinsic rotation ([α]c=0 or {α}) can be obtained from these equations.  
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Figure 6-1. Structures of compounds 1-5. 
 
Results and discussion 
Optical rotations were measured for 1, 2, 4 and 5 at exactly the same experimental 
conditions: room temperature, sodium D line, and concentration of 5 mg/mL in CH2Cl2 
solvent for their original solutions. For each case, intrinsic rotation was obtained by 
measuring specific rotation as a function of finite concentration and extrapolating the date 
to zero concentration (shown in Figure 6-2).  The results of intrinsic rotations and their 
corresponding molar rotations are listed in Table 6-1. 
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Figure 6-2. Observed rotation (α589) and specific rotation ([α]589) of compound 1, 2, 4 and 
5, as a function of concentration in CH2Cl2 solutions. For compound 1, a plot of α589 
versus concentration was fit to α589 =0.0093c and [α]589 versus concentration is a constant; 
[α]589 =9.3. For compound 2, a plot of α589 versus concentration was fit to α589 =0.0826c 
and [α]589 versus concentration is a constant; [α]589 =82.6. For compound 4, a plot of α589 
versus concentration was fit to α589 =0.0452c-0.00174c
2+0.000244c3 and [α]589 versus 
concentration was fit to [α]589 =45.2-1.74c+0.244c
2. For compound 5, a plot of α589 
versus concentration was fit to α589 =-0.0308c and [α]589 versus concentration is a 
constant; [α]589 =-30.8.  
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The POS can be interpreted to suggest that, at a given wavelength λ, the intrinsic 
molar rotation {φ}λ of a given molecule is equal to the sum of molar rotations of 
fragments that constitute the chemical structure of that molecule. That is, {φ}λ 
=∑
i
{ φi}λ, where subscript { φi}λ represents intrinsic molar rotation at wavelength λ 
for ith fragment in the chemical structure of the molecule. For example, the intrinsic 
molar rotation of 4 can be viewed as the sum of those for the fragments A and B. Using 
the definition for molar rotation, {φi}λ={αi}λ x Mi/100 where {αi}λ is the intrinsic 
rotation of fragment i at wavelength λ and Mi is the molar mass of that fragment, it 
follows that, {α}λ =∑
i
{αi}λ x Mi/M where M is the molar mass of the molecule of 
interest. The intrinsic rotations of fragments cannot be measured because fragments may 
not exist as such. However the intrinsic rotation for the parent molecules of those 
fragments can be measured. A necessary condition here is that a given fragment and its 
parent molecule exist in the same conformations and possess the same chiral elements. 
For example the parent molecules for fragments A and B of 4 are 1 and 2, respectively. 
Then the intrinsic rotation of the fragment i can be cast in terms of that for its parent 
molecule p as, {αi}λ Mi= {αp} λ Mp. Thus, {α}λ =∑
p
{αp}λ x Mp/M or equivalently, 
{φ}λ =∑
p
{φp}λ. The experimental intrinsic optical rotations and those determined with 
the POS at 589 nm are summarized in table 6-1. For compounds 4 and 5, the differences 
between the values predicted with the POS and the experimental values are found to be 
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less than 10%. This observation supports the validity of the POS for the molecules 
investigated. 
 
Table 6-1 Comparison of the experimental rotations with those predicted with the 
principle of optical superposition  
 Experimental  Predictedb  
 intrinsic 
rotation 
{α}D(obs.) 
intrinsic 
Molar 
rotation 
{φ}D(obs.) 
intrinsic 
rotation 
{α}D(calc.) 
intrinsic 
Molar 
rotation 
{φ}D(calc.) 
Error(%)b 
1
a 9.3 49.42    
2 82.6 248.88    
4 45.2 318.9 42.3 298.3 6.5 
5 -30.8 -217.31 -28.3 -199.5 8.2 
amolar masses of compounds 1, 2, 4 and 5 are, respectively, 531.44, 301.31, 705.56 and 705.56. 
b{α}D (calc.) of compound 4=(M1/M4)*{α1}D + (M2/M4)* {α2}D; similarly, {α}D (calc.) of compound 5 = 
(M1/M5)*{α1}D -(M2/M5)* {α2}D ; {φ}D (calc.) of compound 4={ φ 1}D +{ φ 2}D; {φ}D (calc.) of compound 
5={ φ 1}D -{ φ 2}D;  fragments A and B of compound 4 are shown in figure 6-3. 
cerror (%) = 100% * ((obs.) - (calc.))/ (obs.) 
 
 
Figure 6-3. Two fragments of compound 4.
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Conclusion 
van’t Hoff’s principle of optical superposition (POS) was examined in a more careful 
and scientific way using using compounds 1, 2, 4 and 5. The same experimental 
conditions were used for optical rotation measurements in all cases. By comparison 
between calculated molar rotations or intrinsic rotations based on the POS and their 
corresponding experimental values in both cases of 4 and 5, it can be concluded that the 
POS is valid. And the POS will enable optical rotation technique to play more 
important roles in stereochemical analysis, especially in determination of absolute 
configuration of chiral centers in molecules. 
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APPENDIX A 
 
MASS SPETRA 
 
High resolution mass spectra of compounds 1, 2, 4, and 5 in chapter VI were acquired 
at Vanderbilt University using a 4700 Proteomics Analyzer (Applied Biosystems, 
Framingham, MA) equipped with a Nd:Yag laser operating in reflector mode. 
The compounds were mixed in equal parts with internal standards (10 pmol each of 
tubocuranine (MW=610.3) and the peptide AcGGGGKGGGR (MW=743.3) and the 
MALDI matrix, 2,5-dihydroxybenzoic acid (10mg/mL in 50:50:0.1 
Acetonitrile/water/TFA). A 10 pmol aliquot of compounds 1, 4 and 5 were analyzed and 
a 100 pmol aliquot of compound 2. 
Each sample was analyzed using 12 independent measurements. The resulting spectra 
were smoothed (Gaussian, 5pt), internally calibrated, and the peak of interest used for 
statistical analysis. The results are shown in the following: 
  Compound 1 Compound 2 Compound 4 Compound 5 
Theoretical mass 531.156  302.1362 705.1853 705.1853 
Experimental 531.1544 302.1333 705.1856 705.186 
  ± 0.0024 ± 0.0032 ± 0.0037 ± 0.0042 
  -3.0311245ppm -9.6976122ppm 0.4254201 ppm 0.9926469ppm 
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Figure A-1. Mass spectrum of Compound 1.
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Figure A-2. Mass spectrum of Compound 2. 
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Figure A-3. Mass spectrum of Compound 4.
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Figure A-4. Mass spectrum of Compound 5. 
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APPENDIX B 
 
NMR SPECTRA 
 
Proton NMR spectra of compounds 1, 2, 4, and 5  in CHAPTER VI at the 
concentration of 1mg/mL in CDCl3 were acquired at Vanderbilt University using 300 
MHz Bruker Spectrometer.  
 
 
 
 
Figure B-1. NMR spectrum of Compound 1.
 168 
 
 
 
Figure B-2. NMR spectrum of Compound 2.
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Figure B-3. NMR spectrum of Compound 4.
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Figure B-4. NMR spectrum of Compound 5  
 
